U.S. patent number RE48,345 [Application Number 15/241,733] was granted by the patent office on 2020-12-08 for compositions and methods for inhibiting gene expression of hepatitis b virus.
This patent grant is currently assigned to Arrowhead Pharmaceuticals Inc.. The grantee listed for this patent is Arrowhead Pharmaceuticals, Inc.. Invention is credited to Daniel J. Chin, Jochen Deckert, Markus Hossbach, Matthias John.
View All Diagrams
United States Patent |
RE48,345 |
Chin , et al. |
December 8, 2020 |
Compositions and methods for inhibiting gene expression of
hepatitis B virus
Abstract
The invention relates to a double-stranded ribonucleic acid
(dsRNA) for inhibiting the expression of a Hepatitis B Virus gene.
The invention also relates to a pharmaceutical composition
comprising the dsRNA or nucleic acid molecules or vectors encoding
the same together with a pharmaceutically acceptable carrier;
methods for treating diseases caused by Hepatitis B Virus infection
using said pharmaceutical composition; and methods for inhibiting
the expression of a Hepatitis B Virus gene in a cell.
Inventors: |
Chin; Daniel J. (Foster City,
CA), Deckert; Jochen (Kulmbach, DE), Hossbach;
Markus (Kulmbach, DE), John; Matthias (Hallstadt,
DE) |
Applicant: |
Name |
City |
State |
Country |
Type |
Arrowhead Pharmaceuticals, Inc. |
Pasadena |
CA |
US |
|
|
Assignee: |
Arrowhead Pharmaceuticals Inc.
(Pasadena, CA)
|
Family
ID: |
1000003852640 |
Appl.
No.: |
15/241,733 |
Filed: |
August 19, 2016 |
Related U.S. Patent Documents
|
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
Issue Date |
|
Reissue of: |
13535454 |
Jun 28, 2012 |
8809293 |
Aug 19, 2014 |
|
|
Foreign Application Priority Data
|
|
|
|
|
Jun 30, 2011 [EP] |
|
|
11172235 |
|
Current U.S.
Class: |
1/1 |
Current CPC
Class: |
A61P
1/16 (20180101); A61P 35/00 (20180101); C12N
15/1131 (20130101); A61K 31/713 (20130101); A61P
29/00 (20180101); A61P 31/12 (20180101); A61K
31/713 (20130101); A61P 31/20 (20180101); C12N
15/1131 (20130101); A61K 31/713 (20130101); A61K
31/713 (20130101); A61K 2300/00 (20130101); A61K
2300/00 (20130101); C12N 2310/315 (20130101); C12N
2310/335 (20130101); C12N 2310/335 (20130101); C12N
2310/14 (20130101); C12N 2310/14 (20130101); C12N
2310/321 (20130101); C12N 2310/3521 (20130101); C12N
2310/321 (20130101); C12N 2310/3521 (20130101); C12N
2310/315 (20130101) |
Current International
Class: |
C12N
15/11 (20060101); A61K 48/00 (20060101); C07H
21/02 (20060101); C12N 15/113 (20100101); A61K
31/713 (20060101); C07H 21/04 (20060101) |
References Cited
[Referenced By]
U.S. Patent Documents
Foreign Patent Documents
|
|
|
|
|
|
|
101426912 |
|
May 2009 |
|
CN |
|
101948834 |
|
Jan 2011 |
|
CN |
|
1752536 |
|
Feb 2007 |
|
EP |
|
1752536 |
|
Feb 2007 |
|
EP |
|
1560840 |
|
May 2015 |
|
EP |
|
1931781 |
|
Jul 2016 |
|
EP |
|
3218487 |
|
Sep 2017 |
|
EP |
|
H10510435 |
|
Oct 1998 |
|
JP |
|
10-2007-0110135 |
|
Nov 2007 |
|
KR |
|
2418068 |
|
May 2011 |
|
RU |
|
I659040 |
|
May 2019 |
|
TW |
|
91/06309 |
|
May 1991 |
|
WO |
|
1991006309 |
|
May 1991 |
|
WO |
|
93/07883 |
|
Apr 1993 |
|
WO |
|
1993007883 |
|
Apr 1993 |
|
WO |
|
WO-1996/39502 |
|
Dec 1996 |
|
WO |
|
00/22113 |
|
Apr 2000 |
|
WO |
|
2000022113 |
|
Apr 2000 |
|
WO |
|
00/31105 |
|
Jun 2000 |
|
WO |
|
2000031105 |
|
Jun 2000 |
|
WO |
|
WO02081494 |
|
Oct 2002 |
|
WO |
|
03/020931 |
|
Mar 2003 |
|
WO |
|
2003020931 |
|
Mar 2003 |
|
WO |
|
2005/065719 |
|
Jul 2005 |
|
WO |
|
2005065719 |
|
Jul 2005 |
|
WO |
|
2005/116204 |
|
Dec 2005 |
|
WO |
|
WO-2005/116204 |
|
Dec 2005 |
|
WO |
|
2006/017932 |
|
Feb 2006 |
|
WO |
|
2006017932 |
|
Feb 2006 |
|
WO |
|
WO-2006/096018 |
|
Sep 2006 |
|
WO |
|
2007022369 |
|
Feb 2007 |
|
WO |
|
WO2009038266 |
|
Mar 2009 |
|
WO |
|
2010/135322 |
|
Nov 2010 |
|
WO |
|
2010135322 |
|
Nov 2010 |
|
WO |
|
2011/003780 |
|
Jan 2011 |
|
WO |
|
2011003780 |
|
Jan 2011 |
|
WO |
|
WO-2011/073218 |
|
Jun 2011 |
|
WO |
|
WO2011148193 |
|
Dec 2011 |
|
WO |
|
WO 2012/024170 |
|
Feb 2012 |
|
WO |
|
WO2013003520 |
|
Jan 2013 |
|
WO |
|
WO2013159109 |
|
Oct 2013 |
|
WO |
|
WO2013176772 |
|
Nov 2013 |
|
WO |
|
WO2014037377 |
|
Mar 2014 |
|
WO |
|
WO2015050871 |
|
Apr 2015 |
|
WO |
|
WO2016057893 |
|
May 2016 |
|
WO |
|
WO2016077321 |
|
May 2016 |
|
WO |
|
WO2016077349 |
|
May 2016 |
|
WO |
|
WO2017015175 |
|
Jan 2017 |
|
WO |
|
WO2017019891 |
|
Feb 2017 |
|
WO |
|
WO2017027350 |
|
Feb 2017 |
|
WO |
|
WO2018027106 |
|
Feb 2018 |
|
WO |
|
WO2018044350 |
|
Mar 2018 |
|
WO |
|
Other References
"Oligo Calc" http://biotools.nubic.northwestern.edu/OligoCalc.html
(accessed Dec. 15, 2017). cited by examiner .
Chen et al. "RNAi for Treating Hepatitis B Viral Infection"
Pharmaceutical Research, vol. 25, No. 1, pp. 72-86, Jan. 2008.
cited by examiner .
Ortigau et al. "Antisense Effect of Oligodeoxynucleotides with
Inverted Terminal Intemucleotidic Linkages: A Minimal Modification
Protecting against Nucleolytic Degradation" Antisense Research and
Development 2:129-146 (1992). cited by examiner .
Elbashir et al. "Functional anatomy of siRNAs for mediating
efficient RNAi in Drosophila melanogaster embryo lysate" EMBO
Journal vol. 20 No. 23 pp. 6877-6888, 2001. cited by examiner .
Reynolds et al. "Rational siRNA design for RNA.interference" Nature
Biotechnology vol. 22 No. 3 pp. 326-330 Mar. 2004. cited by
examiner .
Wooddell, et al.; "Hepatocyte--targeted RNAi Therapeutics for the
Treatment of Chronic Hepatitis B Virus infection"; Molecular
Therapy; vol. 21; No. 5; pp. 973-985; (2013). cited by applicant
.
Notice of First Office Action for corresponding China Application
201280031939.3 dated Dec. 3, 2014. cited by applicant .
Notice on the Second Office Action for corresponding China
Application 201280031939.3 dated Aug. 24, 2015. cited by applicant
.
Notice of Reasons for Rejection for corresponding Japanese Patent
Application No. 2014-518986 dated Feb. 24, 2016. cited by applicant
.
Office Action for corresponding Taiwan Patent Application No.
101123338 dated Mar. 4, 2016. cited by applicant .
Zhang, Y-L et al "RNA Interference inhibits hepatitis B virus of
different genotypes in vitro and in vivo." BMC Microbial. 2010,
vol. 10:214, p. 1-10. cited by applicant .
Cone RD et al., "High-efficiency gene transfer into mammalian
cells: Generation of helper-free recombinant retrovirus with broad
mammalian host range," Proc. Nall. Acad. Sci. USA (1984) 81:
6349-6353. cited by applicant .
Crooke et al., "Pharmacokinetic Properties of Several Novel
Oligonucleolide Analogs in Mice." J. Pharmacal. Exp. Ther. (1996),
277: 923-927. cited by applicant .
Hamm ML et al., "Incorporation of 2'-Deoxy-2'-mercaptocy1idine into
Oligonucleotides via Phosphoramidite Chemistry," J. Org. Chem.
(1997) 62: 3415-3420. cited by applicant .
Kabanov et al., "A new class of antivirals; antisense
oligonucleotides combined with a hydrophobic substituent
effectively inhibit influenza virus reproduction and synthesis of
virus-specific proteins in MOCK cells," FEBS Lett. (1990) 259:
327-330. cited by applicant .
Oberhauser et al., "Effective Incorporation of
2''-0-methyl-oligoribonucleotides Into Liposomes and Enhanced Cell
Association Through Modification with Thiocholesterol," Nucl. Acids
Research (1992) 20: 533-538. cited by applicant .
Samukov VV et al., "2-(4-Nitrophenyl)sulfonylethoxycarbonyl (Nsc)
Group as a Base-Labile a-Amino Protection for Solid Phase Peptide
Synthesis," Tetrahedron Letters (1994) 35(42): 7821-7824. cited by
applicant .
Genbank Accession No. AP007263; (2005). cited by applicant .
Genbank Accession No. AB602818; (2011). cited by applicant .
Genbank Accession No. AB644286; (2012). cited by applicant .
Genbank Accession No. AB554024; (2011). cited by applicant .
First Substantive Examination Report for corresponding Israeli
Patent Application No. 230226 dated Nov. 7, 2016. cited by
applicant .
Search Report for corresponding Eurasian Application No. 201690497
dated Aug. 12, 2016. cited by applicant .
English translation of the Notification of Reasons for Refusal
issued in corresponding JP Patent Application No. 2014-518986 dated
Jun. 8, 2017, 8 pages. cited by applicant .
English translation of the Notice of Reasons for Rejection, issued
in Japanese Patent Application No. 2017-073870, dated Apr. 26,
2018, 10 pages. cited by applicant .
Kurreck, "siRNA Efficiency: Structure or Sequence--That Is The
Question," Journal of Biomedicine and Biotechnology, vol. 2006, pp.
1-7, 2006. cited by applicant .
Zhang, Ya-Li et al., "RNA Interference inhibits Hepatitis B Virus
of different genotypes in Vitro and in Vivo," BMC Microbiology,
vol. 10:214, 2010. cited by applicant .
Chen, Z. et al. (Apr. 2005; e-pub. Mar. 20, 2005). "Combination of
Small Interfering RNAs Mediates Greater Inhibition of Human
Hepatitis B Virus Replication and Antigen Expression," Journal of
Zhejiang University 6B(4):236-241. cited by applicant .
Muzyczka, N. (1992). "Use of Adeno-Associated Virus as a General
Transduction Vector for Mammalian Cells," in Current Topics in
Microbiology and Immunology, Springer-Verlag, Berlin, Heidelberg,
158:97-129. cited by applicant .
Tei, K. et al.(Oct. 1, 2006). "Q&A Regarding Selection of siRNA
Sequences," Chapter 4 in Jikken Naruhodo Q&A, Yodosha Co.,
Ltd., pp. 91-93, English translation provided. cited by applicant
.
Australian Office Action dated Oct. 11, 2018 for AU Application No.
2017210563 filed on Aug. 3, 2017, 3 pages. cited by applicant .
Chinese Office Action dated Oct. 8, 2018 for Chinese Application
No. 201610903171.4 filed on Oct. 17, 2016, 6 pages. cited by
applicant .
Eurasian Office Action dated Jul. 5, 2018 for Eurasian Application
No. 201690497 filed on Mar. 28, 2016, 2 pages. cited by applicant
.
European Search Report dated Nov. 21, 2018 (Partial) for EP
Application No. 18187709.3 filed on Aug. 7, 2018, 12 pages. cited
by applicant .
European Search Report dated Mar. 21, 2019 (Extended) for EP
Application No. 18187709.3 filed on Aug. 7, 2018, 13 pages. cited
by applicant .
European Search Report dated Nov. 10, 2014 for EP Application No.
12804876.6 filed on Jun. 28, 2012, 6 pages. cited by applicant
.
International Search Report and Written Opinion dated Sep. 24, 2019
for PCT Application No. PCT/US2012/044505 filed Jun. 28, 2012, 10
pages. cited by applicant .
Israeli Office Action dated Jul. 29, 2018 for corresponding Israeli
Patent Application No. 230226, filed on Feb. 27, 2014, 5 pages.
cited by applicant .
Korean Office Action dated Aug. 16, 2018 for KR Application No.
10-2013-7031029 filed on Nov. 22, 2013, 9 pages. cited by applicant
.
Taiwanese Notice of Allowance dated Dec. 6, 2018 for Taiwanese
Patent Application No. 101123338 filed on Jun. 28, 2012, 5 pages.
cited by applicant .
Australian Notice of Allowance dated Sep. 30, 2019 for AU
Application No. 2017210563 filed on Aug. 3, 2017, 3 pages. cited by
applicant .
Canadian Notice of Allowance dated May 27, 2019, for Canadian
Application No. 2,833,778, 1 page. cited by applicant .
Eurasian Office Action dated Sep. 10, 2019 for Eurasian Application
No. 201690497 filed on Mar. 28, 2016, 3 pages. cited by applicant
.
Indian Office Action dated May 24, 2019 for IN Application No.
9755/DELNP/2013 filed on Nov. 12, 2013, 7 pages. cited by applicant
.
Israeli Notice of Acceptance dated Aug. 26, 2019 for corresponding
Israeli Patent Application No. 230226, filed on Feb. 27, 2014, 6
pages. cited by applicant .
Korean Notice of Allowance dated Jun. 20, 2019 for KR Application
No. 10-2013-7031029 filed on Nov. 22, 2013, 4 pages. cited by
applicant .
Eurasian Notice of Allowance dated Jan. 10, 2020, for Eurasian
Application No. 201690497 filed on Mar. 28, 2016, 4 pages. cited by
applicant .
Korean Office Action dated Jan. 10, 2020, for KR Application No.
10-2019-7027444 filed on Sep. 19, 2019, 12 pages. cited by
applicant .
Ambardekar, V et al. (Feb. 2011). "The Modification of siRNA With
3' Cholesterol to Increase Nuclease Protection and Suppression of
Native mRNA by Select siRNA Polyplexes," Biomaterials
32(5):1404-1411. cited by applicant .
Haraszti, R.A. et al. (Aug. 2018). "Optimized Cholesterol-SiRNA
Chemistry Improves Productive Loading onto Extracellular Vesicles,"
Molecular Therapy 26(8):1973-1982. cited by applicant .
Taiwanese Notice of Allowance dated Feb. 10, 2020 for Taiwanese
Patent Application No. 106137891 filed on Jun. 28, 2012, 9 pages.
cited by applicant .
Canadian Examination Report dated Jul. 17, 2020, for Canadian
Application No. 2,833,778, 4 pages. cited by applicant .
Korean Office Action dated Jul. 16, 2020, for KR Application No.
10-2019-7027444 filed on Sep. 19, 2019, 5 pages. cited by applicant
.
Elbashir et al. (The EMBO Journal, 2001 vol. 20, No. 23:6877-6888).
cited by examiner .
Akhtar S et al., "Nonviral delivery of synthetic siRNAs in vivo,"
Journal of Clinical Investigation (2007) 117: 3623-3632. cited by
applicant .
Atherton E et al., "The Fluorenylmethoxycarbonyl Amino Protecting
Group" The Peptides, S. Udenfriend, J. Meienhofer, Eds., Academic
Press, Inc. (1987) 9: 1-38. cited by applicant .
Berkner KL et al., "Development of adenovirus vectors for the
expression of heterologous genes," BioTechniques (1988) 6: 616-629.
cited by applicant .
Bucchini D et al., "Pancreatic expression of human insulin gene in
transgenic mice," Proc. Natl. Acad. Sci. USA (1986) 83: 2511-2515.
cited by applicant .
Cook PD, "Medicinal Chemistry of Antisense Oligonucleotides-Future
Opportunities." Anti-Cancer Drug Design (1991) 6: 585-607. cited by
applicant .
Chen S-H et al. "Gene therapy for brain tumors: Regression of
experimental gliomas by adenovirus-mediated gene transfer in vivo,"
Proc. Natl. Acad. Sci. USA (1994) 91: 3054-3057. cited by applicant
.
Cone RD et al., "High-efficiency gene transfer into mammalian
cells: Generation of helper-free recombinant retrovirus with broad
mammalian host range," Proc. Natl. Acad. Sci. USA (1984) 81:
6349-6353. cited by applicant .
Cornetta K et al., "Safety issues related to retroviral-mediated
gene transfer in humans," Human Gene Therapy (1991) 2: 5-14. cited
by applicant .
Crooke et al., "Pharmacokinetic Properties of Several Novel
Oligonucleotide Analogs in Mice." J. Pharmacal. Exp. Ther. (1996),
277: 923-927. cited by applicant .
Danos O et al., "Safe and efficient generation of recombinant
retroviruses with amphotropic and ecotropic host ranges," Proc.
Natl. Acad. Sci. USA (1988) 85: 6460-6464. cited by applicant .
Delgado C et al., "The Uses and Properties of PEG-Linked Proteins,"
Critical Reviews in Therapeutic Drug Carrier Systems (1992) 9(3,4):
249-304. cited by applicant .
Docherty K et al., "Nutrient regulation of insulin gene
expression," FASEB J. (1994) 8:20-24. cited by applicant .
Englisch U et al., "Chemically Modified Oligonucleotides as Probes
and Inhibitors," Angewandte Chemie, International Edition (1991)
30(6): 613-629. cited by applicant .
Gassmann M et al., "Maintenance of an extrachromosomal plasmid
vector in mouse embryonic stem cells," Proc. Natl. Acad. Sci. USA
(1995) 92: 1292-1296. cited by applicant .
Kroschwitz JL, "Monomers," Encyclopedia of Polymer Science and
Engineering, John Wiley & Sons, New York, pp. 715-727. cited by
applicant .
Greene et al. Protective Groups in Organic Synthesis, Chapter 2, 2d
ed., John Wiley & Sons, New York, 1991, and Oligonucleotides
and Analogues a Practical Approach, Ekstein, F. Ed., IRL Press,
N.Y, 1991. cited by applicant .
Guzaev AP et al., "A Conformationally Preorganized Universal Solid
Support for Efficient Oligonucleotide Synthesis," J. Am. Chem. Soc.
(2003) 125: 2380-2381. cited by applicant .
Hamm ML et al., "Incorporation of 2'-Deoxy-2'-mercaptocytidine into
Oligonucleotides via Phosphoramidite Chemistry," J. Org. Chem.
(1997) 62: 3415-3420. cited by applicant .
Hsu K-HL et al., "Immunogenicity of Recombinant
Adenovirus-Respiratory Syncytial Virus Vaccines with Adenovirus
Types 4, 5, and 7 Vectors in Dogs and a Chimpanzee," J. Infectious
Disease, (1992) 166: 769-775. cited by applicant .
Kabanov et al., "A new class of antivirals; antisense
oligonucleotides combined with a hydrophobic substituent
effectively inhibit influenza virus reproduction and synthesis of
virus-specific proteins in MDCK cells," FEBS Lett. (1990) 259:
327-330. cited by applicant .
Letsinger RL et al., "Cholesteryl-conjugated oligonucleotides:
Synthesis, properties, and activity as inhibitors of replication of
human immunodeficiency virus in cell culture," Proc. NatL Acad.
Sci. USA (1989) 85: 5553-5556. cited by applicant .
Li S et al., "Folate-Mediated Targeting of Antisense
Oligodeoxynucleotides to Ovarian Cancer Cells," Pharmaceutical
Research (1998) 15(10): 1540-1545. cited by applicant .
Manoharan M et al., "Chemical Modifications to Improve Uptake and
Bioavailability of Antisense Oligonucleotides," Ann. N.Y. Acad.
Sci. (1992) 660: 306-309. cited by applicant .
Manoharan M et al., "Introduction of a Lipophilic Thioether Tether
in the Minor Groove of Nucleic Acids for Antisense Applications,"
Bioorg. & Med. Chem. Letters (1993) 3: 2765-2770. cited by
applicant .
Manoharan Met al., "Cholic Acid-Oligonucleotide Conjugates for
Antisense Applications," Bioorg. Med. & Chem. Lett. (1994) 4:
1053-1060. cited by applicant .
Manoharan M et al., "Oligonucleotide Conjugates: Alteration of the
Pharmacokinetic Properties of Antisense Agents," Nucleosides &
Nucleotides (1995) 14: 969-973. cited by applicant .
Manoharan M et al., "Lipidic Nucleic Acids," Tetrahedron Letters
(1995) 36: 3651-3654. cited by applicant .
Manoharan M, "Oligonucleotide Conjugates as Potential Antisense
Drugs with Improved Uptake, Biodistribution, Targeted Delivery, and
Mechanism of Action," Antisense & Nucleic Acid Drug Devel.
(2002) 12: 103-128. cited by applicant .
Mishra RK et al., "Improved leishmanicidal effect of
phosphorothioate antisense oligonucleotides by LDL-mediated
delivery," Biochim. et Biophysica Acta (1995) 1264: 229-237. cited
by applicant .
Nawrot B et al., "Chemical and Structural Diversity of siRNA
Molecules," Current Topics in Medicinal Chemistry (2006) 6:
913-925. cited by applicant .
Nguyen T et al., "RNAi therapeutics: an update on delivery."
Current Opinion in Molecular Therapeutics (2008) 10(2): 158-167.
cited by applicant .
Oberhauser et al., "Effective Incorporation of
2'-O-methyl-oligoribonucleotides Into Liposomes and Enhanced Cell
Association Through Modification with Thiocholesterol," Nucl. Acids
Research (1992) 20: 533-538. cited by applicant .
Polushin NN et al., "Synthesis of Oligonucleotides Containing
2'-Azido- and 2'-Amino-2'-deoxyuridine Using Phosphotriester
Chemistry," Tetrahedron Letters (1996) 37(19): 3227-3230. cited by
applicant .
Rosenfeld MA et al., "Adenovirus-mediated transfer of a recombinant
alpha 1-antitrypsin gene to the lung epithelium in vivo," Science
(1991) 252: 431-434. cited by applicant .
Saison-Behmoaras et al., "Short Modified Antisense Oligonucleotides
Directed Against Ha-ras Point Mutation Induce Selective Cleavage of
the mRNA and Inhibit T24 Cells Proliferation," The EMBO Journal
(1991) 10: 1111-1118. cited by applicant .
Samukov VV et al., "2-(4-Nitrophenyl)sulfonylethoxycarbonyl (Nsc)
Group as a Base-Labile .alpha.-Amino Protection for Solid Phase
Peptide Synthesis," Tetrahedron Letters (1994) 35(42): 7821-7824.
cited by applicant .
Shea et al., "Synthesis, Hybridization Properties and Antiviral
Activity of Lipid-oligodeoxynucleotide Conjugates," Nucl. Acids
Research (1990) 18: 3777-3783. cited by applicant .
Svinarchuk et al, "Inhibition of HIV proliferation in MT-4 cells by
antisense oligonucleotide conjugated to lipophilic groups,"
Biochimie (1993) 75: 49-54. cited by applicant .
Thomson JB et al., "Synthesis and Properties of Diuridine Phosphate
Analogues Containing Thio and Amino Modifications," J. Org. Chem.
(1996) 61: 6273-6281. cited by applicant .
Wagner RW, "The state of the art in antisense research." Nature
Medicine (1995) 1(11): 1116-1118. cited by applicant .
Williams DJ et al., "Thermodynamic Comparison of the Salt
Dependence of Natural RNA Hairpins and RNA Hairpins with
Non-Nucleotide Spacers," Biochemistry (1996) 35: 14665-14670. cited
by applicant .
Zamboni, "Liposomal, Nanoparticle, and Conjugated Formulations of
Anticancer Agents," Clin. Cancer Res. (2005) 11: 8230-8234. cited
by applicant .
Ikeda et al., "Ligand-Targeting Delivery of Therapeutic siRNA,"
Pharmaceutical Research (2006) 23: 1631-1640. cited by applicant
.
Rosenfeld MA et al., "In vivo transfer of the human cystic fibrosis
transmembrane conductance regulator gene to the airway epithelium"
Cell (1992) 68(1): 143-155. cited by applicant .
Sanghvi, Antisense Research and Applications, (1993) Chapter 15, p.
289-302, Crooke ST and Lebleu B ed., CRC Press. cited by applicant
.
Genbank Accession Nos. AP007263, AB 602818, AB644286, and AB554024.
cited by applicant .
Zhang, Y-L et al "RNA Interference inhibits hepatitis B virus of
different genotypes in vitro and in vivo." BMC Microbiol. 2010,
vol. 10:214, p. 1-10. cited by applicant.
|
Primary Examiner: Cambell; Bruce R
Attorney, Agent or Firm: Morrison & Foerster LLP
Claims
The invention claimed is:
1. A double-stranded ribonucleic acid molecule capable of
inhibiting the expression of a Hepatitis B Virus gene in vitro
wherein said double-stranded ribonucleic acid molecule comprises a
sense strand comprising.Iadd., .Iaddend.in order.Iadd.,
.Iaddend.nucleotides 1-19 of SEQ ID 2.[.,.]. or 6 and an antisense
strand at least partially complementary to the sense strand,
wherein said sense strand and said antisense strand are each less
than 30 nucleotides in length.
2. The double-stranded ribonucleic acid molecule of claim 1,
wherein said antisense strand comprises in order nucleotides 1-19
of SEQ ID 158 or 163.
3. The double-stranded ribonucleic acid molecule of claim 2,
wherein said double-stranded ribonucleic acid molecule comprises
sequence pairs selected from the group consisting of SEQ ID NOs:
2/158 and 6/163.
4. The double-stranded ribonucleic acid molecule of claim 1,
wherein the sense strand or the antisense strand further comprises
a 3' overhang of 1-5 nucleotides in length.
5. The double-stranded ribonucleic acid molecule of claim 4,
wherein the 3' overhang of the antisense strand comprises uracil or
nucleotides which are complementary to the pregenomic RNA and/or
the mRNA encoding the protein necessary for replication or
pathogenesis of Hepatitis B Virus.
6. The double-stranded ribonucleic acid molecule of claim 4.Iadd.,
.Iaddend.wherein the 3' overhang of the sense strand comprises
uracil or nucleotides .[.which.]. .Iadd.that .Iaddend.are identical
to the pregenomic RNA and/or the mRNA encoding the protein
necessary for replication or pathogenesis of Hepatitis B Virus.
7. The double-stranded ribonucleic acid molecule of claim 1,
wherein said double-stranded ribonucleic acid molecule comprises at
least one modified nucleotide selected from the group consisting
of: 2'-O-methyl modified nucleotide, nucleotide comprising a
5'-phosphorothioate group, terminal nucleotide linked to a
cholesteryl derivative, terminal nucleotide linked to a dodecanoic
acid bisdecylamide group, 2'-deoxy- 2'-fluoro modified nucleotide,
.[.2-deoxy-nucleotide.]. .Iadd.2'-deoxy-nucleotide.Iaddend., locked
nucleotide, abasic nucleotide, deoxythymidine, inverted
deoxythymidine, 2'-amino-modified nucleotide, 2'-alkyl-modified
nucleotide, morpholino nucleotide, phosphoramidate, and non-natural
base comprising nucleotide.
8. The double-stranded ribonucleic acid molecule of claim 7,
wherein said double-stranded ribonucleic acid molecule contains a
2'-O-methyl modified nucleotide, a nucleotide comprising a
.[.5'-phosphomthioate.]. .Iadd.5'-phosphorothioate .Iaddend.group,
and a deoxythymidine.
9. The double-stranded ribonucleic acid molecule of claim 8,
wherein said sense strand or said antisense strand .Iadd.further
.Iaddend.comprises an overhang of 1-2 deoxythymidines.
10. The double-stranded ribonucleic acid molecule of claim 9,
wherein said double-stranded ribonucleic acid molecule comprises
.[.the sequence pairs.]. .Iadd.a sequence pair .Iaddend.selected
from the group consisting of SEQ ID NOs: 322/486 and 327/491.
11. The double-stranded ribonucleic acid molecule of claim 1.Iadd.,
.Iaddend.wherein said double-stranded ribonucleic acid molecule
comprises a nucleic acid sequence encoding said sense strand or
said antisense strand.
12. A pharmaceutical composition comprising: a) .Iadd.a
.Iaddend.first and .Iadd.a .Iaddend.second double-stranded
ribonucleic acid molecules each as defined in claim 1; b) at least
one nucleic acid sequence encoding sense strands or antisense
strands comprising .Iadd.a .Iaddend.first and .Iadd.a
.Iaddend.second double-stranded ribonucleic acid molecules each as
defined in claim 1; or, c) a cell, tissue or non-human organism
comprising .Iadd.a .Iaddend.first and .Iadd.a .Iaddend.second
double-stranded ribonucleic acid molecules each as defined in claim
1.
13. .[.The.]. .Iadd.A .Iaddend.pharmaceutical composition .[.of
claim 12 wherein.]. .Iadd.comprising.Iaddend.: a) .[.said.].
.Iadd.a .Iaddend.first .[.double stranded.]. .Iadd.double-stranded
.Iaddend.ribonucleic acid .[.has.]. .Iadd.comprising .Iaddend.a
sense strand comprising.Iadd., .Iaddend.in order.Iadd.,
.Iaddend.nucleotides 1-19 of SEQ ID .Iadd.NO: .Iaddend.2 and
.[.said.]. .Iadd.a .Iaddend.second double-stranded ribonucleic acid
.[.has.]. .Iadd.comprising .Iaddend.a sense strand
comprising.Iadd., .Iaddend.in order.Iadd., .Iaddend.nucleotides
1-19 of SEQ ID .Iadd.NO: .Iaddend.4 or 6.Iadd.; .Iaddend.or b)
.[.said.]. .Iadd.a .Iaddend.first .[.double stranded.].
.Iadd.double-stranded .Iaddend.ribonucleic acid .[.has.].
.Iadd.comprising .Iaddend.a sense strand comprising.Iadd.,
.Iaddend.in order.Iadd., .Iaddend.nucleotides 1-19 of SEQ ID
.Iadd.NO: .Iaddend.6 and .[.said.]. .Iadd.a .Iaddend.second
double-stranded ribonucleic acid .[.has.]. .Iadd.comprising
.Iaddend.a sense strand comprising.Iadd., .Iaddend.in order.Iadd.,
.Iaddend.nucleotides 1-19 of SEQ ID .Iadd.NO: .Iaddend.2 or 7.
14. The pharmaceutical composition of claim 12.Iadd.,
.Iaddend.further comprising a pharmaceutically acceptable carrier,
stabilizer.Iadd., .Iaddend.and/or diluent.
15. A method for inhibiting the expression of .Iadd.a
.Iaddend.Hepatitis B Virus gene in a cell, a tissue, or an
organism.Iadd., the method .Iaddend.comprising: a) introducing into
the cell, tissue, or organism the double-stranded ribonucleic acid
molecule as defined in claim 1; and b) maintaining the cell,
tissue.Iadd., .Iaddend.or organism produced in step a) for a time
sufficient to obtain degradation of the mRNA transcript of .[.a.].
.Iadd.the .Iaddend.Hepatitis B Virus gene.[., thereby inhibiting
expression of a Hepatitis B Virus gene.]. in the cell.Iadd.,
tissue, or organism.Iaddend..
16. The method of claim 15.Iadd., .Iaddend.wherein inhibiting
.Iadd.the .Iaddend.expression of .Iadd.the .Iaddend.Hepatitis B
Virus gene in an organism treats or manages a pathological
condition or disease caused by infection with .[.the.]. Hepatitis B
Virus.
17. The method .Iadd.of .Iaddend.claim 16.Iadd., .Iaddend.wherein
the pathological condition and disease caused by the infection with
the Hepatitis B Virus is selected from the group consisting of:
chronic liver disorder, inflammation, fibrotic condition, and
proliferative disorder.
.Iadd.18. The double-stranded ribonucleic acid molecule of claim 1,
wherein the sense strand comprises, in order, nucleotides 1-19 of
SEQ ID NO: 2, wherein the antisense strand is at least partially
complementary to the sense strand, and wherein the sense strand and
the antisense strand are each less than 30 nucleotides in
length..Iaddend.
.Iadd.19. The double-stranded ribonucleic acid molecule of claim
18, wherein the double-stranded ribonucleic acid molecule contains
at least one modified nucleotide..Iaddend.
.Iadd.20. The double-stranded ribonucleic acid molecule of claim
19, wherein the one or more modified nucleotides are independently
selected from the group consisting of: a 2'-O-methyl modified
nucleotide, a nucleotide comprising a 5'-phosphorothioate group, a
terminal nucleotide linked to a cholesteryl derivative, a terminal
nucleotide linked to a dodecanoic acid bisdecylamide group, a
2'-deoxy-2'-fluoro-modified nucleotide, a 2'-deoxy-nucleotide, a
locked nucleotide, an abasic nucleotide, a deoxythymidine, an
inverted deoxythymidine, a 2'-amino-modified nucleotide, a
2'-alkyl-modified nucleotide, a morpholino nucleotide, a
phosphoroamidate, and a non-natural base comprising a
nucleotide..Iaddend.
.Iadd.21. The double-stranded ribonucleic acid molecule of claim
19, wherein the double-stranded ribonucleic acid molecule comprises
at least one 2'-O-methyl-modified nucleotide, at least one
nucleotide comprising a 5'-phosphorothioate group, and at least one
deoxythymidine..Iaddend.
.Iadd.22. The double-stranded ribonucleic acid molecule of claim
21, wherein the sense strand or the antisense strand further
comprises an overhang of 1 or 2 deoxythymidine(s)..Iaddend.
.Iadd.23. The double-stranded ribonucleic acid molecule of claim
18, wherein the double-stranded ribonucleic acid molecule comprises
the sequence pair of SEQ ID NOs: 2/158..Iaddend.
.Iadd.24. The double-stranded ribonucleic acid molecule of claim
19, wherein the sense strand, or the antisense strand, or both the
sense strand and the antisense strand, further comprises a 3'
overhang of 1-5 nucleotides in length..Iaddend.
.Iadd.25. A pharmaceutical composition comprising: a) a
double-stranded ribonucleic acid molecule of claim 19; or b) a
cell, tissue, or non-human organism comprising a double-stranded
ribonucleic acid molecule of claim 19..Iaddend.
.Iadd.26. A pharmaceutical composition comprising: a) a first
double-stranded ribonucleic acid molecule of claim 19 and a second
double-stranded ribonucleic acid molecule that is different from
the first double-stranded ribonucleic acid molecule and inhibits
the expression of a Hepatitis B Virus gene; or b) a cell, tissue,
or non-human organism comprising a first double-stranded
ribonucleic acid molecule of claim 19 and a second double-stranded
ribonucleic acid molecule that is different from the first
double-stranded ribonucleic acid molecule and inhibits the
expression of a Hepatitis B Virus gene..Iaddend.
.Iadd.27. The pharmaceutical composition of claim 26, wherein the
second double-stranded ribonucleic acid has a sense strand
comprising, in order, nucleotides 1-19 of SEQ ID NO:
3..Iaddend.
.Iadd.28. The pharmaceutical composition of claim 26, wherein the
second double-stranded ribonucleic acid has a sense strand
comprising, in order, nucleotides 1-19 of SEQ ID NO:
6..Iaddend.
.Iadd.29. The pharmaceutical composition of claim 27, wherein the
first double-stranded ribonucleic acid molecule and the second
double-stranded ribonucleic acid molecule each comprise at least
one 2'-O-methyl modified nucleotide and at least one nucleotide
comprising a 5'-phosphorothioate group..Iaddend.
.Iadd.30. The pharmaceutical composition of claim 26, wherein the
first double-stranded ribonucleic acid molecule comprises the
sequence pair of SEQ ID NOs: 322/486; and the second
double-stranded ribonucleic acid molecule comprises the sequence
pair of SEQ ID NOs: 323/487, 324/488, or 327/491..Iaddend.
.Iadd.31. The pharmaceutical composition of claim 25, wherein the
double-stranded ribonucleic acid molecule comprises the sequence
pair of SEQ ID NOs: 322/486..Iaddend.
.Iadd.32. The pharmaceutical composition of claim 26, wherein the
first double-stranded ribonucleic acid molecule comprises the
sequence pair of SEQ ID NOs: 322/486..Iaddend.
.Iadd.33. A method for inhibiting the expression of a Hepatitis B
Virus gene in a cell, a tissue, or an organism, the method
comprising: a) introducing into the cell, tissue, or organism a
double-stranded ribonucleic acid molecule of claim 19; and b)
maintaining the cell, tissue or organism produced in step a) for a
time sufficient to obtain degradation of an mRNA transcript of the
Hepatitis B Virus gene in the cell, tissue, or
organism..Iaddend.
.Iadd.34. The method of claim 33, wherein the double-stranded
ribonucleic acid molecule comprises the sequence pair of SEQ ID
NOs: 2/158..Iaddend.
.Iadd.35. The method of claim 33, wherein inhibiting expression of
a Hepatitis B Virus gene in an organism treats or manages a
pathological condition or disease caused by infection with a
Hepatitis B Virus..Iaddend.
.Iadd.36. The method of claim 35, wherein the pathological
condition and disease caused by the infection with a Hepatitis B
Virus is selected from the group consisting of: chronic liver
disorder, inflammation, fibrotic condition, and proliferative
disorder..Iaddend.
.Iadd.37. A method of treating a subject having a pathological
condition or disease caused by infection with a Hepatitis B Virus,
the method comprising administering to the subject a
therapeutically effective amount of the pharmaceutical composition
of claim 12..Iaddend.
.Iadd.38. The method of claim 37, wherein the pathological
condition or disease caused by infection with a Hepatitis B Virus
is selected from the group consisting of: chronic liver disorder,
inflammation, fibrotic condition, and proliferative
disorder..Iaddend.
.Iadd.39. A method of treating a subject having a pathological
condition or disease caused by infection with a Hepatitis B Virus,
the method comprising administering to the subject a
therapeutically effective amount of the pharmaceutical composition
of claim 13..Iaddend.
.Iadd.40. The method of claim 39, wherein the pathological
condition or disease caused by infection with a Hepatitis B Virus
is selected from the group consisting of: chronic liver disorder,
inflammation, fibrotic condition, and proliferative
disorder..Iaddend.
.Iadd.41. A method of treating a subject having a pathological
condition or disease caused by infection with a Hepatitis B Virus,
the method comprising administering to the subject a
therapeutically effective amount of the pharmaceutical composition
of claim 25..Iaddend.
.Iadd.42. The method of claim 41, wherein the pathological
condition or disease caused by infection with a Hepatitis B Virus
is selected from the group consisting of: chronic liver disorder,
inflammation, fibrotic condition, and proliferative
disorder..Iaddend.
.Iadd.43. A method of treating a subject having a pathological
condition or disease caused by infection with a Hepatitis B Virus,
the method comprising administering to the subject a
therapeutically effective amount of the pharmaceutical composition
of claim 26..Iaddend.
.Iadd.44. The method of claim 43, wherein the first double-stranded
ribonucleic acid in the pharmaceutical composition has a sense
strand comprising, in order, nucleotides 1-19 of SEQ ID NO: 2 and
the second double-stranded ribonucleic acid in the pharmaceutical
composition has a sense strand comprising, in order, nucleotides
1-19 of SEQ ID NO: 3..Iaddend.
.Iadd.45. The method of claim 43, wherein the first double-stranded
ribonucleic acid in the pharmaceutical composition has a sense
strand comprising, in order, nucleotides 1-19 of SEQ ID NO: 2 and
the second double-stranded ribonucleic acid in the pharmaceutical
composition has a sense strand comprising, in order, nucleotides
1-19 of SEQ ID NO: 6..Iaddend.
.Iadd.46. The method of claim 43, wherein the pathological
condition or disease caused by infection with a Hepatitis B Virus
is selected from the group consisting of: chronic liver disorder,
inflammation, fibrotic condition, and proliferative
disorder..Iaddend.
.Iadd.47. The method of claim 43, further comprising administering
to the subject a different second pharmaceutical
composition..Iaddend.
.Iadd.48. A double-stranded ribonucleic acid molecule that inhibits
the expression of a Hepatitis B Virus gene, wherein the
double-stranded ribonucleic acid molecule comprises an antisense
strand comprising, in order, nucleotides 1-19 of SEQ ID NO: 158 and
a sense strand at least partially complementary to the antisense
strand, wherein the sense strand and the antisense strand are each
less than 30 nucleotides in length..Iaddend.
.Iadd.49. The double-stranded ribonucleic acid molecule of claim
48, wherein the double-stranded ribonucleic acid molecule contains
at least one modified nucleotide..Iaddend.
.Iadd.50. The double-stranded ribonucleic acid molecule of claim
49, wherein the one or more modified nucleotides are independently
selected from the group consisting of: a 2'-O-methyl modified
nucleotide, a nucleotide comprising a 5'-phosphorothioate group, a
terminal nucleotide linked to a cholesteryl derivative, a terminal
nucleotide linked to a dodecanoic acid bisdecylamide group, a
2'-deoxy-2'-fluoro-modified nucleotide, a 2'-deoxy-nucleotide, a
locked nucleotide, an abasic nucleotide, a deoxythymidine, an
inverted deoxythymidine, a 2'-amino-modified nucleotide, a
2'-alkyl-modified nucleotide, a morpholino nucleotide, a
phosphoroamidate, and a non-natural base comprising
nucleotide..Iaddend.
.Iadd.51. The double-stranded ribonucleic acid molecule of claim
40, wherein the double-stranded ribonucleic acid molecule comprises
at least one 2'-O-methyl-modified nucleotide, at least one
nucleotide comprising a 5'-phosphorothioate group, and at least one
deoxythymidine..Iaddend.
.Iadd.52. The double-stranded ribonucleic acid molecule of claim
51, wherein the sense strand or the antisense strand further
comprises an overhang of 1 or 2 deoxythymidine(s)..Iaddend.
.Iadd.53. The double-stranded ribonucleic acid molecule of claim
49, wherein the sense strand, or the antisense strand, or both the
sense strand and the antisense strand, further comprises a 3'
overhang of 1-5 nucleotides in length..Iaddend.
.Iadd.54. A pharmaceutical composition comprising: a) a
double-stranded ribonucleic acid molecule of claim 49; or b) a
cell, tissue, or non-human organism comprising a double-stranded
ribonucleic acid molecule of claim 49..Iaddend.
.Iadd.55. A pharmaceutical composition comprising: a) a first
double-stranded ribonucleic acid molecule of claim 49 and a second
double-stranded ribonucleic acid molecule that is different from
the first double-stranded ribonucleic acid molecule and inhibits
the expression of a Hepatitis B Virus gene; or b) a cell, tissue,
or non-human organism comprising a first double-stranded
ribonucleic acid molecule of claim 49 and a second double-stranded
ribonucleic acid molecule that is different from the first
double-stranded ribonucleic acid molecule and inhibits the
expression of a Hepatitis B Virus gene..Iaddend.
.Iadd.56. The pharmaceutical composition of claim 55, wherein the
first double-stranded ribonucleic acid has an antisense strand
comprising, in order, nucleotides 1-19 of SEQ ID NO: 158 and the
second double-stranded ribonucleic acid has an antisense strand
comprising, in order, nucleotides 1-19 of SEQ ID NO: 159 or
160..Iaddend.
.Iadd.57. The pharmaceutical composition of claim 55, wherein the
first double-stranded ribonucleic acid has an antisense strand
comprising, in order, nucleotides 1-19 of SEQ ID NO: 158 and the
second double-stranded ribonucleic acid has an antisense strand
comprising, in order, nucleotides 1-19 of SEQ ID NO:
163..Iaddend.
.Iadd.58. The pharmaceutical composition of claim 56, wherein the
first double-stranded ribonucleic acid molecule and the second
double-stranded ribonucleic acid molecule each comprise at least
one 2'-O-methyl modified nucleotide and at least one nucleotide
comprising a 5'-phosphorothioate group..Iaddend.
.Iadd.59. The pharmaceutical composition of claim 57, wherein the
first double-stranded ribonucleic acid molecule and the second
double-stranded ribonucleic acid molecule each comprise at least
one 2'-O-methyl modified nucleotide and at least one nucleotide
comprising a 5'-phosphorothioate group..Iaddend.
.Iadd.60. A method for inhibiting the expression of a Hepatitis B
Virus gene in a cell, a tissue, or an organism, the method
comprising: a) introducing into the cell, tissue, or organism the
double-stranded ribonucleic acid molecule of claim 49; and b)
maintaining the cell, tissue or organism produced in step a) for a
time sufficient to obtain degradation of the mRNA transcript of the
Hepatitis B Virus gene in the cell, tissue, or
organism..Iaddend.
.Iadd.61. The method of claim 60, wherein inhibiting the expression
of the Hepatitis B Virus gene in an organism treats a pathological
condition or disease caused by infection with the Hepatitis B
Virus..Iaddend.
.Iadd.62. The method of claim 61, wherein the pathological
condition and disease caused by the infection with the Hepatitis B
Virus is selected from the group consisting of: chronic liver
disorder, inflammation, fibrotic condition, and proliferative
disorder..Iaddend.
.Iadd.63. A method of treating a subject having a pathological
condition or disease caused by infection with a Hepatitis B Virus,
the method comprising administering to the subject a
therapeutically effective amount of the pharmaceutical composition
of claim 54..Iaddend.
.Iadd.64. The method of claim 63, wherein the pathological
condition or disease caused by infection with a Hepatitis B Virus
is selected from the group consisting of: chronic liver disorder,
inflammation, fibrotic condition, and proliferative
disorder..Iaddend.
.Iadd.65. A method of treating a subject having a pathological
condition or disease caused by infection with a Hepatitis B Virus,
the method comprising administering to the subject a
therapeutically effective amount of the pharmaceutical composition
of claim 55..Iaddend.
.Iadd.66. The method of claim 65, wherein the first double-stranded
ribonucleic acid in the pharmaceutical composition has an antisense
strand comprising, in order, nucleotides 1-19 of SEQ ID NO: 158 and
the second double-stranded ribonucleic acid in the pharmaceutical
composition has an antisense strand comprising, in order,
nucleotides 1-19 of SEQ ID NO: 159 or 160..Iaddend.
.Iadd.67. The method of claim 65, wherein the first double-stranded
ribonucleic acid in the pharmaceutical composition has an antisense
strand comprising, in order, nucleotides 1-19 of SEQ ID NO: 158 and
the second double-stranded ribonucleic acid in the pharmaceutical
composition has an antisense strand comprising, in order,
nucleotides 1-19 of SEQ ID NO: 163..Iaddend.
.Iadd.68. The method of claim 65, wherein the pathological
condition or disease caused by infection with a Hepatitis B Virus
is selected from the group consisting of: chronic liver disorder,
inflammation, fibrotic condition, and proliferative
disorder..Iaddend.
.Iadd.69. The method of claim 65, further comprising administering
to the subject a different second pharmaceutical composition for
treating a subject having a pathological condition or disease
caused by infection with a Hepatitis B Virus..Iaddend.
Description
.Iadd.CROSS-REFERENCE TO RELATED APPLICATIONS.Iaddend.
.Iadd.This application is a reissue application based on U.S.
application Ser. No. 13/535,454 filed on Jun. 28, 2012, which
previously issued as U.S. Pat. No. 8,809,293 on Aug. 19, 2014, and
claims foreign priority to EP Application No. 11172235 filed on
Jun. 30, 2011..Iaddend.
BACKGROUND OF THE INVENTION
This invention relates to double-stranded ribonucleic acids
(dsRNAs), and their use in mediating RNA interference to inhibit
the expression of genes, necessary for replication and pathogenesis
of Hepatitis B Virus, in particular in the inhibition of viral
polymerase, surface antigen, e-antigen and the X protein.
Furthermore, the use of said dsRNAs to treat or prevent chronic
liver diseases/disorders, inflammations, fibrotic conditions and
proliferative disorders, like cancers, as consequence of Hepatitis
B Virus infection, is part of this invention.
The Hepatitis B Virus is a strict hepatotrophic, double-stranded
DNA containing virus. Although DNA is the genetic material, the
replication cycle involves a reverse transcription step to copy a
pregenomic RNA into DNA. In order to accomplish this essential
step, the viral-encoded polymerase possesses reverse transcriptase
activity. Hepatitis B virus is classified as one member of the
Hepadnaviruses and belongs to the family of Hepadnaviridae. The
primary infection of adult humans with Hepatitis B Virus causes an
acute hepatitis with symptoms of organ inflammation, fever,
jaundice and increased liver transaminases in blood. About 95% of
acute hepatitis resolve without treatment. Those patients, that are
not able to overcome the virus infection, suffer a chronic disease
progression over many years with increased risk of developing
cirrhotic liver or liver cancer. Perinatal transmission from
Hepatitis B virus-infected mothers to newborns also leads to
chronic hepatitis. The treatment options for chronic Hepatitis B
Virus infection are limited and lead only in some cases to complete
and lasting remission. Additional clinical and therapeutical
complications arise in Hepatitis B Virus patients co-infected with
Hepatitis C, Hepatitis D or Human Immunodeficiency Virus.
The Hepatitis B Virus is transmitted via blood or blood products,
sperm, vaginal secrets, or saliva. Drug abuse and sexual
intercourse are dangerous activities and support spreading the
virus. Contact of damaged, mucoid epithelia with contaminated body
fluids may be sufficient for infection. Incubation time is between
40 to 200 days. The risk for infection is proportional to the
number of transmitted Hepatitis B Virus particles. Babies are often
infected perinatally by their Hepatitis B Virus carrying mother, a
major health problem in endemic areas.
About 2 billion people are infected with Hepatitis B Virus and 400
million are chronic carriers. Areas with high prevalence are Africa
and South-East Asia, with local accumulation of 20-80% infected
persons.
Based on sequence homology, Hepatitis B Viruses are classified into
genotypes A-H, with genotypes A-D being the most important ones.
Genotype A is frequent in North-Western Europe, USA, South and
Central America. Genotype B and C are dominant in China, Japan,
Indonesia and other countries in East Asia. Genotype D is found in
Southern Europe, Northern Africa and South Africa. Disease
progression and response to pharmaceutical treatment differ among
genotypes.
Infectious Hepatitis B Virus particles have a diameter of about 42
nm. The outer membrane bilayer contains the large, middle and small
surface protein. The cognate hepatocellular receptor for virus
surface protein binding and internalization is unknown. Many copies
of core protein form a spherical nucleocapsid structure inside the
virus particle. Each nucleocapsid carries partial double-stranded
DNA as genetic material, together with viral polymerase.
Upon uptake by hepatocytes, the nucleocapsid is transferred to the
nucleus and DNA is released. There, the DNA strand synthesis is
completed and gaps repaired to give the covalently closed circular
(ccc) supercoiled DNA of 3.2 kb. The cccDNA serves as template for
transcription of four major viral mRNAs, which are 3.5, 2.4, 2.1
and 0.7 kb long. All mRNAs are 5'-capped and polyadenylated at the
3'-end. There is sequence overlap at the 3'-end between all four
mRNAs.
The 3.5 kb mRNA serves as template for core protein and polymerase
production. In addition, the same transcript serves as a
pre-genomic replication intermediate and allows the viral
polymerase to initiate the reverse transcription into DNA. Core
protein is needed for nucleocapsid formation. In addition,
sequential processing activities transforms some core protein into
the secretable e-antigen. The abundance of e-antigen in blood
correlates with Hepatitis B Virus replication in liver and serves
as important diagnostic marker for monitoring the disease
progression.
The 2.4 and 2.1 kb mRNAs carry the open reading frames pre-S1,
pre-S2 and S2 for expression of viral large, medium and small
surface antigen. The s-antigen is associated with infectious,
complete particles. In addition, blood of infected patients also
contain non-infectious particles derived from s-antigen alone, free
of genomic DNA or polymerase. The function of these particles is
not fully understood. The complete and lasting depletion of
detectable s-antigen in blood is considered as reliable indicator
for Hepatitis B Virus clearance and thus, successful cure.
The 0.7 kb mRNA encodes the X protein. This gene product is
important for efficient transcription of viral genes and also acts
as a transactivator on host gene expression. The latter activity
seems to be important for hepatocyte transformation during
development of liver cancer.
Recombinant Hepatitis B Virus s-antigen is used for vaccination.
The injection of three doses of formulated s-antigen at day 1, at 4
weeks and at 6 months usually induces a sufficient titer of
neutralizing antibodies. Vaccinated patients are protected for 10
years or longer. However, the vaccines are no substitute for
therapy.
Patients with acute Hepatitis B Virus infection are not treated due
to the high, natural remission rate. However, those patients with
detectable s-antigen, e-antigen or viral DNA in the blood for more
than 6 months are considered chronically infected. Nucleoside
analogs as inhibitors of reverse transcriptase activity are the
first treatment option for many patients. Lamivudine, Tenofovir, or
Entecavir suppress Hepatitis B Virus replication, sometimes to
undetectable levels. Improvement of liver function and reduction of
liver inflammation are the most important benefits. However, only
few patients achieve complete and lasting remission after the end
of treatment. Furthermore, the Hepatitis B Virus develops drug
resistance with increasing duration of treatment. This is
especially difficult for patients co-infected with Hepatitis B and
Human Immunodeficiency Virus. Both viruses are susceptible to
nucleoside analogue drugs and may co-develop resistance.
The second treatment option is the administration of
interferon-alpha. Here, patients receive high doses of
interferon-alpha over a period of 6 months. Depending on the virus
genotype, up to 50% of chronic infection are curable. However, the
Asian genotype B gives very poor response rates. Co-infection with
Hepatitis D or Human Immunodeficiency Virus renders
interferon-alpha therapy completely ineffective. Patients with
strong liver damage and heavy fibrotic conditions are not qualified
for interferon-alpha therapy.
Despite significant advances in the field of Hepatitis B Virus
treatment, there remains a need for an agent that can selectively
and efficiently silence the gene expression of the virus, blocks
replication and subsequently reduces viral burden in chronically
infected patients.
Double-stranded RNA molecules (dsRNA) have been shown to block gene
expression in a highly conserved regulatory mechanism known as RNA
interference (RNAi). The invention provides double-stranded
ribonucleic acid molecules (dsRNAs), as well as compositions and
methods for inhibiting the expression of the Hepatitis B Virus
gene, in particular the expression of the Hepatitis B Virus gene,
in a cell, tissue or mammal using such dsRNA. The invention also
provides compositions and methods for treating or preventing
pathological conditions and diseases caused by the infection of the
Hepatitis B Virus such as in chronic liver diseases/disorders,
inflammations, fibrotic conditions and proliferative disorders,
like cancers.
SUMMARY OF THE INVENTION
The invention provides double-stranded ribonucleic acid (dsRNA)
molecules able to selectively and efficiently decrease the
expression of Hepatitis B Virus gene. The use of Hepatitis B Virus
RNAi provides a method for the therapeutic and/or prophylactic
treatment of diseases/disorders which are associated with chronic
liver diseases/disorders, inflammations, fibrotic conditions and
proliferative disorders, like cancers, such method comprises
administration of dsRNA targeting Hepatitis B Virus to a human
being or animal. In one preferred embodiment the described dsRNA
molecule is capable of inhibiting the expression of a Hepatitis B
Virus gene by at least 60%, preferably by at least 70%, most
preferably by at least 80%.
In one embodiment, the invention provides double-stranded
ribonucleic acid (dsRNA) molecules for inhibiting the expression of
a Hepatitis B Virus gene, in particular the expression of the genes
related to replication or pathogenesis of Hepatitis B Virus. The
dsRNA comprises at least two sequences that are complementary to
each other. The dsRNA comprises a sense strand comprising a first
sequence and an antisense strand comprising a second sequence, see
sequences provided in the sequence listing and also the specific
dsRNA pairs in the appended Table 1 and Table 2. In one embodiment
the sense strand comprises a sequence which has an identity of at
least 90% to at least a portion of an Hepatitis B Virus mRNA. Said
sequence is located in a region of complementarity of the sense
strand to the antisense strand, preferably within nucleotides 2-7
of the 5' terminus of the antisense strand. In one preferred
embodiment the dsRNA specifically targets the Hepatitis B Virus
gene that encodes core protein, viral polymerase, surface antigen,
e-antigen or the X protein. Furthermore, it is preferred that the
dsRNA specifically targets a consensus sequence which has a highly
conserved nucleic acid sequence among the Hepatitis B Virus genomic
sequences of genotype A, B, C and D. Preferably, the consensus
sequence is at least 13 contiguous nucleotides in length, more
preferably at least 17 contiguous nucleotides, and most preferably
at least 19 contiguous nucleotides. Preferred highly conserved
nucleic acid sequences are listed in Table 5.
In one embodiment, the antisense strand comprises a nucleotide
sequence which is substantially complementary to at least part of
an mRNA encoding said Hepatitis B Virus gene, and the region of
complementarity is most preferably less than 30 nucleotides in
length. Furthermore, it is preferred that the length of the herein
described inventive dsRNA molecules (duplex length) is in the range
of about 16 to 30 nucleotides, in particular in the range of about
18 to 28 nucleotides. Particularly useful in context of this
invention are duplex lengths of about 19, 20, 21, 22, 23 or 24
nucleotides. Most preferred are duplex stretches of 19, 21 or 23
nucleotides. The dsRNA, upon delivery to a cell infected by a
Hepatitis B Virus, inhibits the expression of a Hepatitis B Virus
gene in vitro by at least 60%, preferably by at least 70%, and most
preferably by 80%.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1. Table 1. Core sequences of dsRNAs targeting Hepatitis B
Virus gene. Letters in capitals represent RNA nucleotides.
FIG. 2. Table 2. Characterization of dsRNAs targeting Hepatitis B
Virus: Activity testing with single dose. Letters in capitals
represent RNA nucleotides, lower case letters "c", "g", "a" and "u"
represent 2' O-methyl-modified nucleotides, "s" represents
phosphorothioate, "dT" represents deoxythymidine, upper case
letters A, C, G, U followed by "f" indicates a 2'-fluoro
nucleotide. Lower case "p" indicates a 5'-phosphate. (invdT)
represents an inverted deoxythimidine (3'-3'-linked).
FIG. 3. Table 3. Characterization of dsRNAs targeting Hepatitis B
Virus: Stability. t1/2: half-life of a strand as defined in
examples.
FIG. 4. Table 4. Core sequences of dsRNAs targeting Hepatitis B
Virus gene and their modified counterparts. Letters in capitals
represent RNA nucleotides, lower case letters "c", "g", "a" and "u"
represent 2' O-methyl-modified nucleotides, "s" represents
phosphorothioate, "dT" represents deoxythymidine, upper case
letters A, C, G, U followed by "t" indicates a 2'-fluoro
nucleotide. Lower case "p" indicates a 5'-phosphate. (invdT)
represents an inverted deoxythimidine (3'-3'-linked).
FIG. 5. Table 5. Target site sequences of dsRNAs targeting
Hepatitis B Virus and their coverage rate with respect to Hepatitis
B Virus genotypes A, B, C and D. n=number of available HBV
sequences of each genotype
FIG. 6. Table 6. NCBI Genbank accession Nos. of Hepatitis B Virus
genomic sequences.
FIG. 7. Table 7. Comparison of knockdown efficacies and coverage of
HBV genomes for single dsRNAs and combinations thereof. Activity
testing for combinations of two dsRNAs was done at final
concentrations of 10 nM and at 1 nM with the best performing dsRNAs
according to Table 2 and compared with respective data.
FIG. 8. Table 8. Sequences of the negative control ds RNAs used in
the psiCHECK.TM.-2 screening assay.
DETAILED DESCRIPTION OF THE INVENTION
Appended Table 1 relates to preferred molecules to be used as dsRNA
in accordance with this invention. Also modified dsRNA molecules
are provided herein and are in particular disclosed in appended
Table 2, providing illustrative examples of modified dsRNA
molecules of the present invention. As pointed out herein above,
Table 2 provides for illustrative examples of modified dsRNAs of
this invention (whereby the corresponding sense strand and
antisense strand is provided in this Table). The relation of the
unmodified preferred molecules shown in Table 1 to the modified
dsRNAs of Table 2 is illustrated in Table 4. Yet, the illustrative
modifications of these constituents of the inventive dsRNAs are
provided herein as examples of modifications.
Table 3 provides for selective biological, clinical and
pharmaceutical relevant parameters of certain dsRNA molecules of
this invention.
Some of the preferred dsRNA molecules are provided in the appended
Table 1 and, inter alia and preferably, wherein the sense strand is
selected from the group consisting of the nucleic acid sequences
depicted in SEQ ID NOs: 1, 2, 3, 4, 5, 6, 7, and 26. The antisense
strand is selected from the group consisting of the nucleic acid
sequences depicted in SEQ ID NOs: 157, 158, 160, 161, 162, 163,
164, and 186. Accordingly, the inventive dsRNA molecule may, inter
alia, comprise the sequence pairs selected from the group
consisting of SEQ ID NOs: 1/157, 2/158, 3/160, 4/161, 5/162, 6/163,
7/164, and 26/186. In the context of specific dsRNA molecules
provided herein, pairs of SEQ ID NOs relate to corresponding sense
and antisense strands sequences (5' to 3') as also shown in the
Tables.
In one embodiment the dsRNA molecules comprise an antisense strand
with a 3' overhang of 1-5 nucleotides in length, preferably 1-2
nucleotides in length. Preferably said overhang of the antisense
strand comprises uracil or nucleotides which are complementary to
the mRNA encoding a protein necessary for replication or
pathogenesis of Hepatitis B Virus, in particular core protein,
viral polymerase, surface antigen, e-antigen and X protein. In
another preferred embodiment, said dsRNA molecules comprise a sense
strand with a 3' overhang of 1-5 nucleotides in length, preferably
1-2 nucleotides in length. Preferably said overhang of the sense
strand comprises uracil or nucleotides which are identical to the
mRNA encoding a protein necessary for replication or (pathogenesis
of Hepatitis B Virus.
In another preferred embodiment, the dsRNA molecules comprise a
sense strand with a 3' overhang of 1-5 nucleotides in length,
preferably 1-2 nucleotides in length, and an antisense strand with
a 3' overhang of 1-5 nucleotides in length, preferably 1-2
nucleotides in length. Preferably said overhang of the sense strand
comprises uracil or nucleotides which are at least 90% identical to
the pregenomic RNA and/or the mRNA encoding the protein necessary
for replication or pathogenesis of Hepatitis B Virus and said
overhang of the antisense strand comprises uracil or nucleotides
which are at least 90% complementary to the mRNA encoding the
protein necessary for replication or pathogenesis of Hepatitis B
Virus.
The dsRNA molecules of the invention may be comprised of naturally
occurring nucleotides or may be comprised of at least one modified
nucleotide, such as a 2'-O-methyl modified nucleotide, inverted
deoxythymidine, a nucleotide comprising a 5'-phosphorothioate
group, and a terminal nucleotide linked to a cholesteryl derivative
or dodecanoic acid bisdecylamide group. 2' modified nucleotides may
have the additional advantage that certain immunostimulatory
factors or cytokines are suppressed when the inventive dsRNA
molecules are employed in vivo, for example in a medical setting.
Alternatively and non-limiting, the modified nucleotide may be
chosen from the group of: a 2'-deoxy-2'-fluoro modified nucleotide,
a 2'-deoxy-modified nucleotide, a locked nucleotide, an abasic
nucleotide, 2'-amino-modified nucleotide, 2'-alkyl-modified
nucleotide, morpholino nucleotide, a phosphoramidate, and a
non-natural base comprising nucleotide. In one preferred embodiment
the dsRNA molecules comprises at least one of the following
modified nucleotides: a 2'-.beta.-methyl modified nucleotide, a
nucleotide comprising a 5'-phosphorothioate group and a
deoxythymidine. Preferred dsRNA molecules comprising modified
nucleotides are given in Table 2. In another preferred embodiment
one of those deoxythymidine nucleotides at the 3' of both strand is
an inverted deoxythymidine.
In a preferred embodiment the inventive dsRNA molecules comprise
modified nucleotides as detailed in the sequences given in Table 2.
In one preferred embodiment the inventive dsRNA molecule comprises
sequence pairs selected from the group consisting of SEQ ID NOs:
1/157, 2/158, 3/160, 4/161, 5/162, 6/163, 7/164, and 26/186, and
comprises overhangs at the antisense and/or sense strand of 1-2
deoxythymidines. In one preferred embodiment the inventive dsRNA
molecule comprises sequence pairs selected from the group
consisting of SEQ ID NOs: 1/157, 2/158, 3/160, 4/161, 5/162, 6/163,
7/164, and 26/186, and comprise modifications as detailed in Table
2. Preferred dsRNA molecules comprising modified nucleotides are
listed in Table 2-4, with the most preferred dsRNA molecules
depicted in SEQ ID Nos: 321/485, 322/486, 324/488, 325/489,
326/490, 327/491, 328/492, and 350/514.
In another embodiment, the inventive dsRNAs comprise modified
nucleotides on positions different from those disclosed in Table 2.
In one preferred embodiment two deoxythymidine nucleotides are
found at the 3' of both strands of the dsRNA molecule. Preferably
said deoxythymidine nucleotides form an overhang.
In one embodiment the dsRNA molecules of the invention comprise a
sense and an antisense strand wherein both strands have a half-life
of at least 0.9 h. In one preferred embodiment the dsRNA molecules
of the invention comprise a sense and an antisense strand wherein
both strands have a half-life of at least 48 h, preferably in human
serum.
In another embodiment, a nucleic acid sequence encoding a sense
strand and/or an antisense strand comprised in the dsRNAs as
defined herein are provided.
The invention also provides for cells comprising at least one of
the dsRNAs of the invention. The cell is preferably a mammalian
cell, such as a human cell. Furthermore, tissues and/or non-human
organisms comprising the herein defined dsRNA molecules are an
embodiment of this invention, whereby said non-human organisms are
particularly useful for research purposes or as research tools, for
example in drug testing.
Furthermore, the invention relates to a method for inhibiting the
expression of a Hepatitis B Virus gene, in particular a Hepatitis B
Virus gene that encodes core protein, viral polymerase, surface
antigen, e-antigen or the X protein, in a cell, tissue or organism
comprising the following steps: (a) introducing into the cell,
tissue or organism a double-stranded ribonucleic acid (dsRNA) as
defined herein; and (b) maintaining said cell, tissue or organism
produced in step (a) for a time sufficient to obtain degradation of
the mRNA transcript of a Hepatitis B Virus gene, thereby inhibiting
expression of a Hepatitis B Virus gene in a given cell.
The invention also relates to pharmaceutical compositions
comprising at least one kind of the inventive dsRNAs. These
pharmaceutical compositions are particularly useful in the
inhibition of the expression of a Hepatitis B Virus gene in a cell,
a tissue or an organism.
Preferably said at least one kind of the inventive double-stranded
ribonucleic acid molecules target the region of a pregenomic RNA
and/or a mRNA encoding a protein necessary for replication or
pathogenesis of Hepatitis B Virus gene. More preferably said target
region of the inventive double-stranded ribonucleic acid molecules
comprises a consensus sequence which is highly conserved among the
Hepatitis B Virus genomic sequences of genotype A, B, C and D, and
said consensus sequence is at least 13 contiguous nucleotides in
length, preferably at least 17 contiguous nucleotides, most
preferably at least 19 contiguous nucleotides. Preferred highly
conserved nucleic acid sequences are listed in Table 5. The
pharmaceutical compositions may be used to treat patients who are
infected with any genotype of Hepatitis B Virus or co-infected with
different genotypes of Hepatitis B Virus.
In case the pharmaceutical composition comprises at least two kinds
of inventive double-stranded ribonucleic acid molecules, it is
preferable that the targets of said double-stranded ribonucleic
acid molecules are different from each other. The inventive
pharmaceutical compositions may be used to treat the patients and
to prevent the Hepatitis B Virus from developing resistance to the
pharmaceutical compositions. In a preferred embodiment the
inventive pharmaceutical compositions comprise the combination of
dsRNA molecules as detailed in the sequences given in Table 7. In
one preferred embodiment the inventive pharmaceutical compositions
comprise combinations of dsRNA pairs selected from the group
consisting of SEQ ID NOs: 322/486 and 333/497, 322/486 and 346/510,
322/486 and 330/494, and, 322/486 and 324/488.
The pharmaceutical compositions described above may also comprise
(a) pharmaceutically acceptable carrier(s), diluent(s) and/or
excipient(s).
In another embodiment, the invention provides methods for treating,
preventing or managing chronic liver diseases/disorders,
inflammations, fibrotic conditions and/or proliferative disorders
like cancers which are associated with Hepatitis B Virus, said
method comprising administering to a subject in need of such
treatment, prevention or management a therapeutically or
prophylactically effective amount of one or more of the dsRNAs of
the invention. Preferably, said subject is a mammal, most
preferably a human patient.
In one embodiment, the invention provides a method for treating a
subject having a pathological condition mediated by the infection
of a Hepatitis B Virus. Such conditions comprise disorders
associated with chronic liver diseases/disorders, inflammations,
fibrotic conditions and/or proliferative disorders like cancers, as
described above. In this embodiment, the dsRNA acts as a
therapeutic agent for controlling the expression of a Hepatitis B
Virus gene. The method comprises administering a pharmaceutical
composition of the invention to the patient (e.g., human), such
that expression of a Hepatitis B Virus gene is silenced. Because of
their high specificity, the dsRNAs of the invention specifically
target mRNAs of a Hepatitis B Virus gene. In one preferred
embodiment the described dsRNAs specifically decrease Hepatitis B
Virus mRNA levels and do not directly affect the expression and/or
mRNA levels of off-target genes in the cell.
In one preferred embodiment the described dsRNA decrease Hepatitis
B Virus mRNA levels in the liver by at least 60%, preferably by at
least 70%, most preferably by at least 80% in vivo. in another
embodiment the described dsRNAs decrease Hepatitis B Virus mRNA
levels in vivo for at least 4 days. In another preferred
embodiment, the dsRNAs of the invention are used for the
preparation of a pharmaceutical composition for the treatment of
chronic liver diseases/disorders, inflammations, fibrotic
conditions and proliferative disorders like cancers. Such diseases
to be treated with said pharmaceutical composition comprise but are
not limited to: chronic hepatitis (CH), hepatic cirrhosis (HC) and
hepatocellular carcinoma (HCC).
In another embodiment, the invention provides vectors for
inhibiting the expression of a Hepatitis B Virus gene in a cell, in
particular a Hepatitis B Virus gene comprising a regulatory
sequence operably linked to a nucleotide sequence that encodes at
least one strand of the dsRNA molecules of the invention.
In another embodiment, the invention provides a cell comprising a
vector for inhibiting the expression of a Hepatitis B Virus gene in
a cell. Said vector comprises a regulatory sequence operably linked
to a nucleotide sequence that encodes at least one strand of the
dsRNA molecule of the invention. Yet, it is preferred that said
vector comprises, besides said regulatory sequence a sequence that
encodes at least one "sense strand" of the inventive dsRNA and at
least one "antisense strand" of said dsRNA. It is also envisaged
that the claimed cell comprises two or more vectors comprising,
besides said regulatory sequences, the herein defined sequence(s)
that encode(s) at least one strand of the dsRNA molecules of the
invention.
In one embodiment, the method comprises administering a composition
comprising a dsRNA, wherein the dsRNA comprises a nucleotide
sequence which is complementary to at least a part of an RNA
transcript of a Hepatitis B Virus gene of the mammal to be treated.
As pointed out above, also vectors and cells comprising nucleic
acid molecules that encode for at least one strand of the herein
defined dsRNA molecules can be used as pharmaceutical compositions
and may, therefore, also be employed in the herein disclosed
methods of treating a subject in need of medical intervention. It
is also of note that these embodiments relating to pharmaceutical
compositions and to corresponding methods of treating a (human)
subject also relate to approaches like gene therapy approaches.
Hepatitis B Virus specific dsRNA molecules as provided herein or
nucleic acid molecules encoding individual strands of these
inventive dsRNA molecules may also be inserted into vectors and
used as gene therapy vectors for human patients. Gene therapy
vectors can be delivered to a subject by, for example, intravenous
injection, local administration (see U.S. Pat. No. 5,328,470) or by
stereotactic injection (see e.g., Chen et al. Proc. Natl. Acad.
Sci. USA (1994) 91:3054-3057). The pharmaceutical preparation of
the gene therapy vector can include the gene therapy vector in an
acceptable diluent, or can comprise a slow release matrix in which
the gene delivery vehicle is imbedded. Alternatively, where the
complete gene delivery vector can be produced intact from
recombinant cells, e.g., retroviral vectors, the pharmaceutical
preparation can include one or more cells which produce the gene
delivery system.
In another aspect of the invention, Hepatitis B Virus specific
dsRNA molecules that modulate Hepatitis B Virus gene expression
activity are expressed from transcription units inserted into DNA
or RNA vectors (see, e.g., Skillern A et al., International PCT
Publication No. WO 00/22113). These transgenes can be introduced as
a linear construct, a circular plasmid, or a viral vector, which
can be incorporated and inherited as a transgene integrated into
the host genome. The transgene can also be constructed to permit it
to be inherited as an extrachromosomal plasmid (Gassmann et al.,
Proc. Natl. Acad. Sci. USA (1995) 92:1292).
The individual strands of a dsRNA can be transcribed by promoters
on two separate expression vectors and co-transfected into a target
cell. Alternatively each individual strand of the dsRNA can be
transcribed by promoters both of which are located on the same
expression plasmid. In a preferred embodiment, a dsRNA is expressed
as an inverted repeat joined by a linker polynucleotide sequence
such that the dsRNA has a stem and loop structure.
The recombinant dsRNA expression vectors are preferably DNA
plasmids or viral vectors. dsRNA expressing viral vectors can be
constructed based on, but not limited to, adeno-associated virus
(for a review, see Muzyczka et al., Curr. Topics Micro. Immunol.
(1992) 158:97-129); adenovirus (see, for example, Berkner et al.,
BioTechniques (1998) 6:616; Rosenfeld et al. Science (1991)
252:431-434; and Rosenfeld et al. Cell (1992) 68:143-155); or
alphavirus as well as others known in the art. Retroviruses have
been used to introduce a variety of genes into many different cell
types, including epithelial cells, in vitro and/or in vivo (see,
e.g., Danos and Mulligan, Proc. Natl. Acad. Sci. USA (1998)
85:6460-6464). Recombinant retroviral vectors capable of
transducing and expressing genes inserted into the genome of a cell
can be produced by transfecting the recombinant retro-viral genome
into suitable packaging cell lines such as PA317 and Psi-CRIP
(Comette et al., Human Gene Therapy (1991) 2:5-10; Cone et al.,
Proc. Natl. Acad. Sci. USA (1984) 81:6349). Recombinant adenoviral
vectors can be used to infect a wide variety of cells and tissues
in susceptible hosts (e.g., rat, hamster, dog, and chimpanzee) (Hsu
et al., J. Infectious Disease, (1992) 166:769), and also have the
advantage of not requiring mitotically active cells for
infection.
The promoter driving dsRNA expression in either a DNA plasmid or
viral vector of the invention may be a eukaryotic RNA polymerase I
(e.g. ribosomal RNA promoter), RNA polymerase II (e.g. CMV early
promoter or actin promoter or U1 snRNA promoter) or preferably RNA
polymerase III promoter (e.g. U6 snRNA or 7SK RNA promoter) or a
prokaryotic promoter, for example the T7 promoter, provided the
expression plasmid also encodes T7 RNA polymerase required for
transcription from a T7 promoter. The promoter can also direct
transgene expression to the pancreas (see, e.g. the insulin
regulatory sequence for pancreas (Bucchini et al., Proc. Natl.
Acad. Sci. USA (1986) 83:2511-2515).
In addition, expression of the transgene can be precisely
regulated, for example, by using an inducible regulatory sequence
and expression systems such as a regulatory sequence that is
sensitive to certain physiological regulators, e.g., circulating
glucose levels, or hormones (Docherty et al., FASEB J. (1994)
8:20-24). Such inducible expression systems, suitable for the
control of transgene expression in cells or in mammals include
regulation by ecdysone, by estrogen, progesterone, tetracycline,
chemical inducers of dimerization, and
isopropyl-beta-D1-thiogalactopyranoside (IPTG). A person skilled in
the art would be able to choose the appropriate regulatory/promoter
sequence based on the intended use of the dsRNA transgene.
Preferably, recombinant vectors capable of expressing dsRNA
molecules are delivered as described below, and persist in target
cells. Alternatively, viral vectors can be used that provide for
transient expression of dsRNA molecules. Such vectors can be
repeatedly administered as necessary. Once expressed, the dsRNAs
bind to target RNA and modulate its function or expression.
Delivery of dsRNA expressing vectors can be systemic, such as by
intravenous or intramuscular administration, by administration to
target cells ex-planted from the patient followed by reintroduction
into the patient, or by any other means that allows for
introduction into a desired target cell.
dsRNA expression DNA plasmids are typically transfected into target
cells as a complex with cationic lipid carriers (e.g.
Oligofectamine) or non-cationic lipid-based carriers (e.g.
Transit-TKO.TM.). Multiple lipid transfections for dsRNA-mediated
knockdowns targeting different regions of a single Hepatitis B
Virus gene or multiple Hepatitis B Virus genes over a period of a
week or more are also contemplated by the invention. Successful
introduction of the vectors of the invention into host cells can be
monitored using various known methods. For example, transient
transfection can be signaled with a reporter, such as a fluorescent
marker, such as Green Fluorescent Protein (GFP). Stable
transfection of ex vivo cells can be ensured using markers that
provide the transfected cell with resistance to specific
environmental factors (e.g., antibiotics and drugs), such as
hygromycin B resistance.
The following detailed description discloses how to make and use
the dsRNA and compositions containing dsRNA to inhibit the
expression of a target Hepatitis B Virus gene, as well as
compositions and methods for treating diseases and disorders caused
by the infection of said Hepatitis B Virus.
Definitions
For convenience, the meaning of certain terms and phrases used in
the specification, examples, and appended claims, are provided
below. If there is an apparent discrepancy between the usage of a
term in other parts of this specification and its definition
provided in this section, the definition in this section shall
prevail.
"G," "C," "A", "U" and "T" or "dT" respectively, each generally
stand for a nucleotide that contains guanine, cytosine, adenine,
uracil and deoxythymidine as a base, respectively. However, the
term "ribonucleotide" or "nucleotide" can also refer to a modified
nucleotide, as further detailed below, or a surrogate replacement
moiety. Sequences comprising such replacement moieties are
embodiments of the invention. As detailed below, the herein
described dsRNA molecules may also comprise "overhangs", i.e.
unpaired, overhanging nucleotides which are not directly involved
in the RNA double helical structure normally formed by the herein
defined pair of "sense strand" and "antisense strand". Often, such
an overhanging stretch comprises the deoxythymidine nucleotide, in
most embodiments, two deoxythymidines in the 3' end. Such overhangs
will be described and illustrated below.
The term "Hepatitis B Virus gene" as used herein relates to the
genes necessary for replication and pathogenesis of Hepatitis B
Virus, in particular to the genes that encode core protein, viral
polymerase, surface antigen, e-antigen and the X protein and the
genes that encode the functional fragments of the same. The term
"Hepatitis B Virus gene/sequence" does not only relate to (the)
wild-type sequence(s) but also to mutations and alterations which
may be comprised in said gene/sequence. Accordingly, the present
invention is not limited to the specific dsRNA molecules provided
herein. The invention also relates to dsRNA molecules that comprise
an antisense strand that is at least 85% complementary to the
corresponding nucleotide stretch of an RNA transcript of a
Hepatitis B Virus gene that comprises such
mutations/alterations.
As used herein, the term "consensus sequence" refers to at least 13
contiguous nucleotides, preferably at least 17 contiguous
nucleotides, most preferably at least 19 contiguous nucleotides,
which is highly conserved among the Hepatitis B Virus genomic
sequences of genotype A, B, C and D.
As used herein, "target sequence" refers to a contiguous portion of
the nucleotide sequence of an mRNA molecule formed during the
transcription of a Hepatitis B Virus gene, including mRNA that is a
product of RNA processing of a primary transcription product.
As used herein, the term "strand comprising a sequence" refers to
an oligonucleotide comprising a chain of nucleotides that is
described by the sequence referred to using the standard nucleotide
nomenclature. However, as detailed herein, such a "strand
comprising a sequence" may also comprise modifications, like
modified nucleotides.
As used herein, and unless otherwise indicated, the term
"complementary," when used to describe a first nucleotide sequence
in relation to a second nucleotide sequence, refers to the ability
of an oligonucleotide or polynucleotide comprising the first
nucleotide sequence to hybridize and form a duplex structure under
certain conditions with an oligonucleotide or polynucleotide
comprising the second nucleotide sequence. "Complementary"
sequences, as used herein, may also include, or be formed entirely
from, non-Watson-Crick base pairs and/or base pairs formed from
non-natural and modified nucleotides, in as far as the above
requirements with respect to their ability to hybridize are
fulfilled.
Sequences referred to as "fully complementary" comprise
base-pairing of the oligonucleotide or polynucleotide comprising
the first nucleotide sequence to the oligonucleotide or
polynucleotide comprising the second nucleotide sequence over the
entire length of the first and second nucleotide sequence.
However, where a first sequence is referred to as "substantially
complementary" with respect to a second sequence herein, the two
sequences can be fully complementary, or they may form one or more,
but preferably not more than 13 mismatched base pairs upon
hybridization.
The terms "complementary", "fully complementary" and "substantially
complementary" herein may be used with respect to the base matching
between the sense strand and the antisense strand of a dsRNA, or
between the antisense strand of a dsRNA and a target sequence, as
will be understood from the context of their use.
The term "double-stranded RNA", "dsRNA molecule", or "dsRNA", as
used herein, refers to a ribonucleic acid molecule, or complex of
ribonucleic acid molecules, having a duplex structure comprising
two anti-parallel and substantially complementary nucleic acid
strands. The two strands forming the duplex structure may be
different portions of one larger RNA molecule, or they may be
separate RNA molecules. Where the two strands are part of one
larger molecule, and therefore are connected by an uninterrupted
chain of nucleotides between the 3'-end of one strand and the 5'
end of the respective other strand forming the duplex structure,
the connecting RNA chain is referred to as a "hairpin loop". Where
the two strands are connected covalently by means other than an
uninterrupted chain of nucleotides between the 3'-end of one strand
and the 5' end of the respective other strand forming the duplex
structure, the connecting structure is referred to as a "linker".
The RNA strands may have the same or a different number of
nucleotides. In addition to the duplex structure, a dsRNA may
comprise one or more nucleotide overhangs. The nucleotides in said
"overhangs" may comprise between 0 and 5 nucleotides, whereby "0"
means no additional nucleotide(s) that form(s) an "overhang" and
whereas "5" means five additional nucleotides on the individual
strands of the dsRNA duplex. These optional "overhangs" are located
in the 3' end of the individual strands. As will be detailed below,
also dsRNA molecules which comprise only an "overhang" in one of
the two strands may be useful and even advantageous in context of
this invention. The "overhang" comprises preferably between 0 and 2
nucleotides. Most preferably two "dT" (deoxythymidine) nucleotides
are found at the 3' end of both strands of the dsRNA. Also two "U"
(uracil) nucleotides can be used as overhangs at the 3' end of both
strands of the dsRNA. Accordingly, a "nucleotide overhang" refers
to the unpaired nucleotide or nucleotides that protrude from the
duplex structure of a dsRNA when a 3'-end of one strand of the
dsRNA extends beyond the 5'-end of the other strand, or vice versa.
For example the antisense strand comprises 23 nucleotides and the
sense strand comprises 21 nucleotides, forming a two nucleotide
overhang at the 3' end of the antisense strand. Preferably, the two
nucleotide overhang is fully complementary to the mRNA of the
target gene. "Blunt" or "blunt end" means that there are no
unpaired nucleotides at that end of the dsRNA, i.e., no nucleotide
overhang. A "blunt ended" dsRNA is a dsRNA that is double-stranded
over its entire length, i.e., no nucleotide overhang at either end
of the molecule.
The term "antisense strand" refers to the strand of a dsRNA which
includes a region that is substantially complementary to a target
sequence. As used herein, the term "region of complementarity"
refers to the region on the antisense strand that is substantially
complementary to a sequence, for example a target sequence. Where
the region of complementarity is not fully complementary to the
target sequence, the mismatches are most tolerated outside
nucleotides 2-7 of the 5' terminus of the antisense strand
The term "sense strand," as used herein, refers to the strand of a
dsRNA that includes a region that is substantially complementary to
a region of the antisense strand. "Substantially complementary"
means preferably at least 85% of the overlapping nucleotides in
sense and antisense strand are complementary.
"Introducing into a cell", when referring to a dsRNA, means
facilitating uptake or absorption into the cell, as is understood
by those skilled in the art. Absorption or uptake of dsRNA can
occur through unaided diffusive or active cellular processes, or by
auxiliary agents or devices. The meaning of this term is not
limited to cells in vitro; a dsRNA may also be "introduced into a
cell", wherein the cell is part of a living organism. In such
instance, introduction into the cell will include the delivery to
the organism. For example, for in vivo delivery, dsRNA can be
injected into a tissue site or administered systemically. It is,
for example envisaged that the dsRNA molecules of this invention be
administered to a subject in need of medical intervention. Such an
administration may comprise the injection of the dsRNA, the vector
or a cell of this invention into a diseased site in said subject,
for example into liver tissue/cells or into cancerous
tissues/cells, like liver cancer tissue. In addition, the injection
is preferably in close proximity to the diseased tissue envisaged.
In vitro introduction into a cell includes methods known in the art
such as electroporation and lipofection.
As used herein, "chronic liver diseases/disorders" refers to the
functional abnormality of liver lasting more than six months which
can be caused by the infection of virus. One example of the chronic
liver diseases/disorders is chronic hepatitis (CH).
The term "inflammation" as used herein refers to the biologic
response of body tissue to injury, irritation, or disease which can
be caused by harmful stimuli, for example, pathogens, damaged
cells, or irritants. Inflammation is typically characterized by
pain and swelling. Inflammation is intended to encompass both acute
responses, in which inflammatory processes are active (e.g.,
neutrophils and leukocytes), and chronic responses, which are
marked by slow progress, a shift in the type of cell present at the
site of inflammation, and the formation of connective tissue. One
example of an inflammation-caused disease is fibrosis.
The term "fibrotic conditions" as used herein refers to the
functional problem of organs which can be caused by growth of
fibrous tissue. One such example of such kind of disease is hepatic
cirrhosis (HC).
The term "proliferating" and "proliferation" as used herein refer
to cells undergoing mitosis. Throughout this application, the term
"proliferative disorder" refers to any disease/disorder marked by
unwanted or aberrant proliferation of tissue. As used herein, the
term "proliferative disorder" also refers to conditions in which
the unregulated and/or abnormal growth of cells can lead to the
development of an unwanted condition or disease, which can be
cancerous or non-cancerous.
Cancers to be treated comprise, but are again not limited to liver
cancer, whereby said liver cancer may, inter alia, be selected from
the group consisting of hepatocellular carcinoma (HCC),
hepatoblastoma, a mixed liver cancer, a cancer derived from
mesenchymal tissue, a liver sarcoma or a cholangiocarcinoma.
The terms "silence", "inhibit the expression of" and "knock down",
in as far as they refer to a Hepatitis B Virus gene, herein refer
to the at least partial suppression of the expression of a
Hepatitis B Virus gene, as manifested by a reduction of the amount
of mRNA transcribed from a Hepatitis B Virus gene which may be
isolated from a first cell or group of cells in which a Hepatitis B
Virus gene is transcribed and which has or have been treated such
that the expression of a Hepatitis B Virus gene is inhibited, as
compared to a second cell or group of cells substantially identical
to the first cell or group of cells but which has or have not been
so treated (control cells). The degree of inhibition is usually
expressed in terms of
.times..times..times..times..times..times..times..times..times..times..ti-
mes..times..times..times..times..times..times..times..times..times.
##EQU00001##
Alternatively, the degree of inhibition may be given in terms of a
reduction of a parameter that is functionally linked to the
Hepatitis B Virus gene transcription, e.g. the amount of protein
encoded by a Hepatitis B Virus gene which is secreted by a cell, or
the number of cells displaying a certain phenotype.
As illustrated in the appended examples and in the appended Tables
provided herein, the inventive dsRNA molecules are capable of
inhibiting the expression of a Hepatitis B Virus by at least about
60%, preferably by at least 70%, most preferably by at least 80% in
in vitro assays, i.e. in vitro. The term "in vitro" as used herein
includes but is not limited to cell culture assays. The person
skilled in the art can readily determine such an inhibition rate
and related effects, in particular in light of the assays provided
herein.
The term "off target" as used herein refers to all non-target mRNAs
of the transcriptome that are predicted by in silico methods to
hybridize to the described dsRNAs based on sequence
complementarity. The dsRNAs of the present invention preferably do
specifically inhibit the expression of Hepatitis B Virus gene, i.e.
do not inhibit the expression of any off-target.
The term "half-life" as used herein is a measure of stability of a
compound or molecule and can be assessed by methods known to a
person skilled in the art, especially in light of the assays
provided herein.
The term "non-immunostimulatory" as used herein refers to the
absence of any induction of an immune response by the invented
dsRNA molecules. Methods to determine immune responses are well
known to a person skilled in the art, for example by assessing the
release of cytokines, as described in the examples section.
The terms "treat", "treatment", and the like, mean in context of
this invention the relief from or alleviation of a disorder related
to Hepatitis B Virus infection, like chronic liver
diseases/disorders, inflammations, fibrotic conditions and
proliferative disorders, like cancers.
As used herein, a "pharmaceutical composition" comprises a
pharmacologically effective amount of at least one kind of dsRNAs
and a pharmaceutically acceptable carrier. However, such a
"pharmaceutical composition" may also comprise individual strands
of such dsRNA molecules or the herein described vector(s)
comprising a regulatory sequence operably linked to a nucleotide
sequence that encodes at least one strand of a sense or an
antisense strand comprised in the dsRNAs of this invention. It is
also envisaged that cells, tissues or isolated organs that express
or comprise the herein defined dsRNAs may be used as
"pharmaceutical compositions". As used herein, "pharmacologically
effective amount," "therapeutically effective amount," or simply
"effective amount" refers to that amount of an RNA effective to
produce the intended pharmacological, therapeutic or preventive
result.
The term "pharmaceutically acceptable carrier" refers to a carrier
for administration of a therapeutic agent. Such carriers include,
but are not limited to, saline, buffered saline, dextrose, water,
glycerol, ethanol, and combinations thereof. The term specifically
excludes cell culture medium. For drugs administered orally,
pharmaceutically acceptable carriers include, but are not limited
to pharmaceutically acceptable excipients such as inert diluents,
disintegrating agents, binding agents, lubricating agents,
sweetening agents, flavoring agents, coloring agents and
preservatives as known to persons skilled in the art.
It is in particular envisaged that the pharmaceutically acceptable
carrier allows for the systemic administration of the dsRNAs,
vectors or cells of this invention. Whereas also the enteric
administration is envisaged the parenteral administration and also
transdermal or transmucosal (e.g. insufflation, buccal, vaginal,
anal) administration as well as inhalation of the drug are feasible
ways of administering to a patient in need of medical intervention
the compounds of this invention. When parenteral administration is
employed, this can comprise the direct injection of the compounds
of this invention into the diseased tissue or at least in close
proximity. However, also intravenous, intraarterial, subcutaneous,
intramuscular, intraperitoneal, intradermal, intrathecal and other
administrations of the compounds of this invention are within the
skill of the artisan, for example the attending physician.
For intramuscular, subcutaneous and intravenous use, the
pharmaceutical compositions of the invention will generally be
provided in sterile aqueous solutions or suspensions, buffered to
an appropriate pH and isotonicity. In a preferred embodiment, the
carrier consists exclusively of an aqueous buffer. In this context,
"exclusively" means no auxiliary agents or encapsulating substances
are present which might affect or mediate uptake of dsRNA in the
cells that express a Hepatitis B Virus gene. Aqueous suspensions
according to the invention may include suspending agents such as
cellulose derivatives, sodium alginate, polyvinyl-pyrrolidone and
gum tragacanth, and a wetting agent such as lecithin. Suitable
preservatives for aqueous suspensions include ethyl and n-propyl
p-hydroxybenzoate. The pharmaceutical compositions useful according
to the invention also include encapsulated formulations to protect
the dsRNA against rapid elimination from the body, such as a
controlled release formulation, including implants and
microencapsulated delivery systems. Biodegradable, biocompatible
polymers can be used, such as ethylene vinyl acetate,
polyanhydrides, polyglycolic acid, collagen, polyorthoesters, and
polylactic acid. Methods for preparation of such formulations will
be apparent to those skilled in the art. Liposomal suspensions and
bi-specific antibodies can also be used as pharmaceutically
acceptable carriers. These can be prepared according to methods
known to those skilled in the art, for example, as described in PCT
publication WO91/06309 and WO2011/003780 which is incorporated by
reference herein.
As used herein, a "transformed cell" is a cell into which at least
one vector has been introduced from which a dsRNA molecule or at
least one strand of such a dsRNA molecule may be expressed. Such a
vector is preferably a vector comprising a regulatory sequence
operably linked to nucleotide sequence that encodes at least one
sense strand or antisense strand of a dsRNA of the present
invention.
It can be reasonably expected that shorter dsRNAs comprising one of
the sequences in Table 1 and 4 minus only a few nucleotides on one
or both ends may be similarly effective as compared to the dsRNAs
described above.
In one preferred embodiment the inventive dsRNA molecules comprise
nucleotides 1-19 of the sequences given in Table 1.
As pointed out above, in most embodiments of this invention, the
dsRNA molecules provided herein comprise a duplex length (i.e.
without "overhangs") of about 16 to about 30 nucleotides.
Particular useful dsRNA duplex lengths are about 19 to about 25
nucleotides. Most preferred are duplex structures with a length of
19 nucleotides. In the inventive dsRNA molecules, the antisense
strand is at least partially complementary to the sense strand.
The dsRNA of the invention can contain one or more mismatches to
the target sequence. In a preferred embodiment, the dsRNA of the
invention contains no more than 13 mismatches. If the antisense
strand of the dsRNA contains mismatches to a target sequence, it is
preferable that the area of mismatch not be located within
nucleotides 2-7 of the 5' terminus of the antisense strand. In
another embodiment it is preferable that the area of mismatch not
be located within nucleotides 2-9 of the 5' terminus of the
antisense strand.
As mentioned above, at least one end/strand of the dsRNA may have a
single-stranded nucleotide overhang of 1 to 5, preferably 1 or 2
nucleotides. dsRNAs having at least one nucleotide overhang have
unexpectedly superior inhibitory properties than their blunt-ended
counterparts. Moreover, the present inventors have discovered that
the presence of only one nucleotide overhang strengthens the
interference activity of the dsRNA, without affecting its overall
stability. dsRNA having only one overhang has proven particularly
stable and effective in viva, as well as in a variety of cells,
cell culture mediums, blood, and serum. Preferably, the
single-stranded overhang is located at the 3'-terminal end of the
antisense strand or, alternatively, at the 3'-terminal end of the
sense strand. The dsRNA may also have a blunt end, preferably
located at the 5'-end of the antisense strand. Preferably, the
antisense strand of the dsRNA has a nucleotide overhang at the
3'-end, and the 5'-end is blunt. In another embodiment, one or more
of the nucleotides in the overhang is replaced with a nucleoside
thiophosphate.
The dsRNA of the present invention may also be chemically modified
to enhance stability. The nucleic acids of the invention may be
synthesized and/or modified by methods well established in the art.
Chemical modifications may include, but are not limited to 2'
modifications, introduction of non-natural bases, covalent
attachment to a ligand, and replacement of phosphate linkages with
thiophosphate linkages, inverted deoxythymidines. In this
embodiment, the integrity of the duplex structure is strengthened
by at least one, and preferably two, chemical linkages. Chemical
linking may be achieved by any of a variety of well-known
techniques, for example by introducing covalent, ionic or hydrogen
bonds; hydrophobic interactions, van der Waals or stacking
interactions; by means of metal-ion coordination, or through use of
purine analogues. Preferably, the chemical groups that can be used
to modify the dsRNA include, without limitation, methylene blue;
bifunctional groups, preferably bis-(2-chloroethyl)amine;
N-acetyl-N'-(p-glyoxylbenzoyl) cystamine; 4-thiouracil; and
psoralen. In one preferred embodiment, the linker is a
hexa-ethylene glycol linker. In this case, the dsRNA are produced
by solid phase synthesis and the hexa-ethylene glycol linker is
incorporated according to standard methods (e.g., Williams D J and
Hall K B, Biochem. (1996) 35:14665-14670). In a particular
embodiment, the 5'-end of the antisense strand and the 3'-end of
the sense strand are chemically linked via a hexaethylene glycol
linker. In another embodiment, at least one nucleotide of the dsRNA
comprises a phosphorothioate or phosphorodithioate groups. The
chemical bond at the ends of the dsRNA is preferably formed by
triple-helix bonds.
In certain embodiments, a chemical bond may be formed by means of
one or several bonding groups, wherein such bonding groups are
preferably poly-(oxyphosphinicooxy-1,3-propandiol) and/or
polyethylene glycol chains. In other embodiments, a chemical bond
may also be formed by means of purine analogs introduced into the
double-stranded structure instead of purines. In further
embodiments, a chemical bond may be formed by azabenzene units
introduced into the double-stranded structure. In still further
embodiments, a chemical bond may be formed by branched nucleotide
analogs instead of nucleotides introduced into the double-stranded
structure. In certain embodiments, a chemical bond may be induced
by ultraviolet light.
In yet another embodiment, the nucleotides at one or both of the
two single strands may be modified to prevent or inhibit the
activation of cellular enzymes, for example certain nucleases.
Techniques for inhibiting the activation of cellular enzymes are
known in the art including, but not limited to, 2'-amino
modifications, 2'-amino sugar modifications, 2'-F sugar
modifications, 2'-F modifications, 2'-alkyl sugar modifications,
uncharged backbone modifications, morpholino modifications,
2'-O-methyl modifications, and phosphoramidate (see, e.g., Wagner,
Nat. Med. (1995) 1:111.6-8). Thus, at least one 2'-hydroxyl group
of the nucleotides on a dsRNA is replaced by a chemical group,
preferably by a 2'-amino or a 2'-methyl group. Also, at least one
nucleotide may be modified to form a locked nucleotide. Such locked
nucleotide contains a methylene bridge that connects the 2'-oxygen
of ribose the 4'-carbon of ribose. Introduction of a locked
nucleotide into an oligonucleotide improves the affinity for
complementary sequences and increases the melting temperature by
several degrees.
Modifications of dsRNA molecules provided herein may positively
influence their stability in vivo as well as in vitro and also
improve their delivery to the (diseased) target side. Furthermore,
such structural and chemical modifications may positively influence
physiological reactions towards the dsRNA molecules upon
administration, e.g. the cytokine release which is preferably
suppressed. Such chemical and structural modifications are known in
the art and are, inter alia, illustrated in Nawrot Current Topics
in Med Chem, (2006) 6:913-925.
Conjugating a ligand to a dsRNA can enhance its cellular absorption
as well as targeting to a particular tissue. In certain instances,
a hydrophobic ligand is conjugated to the dsRNA to facilitate
direct permeation of the cellular membrane. Alternatively, the
ligand conjugated to the dsRNA is a substrate for receptor-mediated
endocytosis. These approaches have been used to facilitate cell
permeation of antisense oligonucleotides. For example, cholesterol
has been conjugated to various antisense oligonucleotides resulting
in compounds that are substantially more active compared to their
non-conjugated analogs (See Manoharan M, Antisense & Nucleic
Acid Drug Development (2002) 12:103). Other lipophilic compounds
that have been conjugated to oligonucleotides include 1-pyrene
butyric acid, 1,3-bis-O-(hexadecyl)glycerol, and menthol. One
example of a ligand for receptor-mediated endocytosis is folic
acid. Folic acid enters the cell by folate-receptor-mediated
endocytosis. dsRNA compounds bearing folic acid would be
efficiently transported into the cell via the
folate-receptor-mediated endocytosis. Attachment of folic acid to
the 3'-terminus of an oligonucleotide results in increased cellular
uptake of the oligonucleotide (Li S, Deshmukh H M, and Huang L,
Pharm. Res. (1998) 15:1540). Other ligands that have been
conjugated to oligonucleotides include polyethylene glycols,
carbohydrate clusters, cross-linking agents, porphyrin conjugates,
and delivery peptides.
In certain instances, conjugation of a cationic ligand to
oligonucleotides often results in improved resistance to nucleases.
Representative examples of cationic ligands are propylammonium and
dimethylpropylammonium. Interestingly, antisense oligonucleotides
were reported to retain their high binding affinity to mRNA when
the cationic ligand was dispersed throughout the oligonucleotide.
See Manoharan M, Antisense & Nucleic Acid Drug Development
(2002) 12:103 and references therein.
The ligand-conjugated dsRNA of the invention may be synthesized by
the use of a dsRNA that bears a pendant reactive functionality,
such as that derived from the attachment of a linking molecule onto
the dsRNA. This reactive oligonucleotide may be reacted directly
with commercially-available ligands, ligands that are synthesized
bearing any of a variety of protecting groups, or ligands that have
a linking moiety attached thereto. The methods of the invention
facilitate the synthesis of ligand-conjugated dsRNA by the use of,
in some preferred embodiments, nucleoside monomers that have been
appropriately conjugated with ligands and that may further be
attached to a solid-support material. Such ligand-nucleoside
conjugates, optionally attached to a solid-support material, are
prepared according to some preferred embodiments of the methods of
the invention via reaction of a selected serum-binding ligand with
a linking moiety located on the 5' position of a nucleoside or
oligonucleotide. In certain instances, a dsRNA bearing an aralkyl
ligand attached to the 3'-terminus of the dsRNA is prepared by
first covalently attaching a monomer building block to a
controlled-pore-glass support via a long-chain aminoalkyl group.
Then, nucleotides are bonded via standard solid-phase synthesis
techniques to the monomer building-block bound to the solid
support. The monomer building block may be a nucleoside or other
organic compound that is compatible with solid-phase synthesis.
The dsRNA used in the conjugates of the invention may be
conveniently and routinely made through the well-known technique of
solid-phase synthesis. It is also known to use similar techniques
to prepare other oligonucleotides, such as the phosphorothioates
and alkylated derivatives.
Teachings regarding the synthesis of particular modified
oligonucleotides may be found in the following U.S. patents: U.S.
Pat. No. 5,218,105, drawn to polyamine conjugated oligonucleotides;
U.S. Pat. No. 5,541,307, drawn to oligonucleotides having modified
backbones; U.S. Pat. No. 5,521,302, drawn to processes for
preparing oligonucleotides having chiral phosphorus linkages; U.S.
Pat. No. 5,539,082, drawn to peptide nucleic acids; U.S. Pat. No.
5,554,746, drawn to oligonucleotides having .beta.-lactam
backbones; U.S. Pat. No. 5,571,902, drawn to methods and materials
for the synthesis of oligonucleotides; U.S. Pat. No. 5,578,718,
drawn to nucleosides having alkylthio groups, wherein such groups
may be used as linkers to other moieties attached at any of a
variety of positions of the nucleoside; U.S. Pat. No. 5,587,361
drawn to oligonucleotides having phosphorothioate linkages of high
chiral purity; U.S. Pat. No. 5,506,351, drawn to processes for the
preparation of 2'-O-alkyl guanosine and related compounds,
including 2,6-diaminopurine compounds; U.S. Pat. No. 5,587,469,
drawn to oligonucleotides having N-2 substituted purines; U.S. Pat.
No. 5,587,470, drawn to oligonucleotides having 3-deazapurines;
U.S. Pat. No. 5,608,046, both drawn to conjugated 4'-desmethyl
nucleoside analogs; U.S. Pat. No. 5,610,289, drawn to
backbone-modified oligonucleotide analogs; U.S. Pat. No. 6,262,241
drawn to, inter alia, methods of synthesizing
2'-fluoro-oligonucleotides.
In the ligand-conjugated dsRNA and ligand-molecule bearing
sequence-specific linked nucleosides of the invention, the
oligonucleotides and oligonucleosides may be assembled on a
suitable oligonucleotide synthesizer utilizing standard nucleotide
or nucleoside precursors, or nucleotide or nucleoside conjugate
precursors that already bear the linking moiety, ligand-nucleotide
or nucleoside-conjugate precursors that already bear the ligand
molecule, or non-nucleoside ligand-bearing building blocks.
When using nucleotide-conjugate precursors that already bear a
linking moiety, the synthesis of the sequence-specific linked
nucleosides is typically completed, and the ligand molecule is then
reacted with the linking moiety to form the ligand-conjugated
oligonucleotide. Oligonucleotide conjugates bearing a variety of
molecules such as steroids, vitamins, lipids and reporter
molecules, has previously been described (see Manoharan et al., PCT
Application WO 93/07883). In a preferred embodiment, the
oligonucleotides or linked nucleosides of the invention are
synthesized by an automated synthesizer using phosphoramidites
derived from ligand-nucleoside conjugates in addition to
commercially available phosphoramidites.
The incorporation of a 2'-O-methyl, 2'-O-ethyl, 2'-O-propyl,
2'-O-allyl, 2'-O-aminoalkyl or 2'-deoxy-2'-fluoro group in
nucleosides of an oligonucleotide confers enhanced hybridization
properties to the oligonucleotide. Further, oligonucleotides
containing phosphorothioate backbones have enhanced nuclease
stability. Thus, functionalized, linked nucleosides of the
invention can be augmented to include either or both a
phosphorothioate backbone or a 2'-.beta.-methyl, 2'-O-ethyl,
2'-O-propyl, 2'-O-aminoalkyl, 2'-O-allyl or 2'-deoxy-2'-fluoro
group.
In some preferred embodiments, functionalized nucleoside sequences
of the invention possessing an amino group at the 5'-terminus are
prepared using a DNA synthesizer, and then reacted with an active
ester derivative of a selected ligand. Active ester derivatives are
well known to those skilled in the art. Representative active
esters include N-hydrosuccinimide esters, tetrafluorophenolic
esters, pentafluorophenolic esters and pentachlorophenolic esters.
The reaction of the amino group and the active ester produces an
oligonucleotide in which the selected ligand is attached to the
5'-position through a linking group. The amino group at the
5'-terminus can be prepared utilizing a 5'-Amino-Modifier C6
reagent. In a preferred embodiment, ligand molecules may be
conjugated to oligonucleotides at the 5'-position by the use of a
ligand-nucleoside phosphoramidite wherein the ligand is linked to
the 5'-hydroxy group directly or indirectly via a linker. Such
ligand-nucleoside phosphoramidites are typically used at the end of
an automated synthesis procedure to provide a ligand-conjugated
oligonucleotide bearing the ligand at the 5'-terminus.
In one preferred embodiment of the methods of the invention, the
preparation of ligand conjugated oligonucleotides commences with
the selection of appropriate precursor molecules upon which to
construct the ligand molecule. Typically, the precursor is an
appropriately-protected derivative of the commonly-used
nucleosides. For example, the synthetic precursors for the
synthesis of the ligand-conjugated oligonucleotides of the
invention include, but are not limited to,
2'-aminoalkoxy-5'-ODMT-nucleosides,
2'-6-aminoalkylamino-5'-ODMT-nucleosides,
5'-6-aminoalkoxy-2'-deoxynucleosides,
5'-6-aminoalkoxy-2-protected-nucleosides,
3'-6-aminoalkoxy-5'-ODMT-nucleosides, and
3'-aminoalkylamino-5'-ODMT-nucleosides that may be protected in the
nucleobase portion of the molecule. Methods for the synthesis of
such amino-linked protected nucleoside precursors are known to
those of ordinary skill in the art.
In many cases, protecting groups are used during the preparation of
the compounds of the invention. As used herein, the term
"protected" means that the indicated moiety has a protecting group
appended thereon. In some preferred embodiments of the invention,
compounds contain one or more protecting groups. A wide variety of
protecting groups can be employed in the methods of the invention.
In general, protecting groups render chemical functionalities inert
to specific reaction conditions, and can be appended to and removed
from such functionalities in a molecule without substantially
damaging the remainder of the molecule.
Protecting groups in general and hydroxyl protecting groups in
particular are well known in the art (Greene and Wuts, Protective
Groups in Organic Synthesis, Chapter 2, 2d ed., John Wiley &
Sons, New York, 1991). Amino-protecting groups stable to acid
treatment are selectively removed with base treatment, and are used
to make reactive amino groups selectively available for
substitution. Examples of such groups are the Fmoc and various
substituted sulfonylethyl carbamates exemplified by the Nsc
group.
Additional amino-protecting groups include, but are not limited to,
carbamate protecting groups, such as 2-trimethylsilylethoxycarbonyl
(Teoc), 1-methyl-1-(4-biphenylyl)-ethoxycarbonyl (Bpoc),
t-butoxycarbonyl (BOC), allyloxycarbonyl (Alloc),
9-fluorenyl-methyloxycarbonyl (Fmoc), and benzyloxycarbonyl (Cbz);
amide protecting groups, such as formyl, acetyl, trihaloacetyl,
benzoyl, and nitrophenylacetyl; sulfonamide protecting groups, such
as 2-nitrobenzenesulfonyl; and imine and cyclic imide protecting
groups, such as phthalimido and dithiasuccinoyl. Equivalents of
these amino-protecting groups are also encompassed by the compounds
and methods of the invention.
Many solid supports are commercially available and one of ordinary
skill in the art can readily select a solid support to be used in
the solid-phase synthesis steps. In certain embodiments, a
universal support is used. A universal support, well known in the
art, allows for the preparation of oligonucleotides having unusual
or modified nucleotides located at the 3-terminus of the
oligonucleotide. In addition, it has been reported that the
oligonucleotide can be cleaved from the universal support under
milder reaction conditions when the oligonucleotide is bonded to
the solid support via a syn-1,2-acetoxyphosphate group which more
readily undergoes basic hydrolysis. See Guzaev A I, and Manoharan M
J. Am. Chem. Soc. (2003) 125:2380.
The nucleosides are linked by phosphorus-containing or
non-phosphorus-containing covalent internucleoside linkages. For
the purposes of identification, such conjugated nucleosides can be
characterized as ligand-bearing nucleosides or ligand-nucleoside
conjugates. The linked nucleosides having an aralkyl ligand
conjugated to a nucleoside within their sequence will demonstrate
enhanced dsRNA activity when compared to like dsRNA compounds that
are not conjugated.
The aralkyl-ligand-conjugated oligonucleotides of the invention
also include conjugates of oligonucleotides and linked nucleosides
wherein the ligand is attached directly to the nucleoside or
nucleotide without the intermediacy of a linker group. The ligand
may preferably be attached, via linking groups, at a carboxyl,
amino or oxo group of the ligand. Typical linking groups may be
ester, amide or carbamate groups.
Specific examples of preferred modified oligonucleotides envisioned
for use in the ligand-conjugated oligonucleotides of the invention
include oligonucleotides containing modified backbones or
non-natural internucleoside linkages. As defined here,
oligonucleotides having modified backbones or internucleoside
linkages include those that retain a phosphorus atom in the
backbone and those that do not have a phosphorus atom in the
backbone. For the purposes of the invention, modified
oligonucleotides that do not have a phosphorus atom in their
intersugar backbone can also be considered to be
oligonucleosides.
Specific oligonucleotide chemical modifications are described
below. It is not necessary for all positions in a given compound to
be uniformly modified. Conversely, more than one modifications may
be incorporated in a single dsRNA compound or even in a single
nucleotide thereof.
Preferred modified internucleoside linkages or backbones include,
for example, phosphorothioates, chiral phosphorothioates,
phosphorodithioates, phosphotriesters, aminoalkylphosphotriesters,
methyl and other alkyl phosphonates including 3'-alkylene
phosphonates and chiral phosphonates, phosphinates,
phosphoramidates including 3'-amino phosphoramidate and
aminoalkylphosphoramidates, thionophosphoramidates,
thionoalkylphosphonates, thionoalkylphosphotriesters, and
boranophosphates having normal 3'-5' linkages, 2'-5' linked analogs
of these, and those having inverted polarity wherein the adjacent
pairs of nucleoside units are linked 3'-5' to 5'-3' or 2'-5' to
5'-2'. Various salts, mixed salts and free-acid forms are also
included.
Representative United States patents relating to the preparation of
the above phosphorus-atom-containing linkages include, but are not
limited to, U.S. Pat. Nos. 4,469,863, 5,023,243, 5,264,423,
5,321,131, 5,399,676, 5,405,939, 5,453,496, 5,455,33, and
5,466,677, each of which is herein incorporated by reference.
Preferred modified internucleoside linkages or backbones that do
not include a phosphorus atom therein (i.e., oligonucleosides) have
backbones that are formed by short chain alkyl or cycloalkyl
intersugar linkages, mixed heteroatom and alkyl or cycloalkyl
intersugar linkages, or one or more short chain heteroatomic or
heterocyclic intersugar linkages. These include those having
morpholino linkages (formed in part from the sugar portion of a
nucleoside); siloxane backbones; sulfide, sulfoxide and sulfone
backbones; formacetyl and thioformacetyl backbones; methylene
formacetyl and thioformacetyl backbones; alkene containing
backbones; sulfamate backbones; methyleneimino and
methylenehydrazino backbones; sulfonate and sulfonamide backbones;
amide backbones; and others having mixed N, O, S and CH.sub.2
component parts.
Representative United States patents relating to the preparation of
the above oligonucleosides include, but are not limited to, U.S.
Pat. Nos. 5,034,506, 5,214,134, 5,216,141, 5,264,562, 5,466,677,
5,470,967, 5,489,677, 5,602,240, and 5,663,312, each of which is
herein incorporated by reference.
In other preferred oligonucleotide mimetics, both the sugar and the
internucleoside linkage, i.e., the backbone, of the nucleoside
units are replaced with novel groups. The nucleobase units are
maintained for hybridization with an appropriate nucleic acid
target compound. One such oligonucleotide, an oligonucleotide
mimetic, that has been shown to have excellent hybridization
properties, is referred to as a peptide nucleic acid (PNA). In PNA
compounds, the sugar-backbone of an oligonucleotide is replaced
with an amide-containing backbone, in particular an
aminoethylglycine backbone. The nucleobases are retained and are
bound directly or indirectly to atoms of the amide portion of the
backbone. Teaching of PNA compounds can be found for example in
U.S. Pat. No. 5,539,082.
Some preferred embodiments of the invention employ oligonucleotides
with phosphorothioate linkages and oligonucleosides with heteroatom
backbones, and in particular --CH.sub.2--NH--O--CH.sub.2,
--CH.sub.2--N(CH.sub.3)--O--CH.sub.2-- [known as a methylene
(methylimino) or MMI backbone],
--CH.sub.2--O--N(CH.sub.3)--CH.sub.2--,
--CH.sub.2--N(CH.sub.3)--N(CH.sub.3)--CH.sub.2--, and
--O--N(CH.sub.3)--CH.sub.2--CH.sub.2-- [wherein the native
phosphodiester backbone is represented as --O--P--O--CH.sub.2--] of
the above referenced U.S. Pat. No. 5,489,677, and the amide
backbones of the above referenced U.S. Pat. No. 5,602,240. Also
preferred are oligonucleotides having morpholino backbone
structures of the above-referenced U.S. Pat. No. 5,034,506.
The oligonucleotides employed in the ligand-conjugated
oligonucleotides of the invention may additionally or alternatively
comprise nucleobase (often referred to in the art simply as "base")
modifications or substitutions. As used herein, "unmodified" or
"natural" nucleobases include the purine bases adenine (A) and
guanine (G), and the pyrimidine bases thymine (T), cytosine (C),
and uracil (U). Modified nucleobases include other synthetic and
natural nucleobases, such as 5-methylcytosine (5-me-C),
5-hydroxymethyl cytosine, xanthine, hypoxanthine, 2-aminoadenine,
6-methyl and other alkyl derivatives of adenine and guanine,
2-propyl and other alkyl derivatives of adenine and guanine,
2-thiouracil, 2-thiothymine and 2-thiocytosine, 5-halouracil and
cytosine, 5-propynyl uracil and cytosine, 6-azo uracil, cytosine
and thymine, 5-uracil (pseudouracil), 4-thiouracil, 8-halo,
8-amino, 8-thiol, 8-thioalkyl, 8-hydroxyl and other 8-substituted
adenines and guanines, 5-halo particularly 5-bromo,
5-trifluoromethyl and other 5-substituted uracils and cytosines,
7-methylguanine and 7-methyladenine, 8-azaguanine and 8-azaadenine,
7-deazaguanine and 7-deazaadenine and 3-deazaguanine and
3-deazaadenine.
Further nucleobases include those disclosed in U.S. Pat. No.
3,687,808, or otherwise known in the art or commercially available.
Certain of these nucleobases are particularly useful for increasing
the binding affinity of the oligonucleotides of the invention.
These include 5-substituted pyrimidines, 6-azapyrimidines and N-2,
N-6 and O-6 substituted purines, including 2-aminopropyladenine,
5-propynyluracil and 5-propynylcytosine. 5-Methylcytosine
substitutions have been shown to increase nucleic acid duplex
stability by 0.6-1.2.degree. C. and are presently preferred base
substitutions, even more particularly when combined with
2'-methoxyethyl sugar modifications.
Representative United States patents relating to the preparation of
certain of the above-noted modified nucleobases as well as other
modified nucleobases include, but are not limited to, the above
noted U.S. Pat. No. 3,687,808, as well as U.S. Pat. Nos. 5,134,066,
5,459,255, 5,552,540, 5,594,121, and 5,596,091 all of which are
hereby incorporated by reference.
In certain embodiments, the oligonucleotides employed in the
ligand-conjugated oligonucleotides of the invention may
additionally or alternatively comprise one or more substituted
sugar moieties. Preferred oligonucleotides comprise one of the
following at the 2' position: OH; F; O-, S-, or N-alkyl, O-, S-, or
N-alkenyl, or O, S- or N-alkynyl, wherein the alkyl, alkenyl and
alkynyl may be substituted or unsubstituted C.sub.1 to C.sub.10
alkyl or C.sub.2 to C.sub.10 alkenyl and alkynyl. Particularly
preferred are O[(CH.sub.2).sub.nO].sub.mCH.sub.3,
O(CH.sub.2).sub.nOCH.sub.3, O(CH.sub.2).sub.nNH.sub.2,
O(CH.sub.2).sub.nCH.sub.3, O(CH.sub.2).sub.nONH.sub.2, and
O(CH.sub.2).sub.nON[CH.sub.2).sub.nCH.sub.3)].sub.2, where n and m
are from 1 to about 10. Other preferred oligonucleotides comprise
one of the following at the 2' position: C1 to C10 lower alkyl,
substituted lower alkyl, alkaryl, aralkyl, O-alkaryl or O-aralkyl,
SH, SCH.sub.3, OCN, Cl, Br, CN, CF.sub.3, OCF.sub.3, SOCH.sub.3,
SO.sub.2CH.sub.3, ONO.sub.2, NO.sub.2, N.sub.3, NH.sub.2,
heterocycloalkyl, heterocycloalkaryl, aminoalkylamino,
polyalkylamino, substituted silyl, an RNA cleaving group, a
reporter group, an intercalator, a group for improving the
pharmacokinetic properties of an oligonucleotide, or a group for
improving the pharmacodynamic properties of an oligonucleotide, and
other substituents having similar properties. A preferred
modification includes 2'-methoxyethoxy
(2'-O--CH.sub.2CH.sub.2OCH.sub.3, also known as
2'-O-(2-methoxyethyl) or 2'-MOE), i.e., an alkoxyalkoxy group. A
further preferred modification includes 2'-dimethylaminooxyethoxy,
i.e., a O(CH.sub.2).sub.2ON(CH.sub.3).sub.2 group, also known as
2'-DMAOE, as described in U.S. Pat. No. 6,127,533.
Other preferred modifications include 2'-methoxy (2'-O--CH.sub.3),
2'-aminopropoxy (2'-OCH.sub.2CH.sub.2CH.sub.2NH.sub.2) and
2'-fluoro (2'-F). Similar modifications may also be made at other
positions on the oligonucleotide, particularly the 3' position of
the sugar on the 3' terminal nucleotide or in 2'-5' linked
oligonucleotides.
As used herein, the term . . . sugar substituent group" or
"2'-substituent group" includes groups attached to the 2'-position
of the ribofuranosyl moiety with or without an oxygen atom. Sugar
substituent groups include, but are not limited to, fluoro,
O-alkyl, O-alkylamino, O-alkylalkoxy, protected O-alkylamino,
O-alkylaminoalkyl, O-alkyl imidazole and polyethers of the formula
(O-alkyl)m, wherein m is 1 to about 10. Preferred among these
polyethers are linear and cyclic polyethylene glycols (PEGs), and
(PEG)-containing groups, such as crown ethers and, inter alia,
those which are disclosed by Delgardo et. al. (Critical Reviews in
Therapeutic Drug Carrier Systems (1992) 9:249). Further sugar
modifications are disclosed by Cook (Anti-fibrosis Drug Design,
(1991) 6:585-607). Fluoro, O-alkyl, O-alkylamino, O-alkyl
imidazole, O-alkylaminoalkyl, and alkyl amino substitution is
described in U.S. Pat. No. 6,166,197, entitled "Oligomeric
Compounds having Pyrimidine Nucleotide(s) with 2' and 5'
Substitutions," hereby incorporated by reference in its
entirety.
Additional sugar substituent groups amenable to the invention
include 2'-SR and 2'-NR.sub.2 groups, wherein each R is,
independently, hydrogen, a protecting group or substituted or
unsubstituted alkyl, alkenyl, or alkynyl. 2'-SR Nucleosides are
disclosed in U.S. Pat. No. 5,670,633, hereby incorporated by
reference in its entirety. The incorporation of 2'-SR monomer
synthons is disclosed by Hamm et al. (J. Org. Chem., (1997)
62:3415-3420). 2'-NR nucleosides are disclosed by Thomson J B, J.
Org. Chem., (1996) 61:6273-6281; and Polushin et al., Tetrahedron
Lett., (1996) 37:3227-3230. Further representative 2'-substituent
groups amenable to the invention include those having one of
formula I or II:
##STR00001## wherein
E is C.sub.1-C.sub.10 alkyl, N(Q3)(Q4) or N.dbd.C(Q3)(Q4); each Q3
and Q4 is, independently, H, C.sub.1-C.sub.10 alkyl,
dialkylaminoalkyl, a nitrogen protecting group, a tethered or
untethered conjugate group, a linker to a solid support; or Q3 and
Q4, together, form a nitrogen protecting group or a ring structure
optionally including at least one additional heteroatom selected
from N and O; q1 is an integer from 1 to 10; q2 is an integer from
1 to 10; q3 is 0 or 1; q4 is 0, 1 or 2; each Z1, Z2, and Z3 is,
independently, C.sub.4-C.sub.7 cycloalkyl, C.sub.5-C.sub.14 aryl or
C.sub.3-C.sub.15 heterocyclyl, wherein the heteroatom in said
heterocyclyl group is selected from oxygen, nitrogen and sulfur; Z4
is OM1, SM1, or N(M1).sub.2; each M1 is, independently, H,
C.sub.1-C.sub.8 alkyl, C.sub.1-C.sub.8 haloalkyl, C(.dbd.NH)N(H)M2,
C(.dbd.O)N(H)M2 or OC(.dbd.O)N(H)M2; M2 is H or C.sub.1-C.sub.8
alkyl; and Z5 is C.sub.1-C.sub.10 alkyl, C.sub.1-C.sub.10
haloalkyl, C.sub.2-C.sub.10 alkenyl, C.sub.2-C.sub.10 alkynyl,
C.sub.6-C.sub.14 aryl, N(Q3)(Q4), OQ3, halo, SQ3 or CN.
Representative 2'-O-sugar substituent groups of formula I are
disclosed in U.S. Pat. No. 6,172,209, entitled "Capped 2'-Oxyethoxy
Oligonucleotides," hereby incorporated by reference in its
entirety. Representative cyclic 2'-O-sugar substituent groups of
formula II are disclosed in U.S. Pat. No. 6,271,358, entitled "RNA
Targeted 2'-Modified Oligonucleotides that are Conformationally
Preorganized," hereby incorporated by reference in its
entirety.
Sugars having O-substitutions on the ribosyl ring are also amenable
to the invention. Representative substitutions for ring O include,
but are not limited to, S, CH.sub.2, CHF, and CF.sub.2.
Oligonucleotides may also have sugar mimetics, such as cyclobutyl
moieties, in place of the pentofuranosyl sugar. Representative
United States patents relating to the preparation of such modified
sugars include, but are not limited to, U.S. Pat. Nos. 5,359,044,
5,466,786, 5,519,134, 5,591,722, 5,597,909, 5,646,265, and
5,700,920, all of which are hereby incorporated by reference.
Additional modifications may also be made at other positions on the
oligonucleotide, particularly the 3' position of the sugar on the
3' terminal nucleotide. For example, one additional modification of
the ligand-conjugated oligonucleotides of the invention involves
chemically linking to the oligonucleotide one or more additional
non-ligand moieties or conjugates which enhance the activity,
cellular distribution or cellular uptake of the oligonucleotide.
Such moieties include but are not limited to lipid moieties, such
as a cholesterol moiety (Letsinger et al., Proc. Natl. Acad. Sci.
USA, (1989) 86:6553), cholic acid (Manoharan et al., Bioorg. Med.
Chem. Lett., (1994) 4:1053), a thioether, e.g., hexyl-S-tylthiol
(Manoharan et al., Ann, N.Y. Acad. Sci., (1992) 660:306; Manoharan
et al., Bioorg. Med. Chem. Let., (1993) 3:2765), a thiocholesterol
(Oberhauser et al., Nucl. Acids Res, (1992) 20:533), an aliphatic
chain, e.g., dodecandiol or undecyl residues (Saison-Behmoaras et
al., EMBO J., (1991) 10:111; Kabanov et al., FEBS Lett., (1990)
259:327; Svinarchuk et al., Biochimie, (1993) 75:49), a
phospholipid, e.g., di-hexadecyl-rac-glycerol or triethylammonium
1,2-di-O-hexadecyl-rac-glycero-3-H-phosphonate (Manoharan et al.,
Tetrahedron Lett., (1995) 36:3651; Shea et al., Nucl. Acids Res.,
(1990) 18:3777), a polyamine or a polyethylene glycol chain
(Manoharan et al., Nucleosides & Nucleotides, (1995) 14:969),
or adamantane acetic acid (Manoharan et al., Tetrahedron Lett.,
(1995) 36:3651), a palmityl moiety (Mishra et al., Biochim.
Biophys. Acta, (1995) 1264:229), or an octadecylamine or
hexylamino-carbonyl-oxycholesterol moiety (Crooke et al., J.
Pharmacol. Exp. Ther., (1996) 277:923).
The invention also includes compositions employing oligonucleotides
that are substantially chirally pure with regard to particular
positions within the oligonucleotides. Examples of substantially
chirally pure oligonucleotides include, but are not limited to,
those having phosphorothioate linkages that are at least 75% Sp or
Rp (Cook et al., U.S. Pat. No. 5,587,361) and those having
substantially chirally pure (Sp or Rp) alkylphosphonate,
phosphoramidate or phosphotriester linkages (Cook, U.S. Pat. Nos.
5,212,295 and 5,521,302).
In certain instances, the oligonucleotide may be modified by a
non-ligand group. A number of non-ligand molecules have been
conjugated to oligonucleotides in order to enhance the activity,
cellular distribution or cellular uptake of the oligonucleotide,
and procedures for performing such conjugations are available in
the scientific literature. Such non-ligand moieties have included
lipid moieties, such as cholesterol (Letsinger et al., Proc. Natl.
Acad. Sci. USA, (1989, 86:6553), cholic acid (Manoharan et al.,
Bioorg. Med. Chem. Lett., (1994, 4:1053), a thioether, e.g.,
hexyl-S-tritylthiol (Manoharan et al., Ann. N.Y. Acad. Sci., (1992,
660:306; Manoharan et al., Bioorg. Med. Chem. Let., (1993, 3:2765),
a thiocholesterol (Oberhauser et al., Nucl. Acids Res., (1992,
20:533), an aliphatic chain, e.g., dodecandiol or undecyl residues
(Saison-Behmoaras et al., EMBO J., (1991) 10:111; Kabanov et al.,
FEBS Lett., (1990) 259:327; Svinarchuk et al., Biochimie, (1993)
75:49), a phospholipid, e.g., di-hexadecyl-rac-glycerol or
triethylammonium 1,2-di-O-hexadecyl-rac-glycero-3-H-phosphonate
(Manoharan et al., Tetrahedron Lett., (1995) 36:3651; Shea et al.,
Nucl. Acids Res., (1990) 18:3777), a polyamine or a polyethylene
glycol chain (Manoharan et al., Nucleosides & Nucleotides,
(1995) 14:969), or adamantane acetic acid (Manoharan et al.,
Tetrahedron Lett., (1995) 36:3651), a palmityl moiety (Mishra et
al., Biochim. Biophys. Acta, (1995) 1264:229), or an octadecylamine
or hexylamino-carbonyl-oxycholesterol moiety (Crooke et al., J.
Pharmacol. Exp. Ther., (1996) 277:923). Typical conjugation
protocols involve the synthesis of oligonucleotides bearing an
aminolinker at one or more positions of the sequence. The amino
group is then reacted with the molecule being conjugated using
appropriate coupling or activating reagents. The conjugation
reaction may be performed either with the oligonucleotide still
bound to the solid support or following cleavage of the
oligonucleotide in solution phase. Purification of the
oligonucleotide conjugate by HPLC typically affords the pure
conjugate.
Alternatively, the molecule being conjugated may be converted into
a building block, such as a phosphoramidite, via an alcohol group
present in the molecule or by attachment of a linker bearing an
alcohol group that may be phosphorylated.
Importantly, each of these approaches may be used for the synthesis
of ligand conjugated oligonucleotides. Amino linked
oligonucleotides may be coupled directly with ligand via the use of
coupling reagents or following activation of the ligand as an NHS
or pentfluorophenolate ester. Ligand phosphoramidites may be
synthesized via the attachment of an aminohexanol linker to one of
the carboxyl groups followed by phosphitylation of the terminal
alcohol functionality. Other linkers, such as cysteamine, may also
be utilized for conjugation to a chloroacetyl linker present on a
synthesized oligonucleotide.
The person skilled in the art is readily aware of methods to
introduce the molecules of this invention into cells, tissues or
organisms. Corresponding examples have also been provided in the
detailed description of the invention above. For example, the
nucleic acid molecules or the vectors of this invention, encoding
for at least one strand of the inventive dsRNAs may be introduced
into cells or tissues by methods known in the art, like
transfections etc.
Also for the introduction of dsRNA molecules, means and methods
have been provided. For example, targeted delivery by glycosylated
and folate-modified molecules, including the use of polymeric
carriers with ligands, such as galactose and lactose or the
attachment of folic acid to various macromolecules allows the
binding of molecules to be delivered to folate receptors. Targeted
delivery by peptides and proteins other than antibodies, for
example, including RGD-modified nanoparticles to deliver siRNA in
vivo or multicomponent (nonviral) delivery systems including short
cyclodextrins, adamantine-PEG are known. Yet, also the targeted
delivery using antibodies or antibody fragments, including
(monovalent) Fab-fragments of an antibody (or other fragments of
such an antibody) or single-chain antibodies are envisaged.
Injection approaches for target directed delivery comprise, inter
alia, hydrodynamic i.v. injection. Also cholesterol conjugates of
dsRNA may be used for targeted delivery, whereby the conjugation to
lipohilic groups enhances cell uptake and improve pharmacokinetics
and tissue biodistribution of oligonucleotides. Also cationic
delivery systems are known, whereby synthetic vectors with net
positive (cationic) charge to facilitate the complex formation with
the polyanionic nucleic acid and interaction with the negatively
charged cell membrane. Such cationic delivery systems comprise also
cationic liposomal delivery systems, cationic polymer and peptide
delivery systems. Other delivery systems for the cellular uptake of
dsRNA/siRNA are aptamer-ds/siRNA. Also gene therapy approaches can
be used to deliver the inventive dsRNA molecules or nucleic acid
molecules encoding the same. Such systems comprise the use of
non-pathogenic virus, modified viral vectors, as well as deliveries
with nanoparticles or liposomes. Other delivery methods for the
cellular uptake of dsRNA are extracorporeal, for example ex vivo
treatments of cells, organs or tissues. Certain of these
technologies are described and summarized in publications, like
Akhtar, Journal of Clinical Investigation (2007) 117:3623-3632,
Nguyen et al., Current Opinion in Molecular Therapeutics (2008)
10:158-167, Zamboni, Clin Cancer Res (2005) 11:8230-8234 or Ikeda
et al., Pharmaceutical Research (2006) 23:1631-1640.
Unless otherwise defined, all technical and scientific terms used
herein have the same meaning as commonly understood by one of
ordinary skill in the art to which this invention belongs. Although
methods and materials similar or equivalent to those described
herein can be used in the practice or testing of the invention,
suitable methods and materials are described below. All
publications, patent applications, and patents are incorporated by
reference in their entirety. In case of conflict, the present
specification, including definitions, will control. In addition,
the materials, methods, and examples are illustrative only and not
intended to be limiting.
The above provided embodiments and items of the present invention
are now illustrated with the following, non-limiting examples.
EXAMPLES
Identification of dsRNAs for therapeutic use. dsRNA design was
carried out to identify dsRNAs specifically targeting Hepatitis B
Virus genotypes A, B, C and D for therapeutic use. First, the known
Hepatitis B Virus genomic sequences were downloaded from NCBI
Genbank (accessions listed in Table. 6). The genotype information
was either extracted form NCBI Genbank files or determined by
computer aided comparison with reference genomes (accessions listed
in Table. 6).
The Hepatitis B Virus genomic sequences of genotype A-D were
examined by computer analysis to identify optimal target regions
for RNAi agents, namely highly conserved 17nucleotide long sequence
stretches that were identical in at least 90% of all sequences.
In identifying RNAi agents, the selection was limited to 17mer
sequences having at least two mismatches to any sequence in the
human RefSeq database (release 41), which we assumed to represent
the comprehensive human transcriptome, by using a proprietary
algorithm.
All 17mer sequences containing four or more consecutive G's (poly-G
sequences) were further excluded from the synthesis.
Sequences of 19 nucleotides length were defined that harbor the
selected 17mers in position 2 to 18.
These 19mer sequences yield RNA interference (RNAi) agents
cross-reactive to Hepatitis B Virus genomic sequences of genotype
A-D and formed the basis for the synthesis of the RNAi agents in
appended Tables 1 and 2.
dsRNA synthesis. Oligoribonucleotides were synthesized according to
the phosphoramidite technology on solid phase. Depending on the
scale either an ABI 394 synthesizer (Applied Biosystems) or an AKTA
oligopilot 100 (GE Healthcare, Freiburg, Germany) was used.
Syntheses were performed on a solid support made of controlled pore
glass (CPG, 520 .ANG., with a loading of 75 .mu.mol/g, obtained
from Prime Synthesis, Aston, Pa., USA). All 2'-modified RNA
phosphoramidites as well as ancillary reagents were purchased from
SAFC (Hamburg, Germany). Specifically, the following 2'-O-Methyl
phosphoramidites were used:
(5'-O-dimethoxytrityl-N.sup.6-(benzoyl)-2'-O-methyl-adenosine-3'-O-(2-cya-
noethyl-N,N-diisopropylamino) phosphoramidite,
5'-O--dimethoxytrityl-N.sup.4-(acetyl)-2'-O-methyl-cytidine-3'-O-(2-cyano-
ethyl-N,N-diisopropylamino) phosphoramidite,
(5'-O-dimethoxytrityl-N.sup.2-(isobutyryl)-2'-O-methyl-guanosine-3'-O-(2--
cyanoethyl-N,N-diisopropylamino)phosphoramidite, and
5'-O-dimethoxy-trityl-2'-O-methyl-uridine-3'-O-(2-cyanoethyl-N,N-diisopro-
pylamino) phosphoramidite. The 2'-Deoxy-2'-fluoro-phosphoramidites
carried the same protecting groups as the 2'-O-methyl RNA amidites.
All amidites were dissolved in anhydrous acetonitrile (100 mM) and
molecular sieves (3 .ANG.) were added. To generate the 5'-phosphate
the
2-[2-(4,4'-Dimethoxytrityloxy)ethylsulfonyl]ethyl-(2-cyanoethyl)-(N,N-dii-
sopropyl)-phosphoramidite from Glen Research (Sterling, Va., USA)
was used. In order to introduce the C-6 aminolinker at the 5'-end
of the oligomers the
6-(Trifluoroacetylamino)-hexyl-(2-cyanoethyl)-(N,N-diisopropyl)-phosphora-
midite from Thermo Fisher Scientific (Milwaukee, Wis., USA) was
employed. The 5'-modifications were introduced without any
modification of the synthesis cycle. 5-Ethyl thiotetrazole (ETT,
500 mM in acetonitrile) was used as activator solution. Coupling
times were 6 min. In order to introduce phosphorothioate linkages,
a 50 mM solution of
3-((Dimethylamino-methylidene)amino)-3H-1,2,4-dithiazole-3-thione
(DDTT, obtained from AM Chemicals, Oceanside, Calif., USA) in
anhydrous Acetonitrile/pyridine (1:1 v/v) was employed.
Cleavage and deprotection of support bound oligomer. After
finalization of the solid phase synthesis, cyanoethyl protecting
groups were removed by a 30 min treatment with 20% Diethyl amine in
ACN without cleaving the oligonucleotides from the support.
Subsequently, the dried solid support was transferred to a 15 mL
tube and treated with concentrated aqueous ammonia (Aldrich) for 18
h at 40.degree. C. After centrifugation the supernatant was
transferred to a new tube and the CPG was washed with aqueous
ammonia. The combined solutions were evaporated and the solid
residue was reconstituted in buffer A (see below).
Purification of oligoribonucleotides. Crude oligomers were purified
by anionic exchange HPLC using a column packed with Source Q15 (GE
Helthcare) and an AKTA Explorer system (GE Helthcare). Buffer A was
10 mM sodium perchlorate, 20 mM Tris, 1 mM EDTA, pH 7.4 (Fluka,
Buchs, Switzerland) and contained 20% Acetonitrile and buffer B was
the same as buffer A with the exception of 500 mM sodium
perchlorate. A gradient of 22% B to 42% B within 32 column volumes
(CV) was employed. UV traces at 280 nm were recorded Appropriate
fractions were pooled and precipitated with 3M NaOAc, pH=5.2 and
70% Ethanol. Finally, the pellet was washed with 70% Ethanol.
Alternatively, desalting was carried out using Sephadex HiTrap
columns (GE Helthcare) according to the manufacturer's
recommendation.
Annealing of oligoribonucleotides to generate siRNA. Complementary
strands were mixed by combining equimolar RNA solutions. The
mixture was lyophilized and reconstituted with an appropriate
volume of annealing buffer (100 mM NaCl, 20 mM sodium phosphate, pH
6.8) to achieve the desired concentration. This solution was placed
into a water bath at 80.degree. C. which was cooled to RT within 3
h.
In Vitro screening of HBV mRNA-targeting dsRNA. The psiCHECK.TM.-2
vector (Promega) contains two reporter genes for monitoring RNAi
activity: a synthetic version of the renilla luciferase (hRluc)
gene and a synthetic firefly luciferase gene (hluc+). Measurement
of firefly luciferase activity permits determination of changes
unrelated to the RNAi activity of tested dsRNA. Renilla and firefly
luciferase activities were measured using the Dual-Glo.RTM.
Luciferase Assay System (Promega). HBV target sites of interest
were inserted into the psiCHECK.TM.-2 vector, after cloning into
the multiple cloning region located 3' of the synthetic renilla
luciferase gene's translational stop codon and the polyA tail. Cell
line COS-7 was transfected with the vector, and subsequently
treated with dsRNA-lipofectamine 2000 lipoplexes targeting the HBV
sequences. The RNAi effect conferred by the dsRNA towards the
cloned HBV target site was determined by measuring activity of the
renilla luciferase fusion gene.
Generation of psiCHECK Vectors Containing Target Sequences. In
order to test the activity of the HBV dsRNAs, a Dual-Luciferase HBV
reporter was constructed. Regions 84 to 805, 1075 to 1992, 2165 to
2530, and 2718 to 2940 of Hepatitis B Virus genomic sequence
accession number EU554538.1 (genotype C) were joined in silico. Two
mutations were inserted intentionally (128 A.fwdarw.T, 598
T.fwdarw.C, positions relative to EU554538.1). One was needed to
remove an internal XhoI site. The second mutation led to removal of
a single mismatch to a dsRNA. This HBV target construct was
extended by adding restriction sites at both the 5' and 3' end. The
artificial DNA sequence was chemically synthesized by Geneart
(Regensburg, Germany) and cloned into the XhoI/NotI site of
psiCHECK.TM.-2 Dual-Luciferase vector.
Transfection and Luciferase Quantification. Cos-7 cells (DSMZ.
Braunschweig, Germany, cat. No. ACC-60) were seeded at a density of
2.25.times.10.sup.4 cells/well in 96-well plates. Plasmid
transfection was carried out at a concentration of 50 ng/well with
0.5 .mu.L/well Lipofectamine 2000 (invitrogen GmbH, Karlsruhe,
Germany, cat. No. 11668-019) as described by the manufacturer. 4 h
after vector transfection, the medium was discarded and fresh
medium was added. After this period, the dsRNAs were added to the
cells in a concentration of 10 nM or 1 nM using Lipofectamine 2000
as described above. In order to optimize the HBV genotype coverage
and to minimize development of resistance against dsRNAs, two
different dsRNAs can be used simultaneously in combination. For
demonstrating the feasibility of such approach, pairs of two
different dsRNAs were selected among the most efficient dsRNAs with
additional bias towards optimized genotype coverage.
The dsRNAs were added to the cells in a concentration of 5 nM or
0.5 nM for each dsRNA, resulting in 10 nM or 1 nM total dsRNA
concentration, using Lipofectamine 2000 as described above. The
cells were lysed 48 hours later using luciferase reagents as
described by the manufacturer. Renilla luciferase protein levels
were normalized to firefly luciferase levels to consider
transfection efficiency. For each dsRNA four individual data points
were collected. At least one dsRNA unrelated to all target sites
was used as a control to determine the relative renilla luciferase
protein levels in cells treated with dsRNA (Table 8). For
comparison of silencing activity under full-match conditions,
dsRNAs with full match to the renilla open reading frame were
synthesized and tested in parallel to the HBV dsRNAs.
Inhibition data are given in appended Table 2.
Stability of dsRNAs. Stability of dsRNAs targeting human Hepatitis
B Virus was determined in in vitro assays with any one of human,
cynomolgous monkey or mouse serum by measuring the half-life of
each single strand.
Measurements were carried out in triplicates for each time point,
using 3 .mu.L 50 .mu.M dsRNA sample mixed with 30 .mu.L human serum
(Sigma), cynomolgous monkey serum (Sigma) or mouse serum (Sigma).
Mixtures were incubated for either 0 min, 30 min, 1 h, 3 h, 6 h, 24
h, or 48 h at 37.degree. C. As control for unspecific degradation
dsRNA was incubated with 30 .mu.L 1.times.PBS pH 6.8 for 48 h.
Reactions were stopped by the addition of 4 .mu.L proteinase K (20
mg/ml), 25 .mu.L of "Tissue and Cell Lysis Solution" (Epicentre)
and 38 .mu.L Millipore water for 30 min at 65.degree. C. Samples
were afterwards spin filtered through a 0.2 .mu.m 96 well filter
plate at 1400 rpm for 8 min, washed with 55 .mu.L Millipore water
twice and spin filtered again.
For separation of single strands and analysis of remaining full
length product (FLP), samples were run through an ion exchange
Dionex Summit HPLC under denaturing conditions using as eluent A 20
mM Na.sub.3PO.sup.4 in 10% ACN pH=11 and for eluent B 1M NaBr in
eluent A.
The following gradient was applied:
TABLE-US-00001 Time (min) % A % B -1.0 75 25 1.00 75 25 19.0 38 62
19.5 0 100 21.5 0 100 22.0 75 25 24.0 75 25
For every injection, the chromatograms were integrated
automatically by the Dionex Chromeleon 6.60 HPLC software, and were
adjusted manually if necessary. All peak areas were corrected to
the internal standard (IS) peak and normalized to the incubation at
t=0 min. The area under the peak and resulting remaining FLP was
calculated for each single strand and triplicate separately.
Half-life (t1/2) of a strand was defined by the average time point
(h) for triplicates at which half of the FLP was degraded. Results
are given in appended Table 3.
SEQUENCE LISTINGS
1
SEQUENCE LISTING <160> NUMBER OF SEQ ID NOS: 792 <210>
SEQ ID NO 1 <211> LENGTH: 19 <212> TYPE: RNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 1 caagguaugu ugcccguuu 19 <210> SEQ ID
NO 2 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 2 cuguaggcau aaauuggua 19 <210> SEQ ID
NO 3 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 3 ucugcggcgu uuuaucaua 19 <210> SEQ ID
NO 4 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 4 accucugccu aaucaucuc 19 <210> SEQ ID
NO 5 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 5 uuuacuagug ccauuugua 19 <210> SEQ ID
NO 6 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 6 accucugccu aaucaucua 19 <210> SEQ ID
NO 7 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 7 cuguaggcau aaauugguc 19 <210> SEQ ID
NO 8 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 8 ugucugcggc guuuuauca 19 <210> SEQ ID
NO 9 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 9 uacuagugcc auuuguuca 19 <210> SEQ ID
NO 10 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 10 caacuuuuuc accucugca 19 <210> SEQ ID
NO 11 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 11 ccauuuguuc agugguucg 19 <210> SEQ ID
NO 12 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 12 ccaaguguuu gcugacgca 19 <210> SEQ ID
NO 13 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: sense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 13 ccauuuguuc agugguuca
19 <210> SEQ ID NO 14 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: sense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 14 uuuacuagug ccauuuguu
19 <210> SEQ ID NO 15 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: sense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 15 caccucugcc uaaucauca
19 <210> SEQ ID NO 16 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: sense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 16 cuggcucagu uuacuagug
19 <210> SEQ ID NO 17 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: sense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 17 caagguaugu ugcccguua
19 <210> SEQ ID NO 18 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: sense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 18 cuggcucagu uuacuagua
19 <210> SEQ ID NO 19 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: sense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 19 gaggcuguag gcauaaauu
19 <210> SEQ ID NO 20 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: sense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 20 caguuuacua gugccauuu
19 <210> SEQ ID NO 21 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: sense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 21 agguauguug cccguuugu
19 <210> SEQ ID NO 22 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: sense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 22 uauguugccc guuugucca
19 <210> SEQ ID NO 23 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: sense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 23 gaggcuguag gcauaaaua
19 <210> SEQ ID NO 24 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: sense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 24 gucugcggcg uuuuaucau
19 <210> SEQ ID NO 25 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: sense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group"
<400> SEQUENCE: 25 caacuuuuuc accucugcc 19 <210> SEQ ID
NO 26 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 26 ccgugugcac uucgcuuca 19 <210> SEQ ID
NO 27 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 27 ucaagguaug uugcccgua 19 <210> SEQ ID
NO 28 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 28 caguuuacua gugccauua 19 <210> SEQ ID
NO 29 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 29 ugguggacuu cucucaauu 19 <210> SEQ ID
NO 30 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 30 agguauguug cccguuuga 19 <210> SEQ ID
NO 31 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 31 cugcucgugu uacaggcgg 19 <210> SEQ ID
NO 32 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 32 uauguugccc guuuguccu 19 <210> SEQ ID
NO 33 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 33 ucaagguaug uugcccguu 19 <210> SEQ ID
NO 34 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 34 ucuuaucaac acuuccgga 19 <210> SEQ ID
NO 35 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 35 caccucugcc uaaucaucu 19 <210> SEQ ID
NO 36 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 36 auaagaggac ucuuggacu 19 <210> SEQ ID
NO 37 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 37 gucugcggcg uuuuaucaa 19 <210> SEQ ID
NO 38 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
sense strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 38 ggcgcugaau cccgcggac 19 <210> SEQ ID
NO 39 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 39 cgcgucgcag aagaucuca 19 <210> SEQ ID
NO 40 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 40 aaugucaacg accgaccuu 19 <210> SEQ ID
NO 41 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 41 gcucaguuua cuagugcca 19 <210> SEQ ID
NO 42 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 42 ugguggacuu cucucaaua 19 <210> SEQ ID
NO 43 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 43 aucgccgcgu cgcagaaga 19 <210> SEQ ID
NO 44 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 44 gccauuuguu cagugguuc 19 <210> SEQ ID
NO 45 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 45 cgauccauac ugcggaacu 19 <210> SEQ ID
NO 46 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 46 ucaccucugc cuaaucauc 19 <210> SEQ ID
NO 47 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 47 guggacuucu cucaauuuu 19 <210> SEQ ID
NO 48 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 48 gggucaccau auucuuggg 19 <210> SEQ ID
NO 49 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 49 gccgcgucgc agaagaucu 19 <210> SEQ ID
NO 50 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 50
ucaaucgccg cgucgcaga 19 <210> SEQ ID NO 51 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 51
uggauguguc ugcggcguu 19 <210> SEQ ID NO 52 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 52
uacuguucaa gccuccaag 19 <210> SEQ ID NO 53 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 53
guuuacuagu gccauuugu 19 <210> SEQ ID NO 54 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 54
acuagugcca uuuguucag 19 <210> SEQ ID NO 55 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 55
ccgcgucgca gaagaucuc 19 <210> SEQ ID NO 56 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 56
uaucuuauca acacuuccg 19 <210> SEQ ID NO 57 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 57
ggccaaaauu cgcaguccc 19 <210> SEQ ID NO 58 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 58
uucaccucug ccuaaucau 19 <210> SEQ ID NO 59 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 59
cucaguuuac uagugccau 19 <210> SEQ ID NO 60 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 60
uguugcccgu uuguccucu 19 <210> SEQ ID NO 61 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 61
uagugccauu uguucagug 19 <210> SEQ ID NO 62 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 62
aggcuguagg cauaaauug 19 <210> SEQ ID NO 63 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 63
augugucugc ggcguuuua 19 <210> SEQ ID NO 64 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 64
acuucgcuuc accucugca 19 <210> SEQ ID NO 65 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 65
cgugugcacu ucgcuucac 19 <210> SEQ ID NO 66 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 66
gugguggacu ucucucaau 19 <210> SEQ ID NO 67 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 67
ugugucugcg gcguuuuau 19 <210> SEQ ID NO 68 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 68
aagguauguu gcccguuug 19 <210> SEQ ID NO 69 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 69
ucaacgaccg accuugagg 19 <210> SEQ ID NO 70 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 70
cauaagagga cucuuggac 19 <210> SEQ ID NO 71 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 71
gucaacgacc gaccuugag 19 <210> SEQ ID NO 72 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 72
auauucuugg gaacaagag 19 <210> SEQ ID NO 73 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 73
ugcucguguu acaggcggg 19 <210> SEQ ID NO 74 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 74
caaucgccgc gucgcagaa 19 <210> SEQ ID NO 75 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 75
acuguucaag ccuccaagc 19
<210> SEQ ID NO 76 <211> LENGTH: 19 <212> TYPE:
RNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 76 cgccgcgucg cagaagauc 19 <210> SEQ ID
NO 77 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 77 cauuuguuca gugguucgu 19 <210> SEQ ID
NO 78 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 78 cgcugaaucc cgcggacga 19 <210> SEQ ID
NO 79 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 79 ugggucacca uauucuugg 19 <210> SEQ ID
NO 80 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 80 uccucugccg auccauacu 19 <210> SEQ ID
NO 81 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 81 augucaacga ccgaccuug 19 <210> SEQ ID
NO 82 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 82 ccucugccua aucaucuca 19 <210> SEQ ID
NO 83 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 83 accgugugca cuucgcuuc 19 <210> SEQ ID
NO 84 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 84 ugccgaucca uacugcgga 19 <210> SEQ ID
NO 85 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 85 cagagucuag acucguggu 19 <210> SEQ ID
NO 86 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 86 cuguucaagc cuccaagcu 19 <210> SEQ ID
NO 87 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 87 ggaggcugua ggcauaaau 19 <210> SEQ ID
NO 88 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 88
aggaggcugu aggcauaaa 19 <210> SEQ ID NO 89 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 89
gguggacuuc ucucaauuu 19 <210> SEQ ID NO 90 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 90
gcaacuuuuu caccucugc 19 <210> SEQ ID NO 91 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 91
cugcucgugu uacaggcga 19 <210> SEQ ID NO 92 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 92
cuagugccau uuguucagu 19 <210> SEQ ID NO 93 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 93
cugccgaucc auacugcgg 19 <210> SEQ ID NO 94 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 94
gugugcacuu cgcuucacc 19 <210> SEQ ID NO 95 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 95
gcucguguua caggcgggc 19 <210> SEQ ID NO 96 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 96
ccuaucuuau caacacuuc 19 <210> SEQ ID NO 97 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 97
ucucaaucgc cgcgucgca 19 <210> SEQ ID NO 98 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 98
gcccgucugu gccuucuca 19 <210> SEQ ID NO 99 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 99
cuaucuuauc aacacuucc 19 <210> SEQ ID NO 100 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 100
auguugcccg uuuguccuc 19 <210> SEQ ID NO 101
<211> LENGTH: 19 <212> TYPE: RNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: sense strand
of dsRNA <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 101
guauguugcc cguuugucc 19 <210> SEQ ID NO 102 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 102
cuucgcuuca ccucugcac 19 <210> SEQ ID NO 103 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 103
ugugcacuuc gcuucaccu 19 <210> SEQ ID NO 104 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 104
gccaaaauuc gcagucccg 19 <210> SEQ ID NO 105 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 105
ccugcucgug uuacaggcg 19 <210> SEQ ID NO 106 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 106
uggagugugg auucgcacu 19 <210> SEQ ID NO 107 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 107
aacgaccgac cuugaggca 19 <210> SEQ ID NO 108 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 108
acagagucua gacucgugg 19 <210> SEQ ID NO 109 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 109
aaucgccgcg ucgcagaag 19 <210> SEQ ID NO 110 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 110
gguauguugc ccguuuguc 19 <210> SEQ ID NO 111 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 111
gccgauccau acugcggaa 19 <210> SEQ ID NO 112 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 112
gcccuaucuu aucaacacu 19 <210> SEQ ID NO 113 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 113 aguuuacuag ugccauuug
19 <210> SEQ ID NO 114 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: sense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 114 ugucaacgac cgaccuuga
19 <210> SEQ ID NO 115 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: sense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 115 acuucucuca auuuucuag
19 <210> SEQ ID NO 116 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: sense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 116 gcgcgggacg uccuuuguc
19 <210> SEQ ID NO 117 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: sense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 117 ucuagacucg ugguggacu
19 <210> SEQ ID NO 118 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: sense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 118 gauccauacu gcggaacuc
19 <210> SEQ ID NO 119 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: sense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 119 cucugccgau ccauacugc
19 <210> SEQ ID NO 120 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: sense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 120 ucugccgauc cauacugcg
19 <210> SEQ ID NO 121 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: sense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 121 ccucugccga uccauacug
19 <210> SEQ ID NO 122 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: sense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 122 gcaccucucu uuacgcggu
19 <210> SEQ ID NO 123 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: sense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 123 aagaacuccc ucgccucgc
19 <210> SEQ ID NO 124 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: sense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 124 gaacucccuc gccucgcag
19 <210> SEQ ID NO 125 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: sense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 125 ucucucaauu uucuagggc
19 <210> SEQ ID NO 126 <211> LENGTH: 19 <212>
TYPE: RNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 126 gggcgcaccu cucuuuacg 19 <210> SEQ
ID NO 127 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 127 ccgauccaua cugcggaac 19 <210> SEQ
ID NO 128 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 128 aacucccucg ccucgcaga 19 <210> SEQ
ID NO 129 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 129 cuccucugcc gauccauac 19 <210> SEQ
ID NO 130 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 130 ggagugugga uucgcacuc 19 <210> SEQ
ID NO 131 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 131 cgggcgcacc ucucuuuac 19 <210> SEQ
ID NO 132 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 132 gucucaaucg ccgcgucgc 19 <210> SEQ
ID NO 133 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 133 auccauacug cggaacucc 19 <210> SEQ
ID NO 134 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 134 cgcaccucuc uuuacgcgg 19 <210> SEQ
ID NO 135 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 135 caacgaccga ccuugaggc 19 <210> SEQ
ID NO 136 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 136 ccauacugcg gaacuccua 19 <210> SEQ
ID NO 137 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 137 ugaaucccgc ggacgaccc 19 <210> SEQ
ID NO 138 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 138 agaacucccu cgccucgca 19 <210> SEQ
ID NO 139 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 139 ggcgcaccuc ucuuuacgc 19 <210> SEQ
ID NO 140 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 140 gcgcaccucu cuuuacgcg 19 <210> SEQ
ID NO 141 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 141 gcugaauccc gcggacgac 19 <210> SEQ
ID NO 142 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 142 cacuucgcuu caccucugc 19 <210> SEQ
ID NO 143 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 143 cucaaucgcc gcgucgcag 19 <210> SEQ
ID NO 144 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 144 ucccgucggc gcugaaucc 19 <210> SEQ
ID NO 145 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 145 cugaaucccg cggacgacc 19 <210> SEQ
ID NO 146 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 146 agagucuaga cucguggug 19 <210> SEQ
ID NO 147 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 147 uccauacugc ggaacuccu 19 <210> SEQ
ID NO 148 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 148 gcgcugaauc ccgcggacg 19 <210> SEQ
ID NO 149 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 149 aguguggauu cgcacuccu 19 <210> SEQ
ID NO 150 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 150 cccugcucgu guuacaggc 19 <210> SEQ
ID NO 151 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 151 gaaucccgcg gacgacccg 19 <210> SEQ
ID NO 152 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 152 aagcugugcc uuggguggc 19 <210> SEQ
ID NO 153 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 153 gcccugcucg uguuacagg 19 <210> SEQ
ID NO 154 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 154 gucccgucgg cgcugaauc 19 <210> SEQ
ID NO 155 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 155 aucuuaucaa cacuuccgg 19 <210> SEQ
ID NO 156 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 156 cuuaucaaca cuuccggaa 19 <210> SEQ
ID NO 157 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 157 aaacgggcaa cauaccuug 19 <210> SEQ
ID NO 158 <211> LENGTH: 19 <212> TYPE: DNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2..19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 158 taccaauuua ugccuacag 19 <210> SEQ ID NO 159
<211> LENGTH: 19 <212> TYPE: RNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 159 uaugauaaaa cgccgcaga 19 <210> SEQ
ID NO 160 <211> LENGTH: 19 <212> TYPE: DNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2..19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 160 taugauaaaa cgccgcaga 19 <210> SEQ ID NO 161
<211> LENGTH: 19 <212> TYPE: RNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 161 gagaugauua ggcagaggu 19 <210> SEQ
ID NO 162 <211> LENGTH: 19 <212> TYPE: DNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2..19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 162 tacaaauggc acuaguaaa 19 <210> SEQ ID NO 163
<211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 2..19
<223> OTHER INFORMATION: /mod_base = "2'-hydroxy
corresponding nucleoside" <400> SEQUENCE: 163 tagaugauua
ggcagaggu 19 <210> SEQ ID NO 164 <211> LENGTH: 19
<212> TYPE: RNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: antisense strand of dsRNA <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
1 <223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 164 gaccaauuua ugccuacag
19 <210> SEQ ID NO 165 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 165 ugauaaaacg ccgcagaca
19 <210> SEQ ID NO 166 <211> LENGTH: 19 <212>
TYPE: DNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 2..19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 166 tgauaaaacg ccgcagaca 19 <210> SEQ
ID NO 167 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 167 ugaacaaaug gcacuagua 19 <210> SEQ
ID NO 168 <211> LENGTH: 19 <212> TYPE: DNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2..19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 168 tgaacaaaug gcacuagua 19 <210> SEQ ID NO 169
<211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2..19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 169 tgcagaggug aaaaaguug 19 <210> SEQ ID NO 170
<211> LENGTH: 19 <212> TYPE: RNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 170 cgaaccacug aacaaaugg 19 <210> SEQ
ID NO 171 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 171 ugcgucagca aacacuugg 19 <210> SEQ
ID NO 172 <211> LENGTH: 19 <212> TYPE: DNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2..19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 172 tgcgucagca aacacuugg 19 <210> SEQ ID NO 173
<211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2..19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 173 tgaaccacug aacaaaugg 19 <210> SEQ ID NO 174
<211> LENGTH: 19 <212> TYPE: RNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 174 aacaaauggc acuaguaaa 19
<210> SEQ ID NO 175 <211> LENGTH: 19 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 2..19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 175 tgaugauuag gcagaggug 19 <210> SEQ
ID NO 176 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 176 cacuaguaaa cugagccag 19 <210> SEQ
ID NO 177 <211> LENGTH: 19 <212> TYPE: DNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2..19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 177 taacgggcaa cauaccuug 19 <210> SEQ ID NO 178
<211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2..19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 178 tacuaguaaa cugagccag 19 <210> SEQ ID NO 179
<211> LENGTH: 19 <212> TYPE: RNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 179 aauuuaugcc uacagccuc 19 <210> SEQ
ID NO 180 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 180 aaauggcacu aguaaacug 19 <210> SEQ
ID NO 181 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 181 acaaacgggc aacauaccu 19 <210> SEQ
ID NO 182 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 182 uggacaaacg ggcaacaua 19 <210> SEQ
ID NO 183 <211> LENGTH: 19 <212> TYPE: DNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2..19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 183 tauuuaugcc uacagccuc 19 <210> SEQ ID NO 184
<211> LENGTH: 19 <212> TYPE: RNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 184 augauaaaac gccgcagac 19 <210> SEQ
ID NO 185 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 185 ggcagaggug aaaaaguug 19 <210> SEQ
ID NO 186 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 186 ugaagcgaag ugcacacgg 19 <210> SEQ
ID NO 187 <211> LENGTH: 19 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 2..19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 187 tgaagcgaag ugcacacgg 19 <210> SEQ
ID NO 188 <211> LENGTH: 19 <212> TYPE: DNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2..19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 188 tacgggcaac auaccuuga 19 <210> SEQ ID NO 189
<211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2..19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 189 taauggcacu aguaaacug 19 <210> SEQ ID NO 190
<211> LENGTH: 19 <212> TYPE: RNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 190 aauugagaga aguccacca 19 <210> SEQ
ID NO 191 <211> LENGTH: 19 <212> TYPE: DNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2..19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 191 tcaaacgggc aacauaccu 19 <210> SEQ ID NO 192
<211> LENGTH: 19 <212> TYPE: RNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 192 ccgccuguaa cacgagcag 19 <210> SEQ
ID NO 193 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 193 aggacaaacg ggcaacaua 19 <210> SEQ
ID NO 194 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 194 aacgggcaac auaccuuga 19 <210> SEQ
ID NO 195 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 195 uccggaagug uugauaaga 19 <210> SEQ
ID NO 196 <211> LENGTH: 19 <212> TYPE: DNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2..19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 196 tccggaagug uugauaaga 19 <210> SEQ ID NO 197
<211> LENGTH: 19 <212> TYPE: RNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 197 agaugauuag gcagaggug 19 <210> SEQ
ID NO 198 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 198 aguccaagag uccucuuau 19 <210> SEQ
ID NO 199
<211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2..19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 199 tugauaaaac gccgcagac 19 <210> SEQ ID NO 200
<211> LENGTH: 19 <212> TYPE: RNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 200 guccgcggga uucagcgcc 19 <210> SEQ
ID NO 201 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 201 ugagaucuuc ugcgacgcg 19 <210> SEQ
ID NO 202 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 202 aaggucgguc guugacauu 19 <210> SEQ
ID NO 203 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 203 uggcacuagu aaacugagc 19 <210> SEQ
ID NO 204 <211> LENGTH: 19 <212> TYPE: DNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2..19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 204 tauugagaga aguccacca 19 <210> SEQ ID NO 205
<211> LENGTH: 19 <212> TYPE: RNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 205 ucuucugcga cgcggcgau 19 <210> SEQ
ID NO 206 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 206 gaaccacuga acaaauggc 19 <210> SEQ
ID NO 207 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 207 aguuccgcag uauggaucg 19 <210> SEQ
ID NO 208 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 208 gaugauuagg cagagguga 19 <210> SEQ
ID NO 209 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 209 aaaauugaga gaaguccac 19 <210> SEQ
ID NO 210 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 210 cccaagaaua uggugaccc 19 <210> SEQ
ID NO 211 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 211 agaucuucug cgacgcggc 19 <210> SEQ
ID NO 212 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 212 ucugcgacgc ggcgauuga 19 <210> SEQ
ID NO 213 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 213 aacgccgcag acacaucca 19 <210> SEQ
ID NO 214 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 214 cuuggaggcu ugaacagua 19 <210> SEQ
ID NO 215 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 215 acaaauggca cuaguaaac 19 <210> SEQ
ID NO 216 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 216 cugaacaaau ggcacuagu 19 <210> SEQ
ID NO 217 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 217 gagaucuucu gcgacgcgg 19 <210> SEQ
ID NO 218 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 218 cggaaguguu gauaagaua 19 <210> SEQ
ID NO 219 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 219 gggacugcga auuuuggcc 19 <210> SEQ
ID NO 220 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 220 augauuaggc agaggugaa 19 <210> SEQ
ID NO 221 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 221 auggcacuag uaaacugag 19 <210> SEQ
ID NO 222 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 222 agaggacaaa cgggcaaca 19 <210> SEQ
ID NO 223 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 223 cacugaacaa auggcacua 19 <210> SEQ
ID NO 224 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 224 caauuuaugc cuacagccu 19
<210> SEQ ID NO 225 <211> LENGTH: 19 <212> TYPE:
RNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 225 uaaaacgccg cagacacau
19 <210> SEQ ID NO 226 <211> LENGTH: 19 <212>
TYPE: DNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 2..19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 226 taaaacgccg cagacacau 19 <210> SEQ
ID NO 227 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 227 ugcagaggug aagcgaagu 19 <210> SEQ
ID NO 228 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 228 gugaagcgaa gugcacacg 19 <210> SEQ
ID NO 229 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 229 auugagagaa guccaccac 19 <210> SEQ
ID NO 230 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 230 auaaaacgcc gcagacaca 19 <210> SEQ
ID NO 231 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 231 caaacgggca acauaccuu 19 <210> SEQ
ID NO 232 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 232 ccucaagguc ggucguuga 19 <210> SEQ
ID NO 233 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 233 guccaagagu ccucuuaug 19 <210> SEQ
ID NO 234 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 234 cucaaggucg gucguugac 19 <210> SEQ
ID NO 235 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 235 cucuuguucc caagaauau 19 <210> SEQ
ID NO 236 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 236 cccgccugua acacgagca 19 <210> SEQ
ID NO 237 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 237 uucugcgacg cggcgauug 19
<210> SEQ ID NO 238 <211> LENGTH: 19 <212> TYPE:
RNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 238 gcuuggaggc uugaacagu
19 <210> SEQ ID NO 239 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 239 gaucuucugc gacgcggcg
19 <210> SEQ ID NO 240 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 240 acgaaccacu gaacaaaug
19 <210> SEQ ID NO 241 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 241 ucguccgcgg gauucagcg
19 <210> SEQ ID NO 242 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 242 ccaagaauau ggugaccca
19 <210> SEQ ID NO 243 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 243 aguauggauc ggcagagga
19 <210> SEQ ID NO 244 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 244 caaggucggu cguugacau
19 <210> SEQ ID NO 245 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 245 ugagaugauu aggcagagg
19 <210> SEQ ID NO 246 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 246 gaagcgaagu gcacacggu
19 <210> SEQ ID NO 247 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 247 uccgcaguau ggaucggca
19 <210> SEQ ID NO 248 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 248 accacgaguc uagacucug
19 <210> SEQ ID NO 249 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 249 agcuuggagg cuugaacag
19 <210> SEQ ID NO 250 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 250 auuuaugccu acagccucc
19 <210> SEQ ID NO 251 <211> LENGTH: 19
<212> TYPE: RNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: antisense strand of dsRNA <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
1 <223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 251 uuuaugccua cagccuccu
19 <210> SEQ ID NO 252 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 252 aaauugagag aaguccacc
19 <210> SEQ ID NO 253 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 253 gcagagguga aaaaguugc
19 <210> SEQ ID NO 254 <211> LENGTH: 19 <212>
TYPE: DNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 2..19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 254 tcgccuguaa cacgagcag 19 <210> SEQ
ID NO 255 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 255 acugaacaaa uggcacuag 19 <210> SEQ
ID NO 256 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 256 ccgcaguaug gaucggcag 19 <210> SEQ
ID NO 257 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 257 ggugaagcga agugcacac 19 <210> SEQ
ID NO 258 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 258 gcccgccugu aacacgagc 19 <210> SEQ
ID NO 259 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 259 gaaguguuga uaagauagg 19 <210> SEQ
ID NO 260 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 260 ugcgacgcgg cgauugaga 19 <210> SEQ
ID NO 261 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 261 ugagaaggca cagacgggc 19 <210> SEQ
ID NO 262 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 262 ggaaguguug auaagauag 19 <210> SEQ
ID NO 263 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 263 gaggacaaac gggcaacau 19 <210> SEQ
ID NO 264
<211> LENGTH: 19 <212> TYPE: RNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 264 ggacaaacgg gcaacauac 19 <210> SEQ
ID NO 265 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 265 gugcagaggu gaagcgaag 19 <210> SEQ
ID NO 266 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 266 aggugaagcg aagugcaca 19 <210> SEQ
ID NO 267 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 267 cgggacugcg aauuuuggc 19 <210> SEQ
ID NO 268 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 268 cgccuguaac acgagcagg 19 <210> SEQ
ID NO 269 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 269 agugcgaauc cacacucca 19 <210> SEQ
ID NO 270 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 270 ugccucaagg ucggucguu 19 <210> SEQ
ID NO 271 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 271 ccacgagucu agacucugu 19 <210> SEQ
ID NO 272 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 272 cuucugcgac gcggcgauu 19 <210> SEQ
ID NO 273 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 273 gacaaacggg caacauacc 19 <210> SEQ
ID NO 274 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 274 uuccgcagua uggaucggc 19 <210> SEQ
ID NO 275 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 275 aguguugaua agauagggc 19 <210> SEQ
ID NO 276 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 276 caaauggcac uaguaaacu 19 <210> SEQ
ID NO 277 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 277 ucaaggucgg ucguugaca
19 <210> SEQ ID NO 278 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 278 cuagaaaauu gagagaagu
19 <210> SEQ ID NO 279 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 279 gacaaaggac gucccgcgc
19 <210> SEQ ID NO 280 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 280 aguccaccac gagucuaga
19 <210> SEQ ID NO 281 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 281 gaguuccgca guauggauc
19 <210> SEQ ID NO 282 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 282 gcaguaugga ucggcagag
19 <210> SEQ ID NO 283 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 283 cgcaguaugg aucggcaga
19 <210> SEQ ID NO 284 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 284 caguauggau cggcagagg
19 <210> SEQ ID NO 285 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 285 accgcguaaa gagaggugc
19 <210> SEQ ID NO 286 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 286 gcgaggcgag ggaguucuu
19 <210> SEQ ID NO 287 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 287 cugcgaggcg agggaguuc
19 <210> SEQ ID NO 288 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 288 gcccuagaaa auugagaga
19 <210> SEQ ID NO 289 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 289 cguaaagaga ggugcgccc
19 <210> SEQ ID NO 290 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 290
guuccgcagu auggaucgg 19 <210> SEQ ID NO 291 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 291
ucugcgaggc gagggaguu 19 <210> SEQ ID NO 292 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 292
guauggaucg gcagaggag 19 <210> SEQ ID NO 293 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 293
gagugcgaau ccacacucc 19 <210> SEQ ID NO 294 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 294
guaaagagag gugcgcccg 19 <210> SEQ ID NO 295 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 295
gcgacgcggc gauugagac 19 <210> SEQ ID NO 296 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 296
ggaguuccgc aguauggau 19 <210> SEQ ID NO 297 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 297
ccgcguaaag agaggugcg 19 <210> SEQ ID NO 298 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 298
gccucaaggu cggucguug 19 <210> SEQ ID NO 299 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 299
uaggaguucc gcaguaugg 19 <210> SEQ ID NO 300 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 300
gggucguccg cgggauuca 19 <210> SEQ ID NO 301 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 301
ugcgaggcga gggaguucu 19 <210> SEQ ID NO 302 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <400> SEQUENCE: 302
gcguaaagag aggugcgcc 19 <210> SEQ ID NO 303 <211>
LENGTH: 19 <212> TYPE: RNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 303 cgcguaaaga gaggugcgc 19 <210> SEQ
ID NO 304 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 304 gucguccgcg ggauucagc 19 <210> SEQ
ID NO 305 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 305 gcagagguga agcgaagug 19 <210> SEQ
ID NO 306 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 306 cugcgacgcg gcgauugag 19 <210> SEQ
ID NO 307 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 307 ggauucagcg ccgacggga 19 <210> SEQ
ID NO 308 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 308 ggucguccgc gggauucag 19 <210> SEQ
ID NO 309 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 309 caccacgagu cuagacucu 19 <210> SEQ
ID NO 310 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 310 aggaguuccg caguaugga 19 <210> SEQ
ID NO 311 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 311 cguccgcggg auucagcgc 19 <210> SEQ
ID NO 312 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 312 aggagugcga auccacacu 19 <210> SEQ
ID NO 313 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 313 gccuguaaca cgagcaggg 19 <210> SEQ
ID NO 314 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 314 cgggucgucc gcgggauuc 19 <210> SEQ
ID NO 315 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 315 gccacccaag gcacagcuu 19 <210> SEQ
ID NO 316 <211> LENGTH: 19 <212> TYPE: RNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence:
antisense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<400> SEQUENCE: 316 ccuguaacac gagcagggc 19
<210> SEQ ID NO 317 <211> LENGTH: 19 <212> TYPE:
RNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 317 gauucagcgc cgacgggac
19 <210> SEQ ID NO 318 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 318 ccggaagugu ugauaagau
19 <210> SEQ ID NO 319 <211> LENGTH: 19 <212>
TYPE: RNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <400> SEQUENCE: 319 uuccggaagu guugauaag
19 <210> SEQ ID NO 320 <211> LENGTH: 19 <212>
TYPE: DNA <213> ORGANISM: Artificial sequence <220>
FEATURE: <223> OTHER INFORMATION: Description of the
artificial sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 2..19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 320 tuccggaagu guugauaag 19 <210> SEQ
ID NO 321 <211> LENGTH: 21 <212> TYPE: DNA <213>
ORGANISM: Artificial sequence <220> FEATURE: <223>
OTHER INFORMATION: Description of the artificial sequence: sense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 6, 8, 10, 11, 13, 14, 15, 17, 18, 19
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 4, 5, 7, 9, 12, 16 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 321 caagguaugu ugcccguuut t 21 <210>
SEQ ID NO 322 <211> LENGTH: 20 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2, 4, 6, 8, 10, 12, 14, 16, 18 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1, 3, 5, 7, 9, 11, 13, 15, 17,
19 <223> OTHER INFORMATION: /mod_base = "2'-deoxy-2'-fluoro
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 20 <223> OTHER
INFORMATION: /mod_base = "3'-3'-linked desoxythymidine" <400>
SEQUENCE: 322 cuguaggcau aaauugguat 20 <210> SEQ ID NO 323
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: sense strand
of dsRNA <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1, 2, 3,
5, 8, 10, 11, 12, 13, 15, 16, 18 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
21 <223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 4, 6, 7, 9, 14, 17, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 323 ucugcggcgu uuuaucauat t 21 <210>
SEQ ID NO 324 <211> LENGTH: 20 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2, 4, 6, 8, 10, 12, 14, 16, 18 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1, 3, 5, 7, 9, 11, 13, 15, 17,
19 <223> OTHER INFORMATION: /mod_base = "2'-deoxy-2'-fluoro
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 20 <223> OTHER
INFORMATION: /mod_base = "3'-3'-linked desoxythymidine" <400>
SEQUENCE: 324 ucugcggcgu uuuaucauat 20 <210> SEQ ID NO 325
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: sense strand
of dsRNA <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1, 2, 3,
4, 5, 6, 8, 9, 10, 13, 14, 16, 17, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 7, 11, 12, 15
<223> OTHER INFORMATION: /mod_base = "2'-hydroxy
corresponding
nucleoside" <400> SEQUENCE: 325 accucugccu aaucaucuct t 21
<210> SEQ ID NO 326 <211> LENGTH: 20 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2, 4, 6, 8, 10, 12, 14, 16, 18 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1, 3, 5, 7, 9, 11, 13, 15, 17,
19 <223> OTHER INFORMATION: /mod_base = "2'-deoxy-2'-fluoro
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 20 <223> OTHER
INFORMATION: /mod_base = "3'-3'-linked desoxythymidine" <400>
SEQUENCE: 326 uuuacuagug ccauuuguat 20 <210> SEQ ID NO 327
<211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: sense strand
of dsRNA <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 2, 4, 6,
8, 10, 12, 14, 16, 18 <223> OTHER INFORMATION: /mod_base =
"2'-O-methyl corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1, 3, 5,
7, 9, 11, 13, 15, 17, 19 <223> OTHER INFORMATION: /mod_base =
"2'-deoxy-2'-fluoro corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 20
<223> OTHER INFORMATION: /mod_base = "3'-3'-linked
desoxythymidine" <400> SEQUENCE: 327 accucugccu aaucaucuat 20
<210> SEQ ID NO 328 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 4, 8, 10, 14, 15, 18, 19 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 5, 6, 7, 9, 11, 12, 13, 16, 17 <223>
OTHER INFORMATION: /mod_base = "2'-hydroxy corresponding
nucleoside" <400> SEQUENCE: 328 cuguaggcau aaauugguct t 21
<210> SEQ ID NO 329 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 7, 10, 12, 13, 14, 15, 17, 18
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 6, 8, 9, 11, 16, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 329 ugucugcggc guuuuaucat t 21 <210>
SEQ ID NO 330 <211> LENGTH: 20 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2, 4, 6, 8, 10, 12, 14, 16, 18 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1, 3, 5, 7, 9, 11, 13, 15, 17,
19 <223> OTHER INFORMATION: /mod_base = "2'-deoxy-2'-fluoro
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 20 <223> OTHER
INFORMATION: /mod_base = "3'-3'-linked desoxythymidine" <400>
SEQUENCE: 330 ugucugcggc guuuuaucat 20 <210> SEQ ID NO 331
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: sense strand
of dsRNA <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1, 2, 3,
4, 7, 9, 10, 12, 13, 14, 16, 17, 18 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
21 <223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 5, 6, 8, 11, 15, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 331 uacuagugcc auuuguucat t 21 <210>
SEQ ID NO 332 <211> LENGTH: 20 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2, 4, 6, 8, 10, 12, 14, 16, 18 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1, 3, 5, 7, 9, 11, 13, 15, 17,
19 <223> OTHER INFORMATION: /mod_base = "2'-deoxy-2'-fluoro
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 20 <223> OTHER
INFORMATION: /mod_base = "3'-3'-linked desoxythymidine" <400>
SEQUENCE: 332 uacuagugcc auuuguucat 20
<210> SEQ ID NO 333 <211> LENGTH: 20 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2, 4, 6, 8, 10, 12, 14, 16, 18 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1, 3, 5, 7, 9, 11, 13, 15, 17,
19 <223> OTHER INFORMATION: /mod_base = "2'-deoxy-2'-fluoro
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 20 <223> OTHER
INFORMATION: /mod_base = "3'-3'-linked desoxythymidine" <400>
SEQUENCE: 333 caacuuuuuc accucugcat 20 <210> SEQ ID NO 334
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: sense strand
of dsRNA <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1, 2, 4,
5, 6, 8, 9, 10, 13, 16, 17, 18 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
21 <223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 7, 11, 12, 14, 15, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 334 ccauuuguuc agugguucgt t 21 <210>
SEQ ID NO 335 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 6, 8, 9, 10, 12, 13, 16, 18 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 4, 5, 7, 11, 14, 15, 17, 19 <223>
OTHER INFORMATION: /mod_base = "2'-hydroxy corresponding
nucleoside" <400> SEQUENCE: 335 ccaaguguuu gcugacgcat t 21
<210> SEQ ID NO 336 <211> LENGTH: 20 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2, 4, 6, 8, 10, 12, 14, 16, 18 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1, 3, 5, 7, 9, 11, 13, 15, 17,
19 <223> OTHER INFORMATION: /mod_base = "2'-deoxy-2'-fluoro
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 20 <223> OTHER
INFORMATION: /mod_base = "3'-3'-linked desoxythymidine" <400>
SEQUENCE: 336 ccaaguguuu gcugacgcat 20 <210> SEQ ID NO 337
<211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: sense strand
of dsRNA <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 2, 4, 6,
8, 10, 12, 14, 16, 18 <223> OTHER INFORMATION: /mod_base =
"2'-O-methyl corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1, 3, 5,
7, 9, 11, 13, 15, 17, 19 <223> OTHER INFORMATION: /mod_base =
"2'-deoxy-2'-fluoro corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 20
<223> OTHER INFORMATION: /mod_base = "3'-3'-linked
desoxythymidine" <400> SEQUENCE: 337 ccauuuguuc agugguucat 20
<210> SEQ ID NO 338 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 5, 6, 9, 11, 12, 14, 15, 16, 18, 19
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 4, 7, 8, 10, 13, 17 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 338 uuuacuagug ccauuuguut t 21 <210>
SEQ ID NO 339 <211> LENGTH: 20 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2, 4, 6, 8, 10, 12, 14, 16, 18 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1, 3, 5, 7, 9, 11, 13, 15, 17,
19 <223> OTHER INFORMATION: /mod_base = "2'-deoxy-2'-fluoro
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 20 <223> OTHER
INFORMATION: /mod_base = "3'-3'-linked desoxythymidine" <400>
SEQUENCE: 339 caccucugcc uaaucaucat 20 <210> SEQ ID NO 340
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 5, 6, 7, 10, 11, 12, 14, 15, 18
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 4, 8, 9, 13, 16, 17, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 340 cuggcucagu uuacuagugt t 21 <210>
SEQ ID NO 341 <211> LENGTH: 20 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2, 4, 6, 8, 10, 12, 14, 16, 18 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1, 3, 5, 7, 9, 11, 13, 15, 17,
19 <223> OTHER INFORMATION: /mod_base = "2'-deoxy-2'-fluoro
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 20 <223> OTHER
INFORMATION: /mod_base = "3'-3'-linked desoxythymidine" <400>
SEQUENCE: 341 caagguaugu ugcccguuat 20 <210> SEQ ID NO 342
<211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: sense strand
of dsRNA <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 2, 4, 6,
8, 10, 12, 14, 16, 18 <223> OTHER INFORMATION: /mod_base =
"2'-O-methyl corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1, 3, 5,
7, 9, 11, 13, 15, 17, 19 <223> OTHER INFORMATION: /mod_base =
"2'-deoxy-2'-fluoro corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 20
<223> OTHER INFORMATION: /mod_base = "3'-3'-linked
desoxythymidine" <400> SEQUENCE: 342 cuggcucagu uuacuaguat 20
<210> SEQ ID NO 343 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 5, 6, 8, 12, 14, 18, 19 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 4, 7, 9, 10, 11, 13, 15, 16, 17
<223> OTHER INFORMATION: /mod_base = "2'-hydroxy
corresponding nucleoside" <400> SEQUENCE: 343 gaggcuguag
gcauaaauut t 21 <210> SEQ ID NO 344 <211> LENGTH: 21
<212> TYPE: DNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: sense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1, 2, 4, 5, 6, 8, 9, 12, 14,
15, 17, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-O-methyl corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 7, 10, 11, 13, 16 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 344 caguuuacua gugccauuut t 21 <210>
SEQ ID NO 345 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 4, 6, 8, 9, 11, 12, 13, 15, 16, 17, 19
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 5, 7, 10, 14, 18 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 345 agguauguug cccguuugut t 21 <210>
SEQ ID NO 346 <211> LENGTH: 20 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2, 4, 6, 8, 10, 12, 14, 16, 18 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1, 3, 5, 7, 9, 11, 13, 15, 17,
19 <223> OTHER INFORMATION: /mod_base = "2'-deoxy-2'-fluoro
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 20 <223> OTHER
INFORMATION: /mod_base = "3'-3'-linked desoxythymidine" <400>
SEQUENCE: 346 uauguugccc guuuguccat 20 <210> SEQ ID NO 347
<211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: sense strand
of dsRNA <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 2, 4, 6, 8, 10, 12, 14, 16, 18
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 3, 5, 7, 9, 11,
13, 15, 17, 19 <223> OTHER INFORMATION: /mod_base =
"2'-deoxy-2'-fluoro corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 20
<223> OTHER INFORMATION: /mod_base = "3'-3'-linked
desoxythymidine" <400> SEQUENCE: 347 gaggcuguag gcauaaauat 20
<210> SEQ ID NO 348 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 6, 9, 11, 12, 13, 14, 16, 17, 19
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 5, 7, 8, 10, 15, 18 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 348 gucugcggcg uuuuaucaut t 21 <210>
SEQ ID NO 349 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 4, 5, 6, 7, 8, 9, 10, 12, 13, 14, 15,
16, 18, 19 <223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 11, 17 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 349 caacuuuuuc accucugcct t 21 <210> SEQ ID NO 350
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: sense strand
of dsRNA <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1, 2, 4,
6, 8, 10, 11, 12, 13, 15, 16, 17, 18 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
21 <223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 5, 7, 9, 14, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 350 ccgugugcac uucgcuucat t 21 <210>
SEQ ID NO 351 <211> LENGTH: 20 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2, 4, 6, 8, 10, 12, 14, 16, 18 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1, 3, 5, 7, 9, 11, 13, 15, 17,
19 <223> OTHER INFORMATION: /mod_base = "2'-deoxy-2'-fluoro
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 20 <223> OTHER
INFORMATION: /mod_base = "3'-3'-linked desoxythymidine" <400>
SEQUENCE: 351 ccgugugcac uucgcuucat 20 <210> SEQ ID NO 352
<211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: sense strand
of dsRNA <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 2, 4, 6,
8, 10, 12, 14, 16, 18 <223> OTHER INFORMATION: /mod_base =
"2'-O-methyl corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1, 3, 5,
7, 9, 11, 13, 15, 17, 19 <223> OTHER INFORMATION: /mod_base =
"2'-deoxy-2'-fluoro corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 20
<223> OTHER INFORMATION: /mod_base = "3'-3'-linked
desoxythymidine" <400> SEQUENCE: 352 ucaagguaug uugcccguat 20
<210> SEQ ID NO 353 <211> LENGTH: 20 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2, 4, 6, 8, 10, 12, 14, 16, 18 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1, 3, 5, 7, 9, 11, 13, 15, 17,
19 <223> OTHER INFORMATION: /mod_base = "2'-deoxy-2'-fluoro
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 20 <223> OTHER
INFORMATION: /mod_base = "3'-3'-linked desoxythymidine" <400>
SEQUENCE: 353 caguuuacua gugccauuat 20 <210> SEQ ID NO 354
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: sense strand
of dsRNA <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 4, 8, 9, 10, 11, 12, 13, 14, 15, 18, 19
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 5, 6, 7, 16, 17 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 354 ugguggacuu cucucaauut t 21 <210>
SEQ ID NO 355 <211> LENGTH: 20 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2, 4, 6, 8, 10, 12, 14, 16, 18 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1, 3, 5, 7, 9, 11, 13, 15, 17,
19 <223> OTHER INFORMATION: /mod_base = "2'-deoxy-2'-fluoro
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 20 <223> OTHER
INFORMATION: /mod_base = "3'-3'-linked desoxythymidine" <400>
SEQUENCE: 355 agguauguug cccguuugat 20 <210> SEQ ID NO 356
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: sense strand
of dsRNA <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1, 2, 4,
5, 6, 8, 10, 11, 13, 17 <223> OTHER INFORMATION: /mod_base =
"2'-O-methyl corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 7, 9, 12, 14, 15, 16, 18, 19 <223>
OTHER INFORMATION: /mod_base = "2'-hydroxy corresponding
nucleoside" <400> SEQUENCE: 356 cugcucgugu uacaggcggt t 21
<210> SEQ ID NO 357 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 5, 6, 8, 9, 10, 12, 13, 14, 16, 17,
18, 19 <223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 4, 7, 11, 15 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 357 uauguugccc guuuguccut t 21 <210> SEQ ID NO 358
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: sense strand
of dsRNA <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1, 2, 7,
9, 11, 12, 14, 15, 16, 18, 19 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
21 <223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 4, 5, 6, 8, 10, 13, 17 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 358 ucaagguaug uugcccguut t 21 <210>
SEQ ID NO 359 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 6, 7, 10, 12, 13, 14, 15, 16
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 5, 8, 9, 11, 17, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 359 ucuuaucaac acuuccggat t 21 <210>
SEQ ID NO 360 <211> LENGTH: 20 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2, 4, 6, 8, 10, 12, 14, 16, 18 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1, 3, 5, 7, 9, 11, 13, 15, 17,
19 <223> OTHER INFORMATION: /mod_base = "2'-deoxy-2'-fluoro
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 20 <223> OTHER
INFORMATION: /mod_base = "3'-3'-linked desoxythymidine" <400>
SEQUENCE: 360 ucuuaucaac acuuccggat 20 <210> SEQ ID NO 361
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: sense strand
of dsRNA <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1, 2, 3,
4, 5, 6, 7, 9, 10, 11, 14, 15, 17, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 8, 12, 13, 16 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 361 caccucugcc uaaucaucut t 21 <210> SEQ ID NO 362
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: sense strand
of dsRNA <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1, 2, 10,
11, 12, 13, 14, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-O-methyl corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 4, 5, 6, 7, 8, 9, 15, 16, 17 <223>
OTHER INFORMATION: /mod_base = "2'-hydroxy corresponding
nucleoside" <400> SEQUENCE: 362 auaagaggac ucuuggacut t 21
<210> SEQ ID NO 363 <211> LENGTH: 20 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2, 4, 6, 8, 10, 12, 14, 16, 18 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1, 3, 5, 7, 9, 11, 13, 15, 17,
19 <223> OTHER INFORMATION: /mod_base = "2'-deoxy-2'-fluoro
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 20 <223> OTHER
INFORMATION: /mod_base = "3'-3'-linked desoxythymidine" <400>
SEQUENCE: 363 gucugcggcg uuuuaucaat 20 <210> SEQ ID NO 364
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: sense strand
of dsRNA <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1, 2, 3,
5, 6, 10, 11, 12, 13, 15, 19 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
21 <223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 4, 7, 8, 9, 14, 16, 17, 18 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 364 ggcgcugaau cccgcggact t 21 <210>
SEQ ID NO 365 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 5, 6, 8, 15, 16, 17, 18 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 4, 7, 9, 10, 11, 12, 13, 14, 19 <223>
OTHER INFORMATION: /mod_base = "2'-hydroxy corresponding
nucleoside" <400> SEQUENCE: 365 cgcgucgcag aagaucucat t 21
<210> SEQ ID NO 366 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 5, 6, 9, 12, 13, 16, 17, 18, 19
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 4, 7, 8, 10, 11, 14, 15 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 366 aaugucaacg accgaccuut t 21 <210>
SEQ ID NO 367 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 7, 8, 9, 11, 12, 15, 17, 18
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 5, 6, 10, 13, 14, 16, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 367 gcucaguuua cuagugccat t 21 <210>
SEQ ID NO 368 <211> LENGTH: 20 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2, 4, 6, 8, 10, 12, 14, 16, 18 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1, 3, 5, 7, 9, 11, 13, 15, 17,
19 <223> OTHER INFORMATION: /mod_base = "2'-deoxy-2'-fluoro
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 20
<223> OTHER INFORMATION: /mod_base = "3'-3'-linked
desoxythymidine" <400> SEQUENCE: 368 ugguggacuu cucucaauat 20
<210> SEQ ID NO 369 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 5, 6, 8, 10, 11, 13 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 4, 7, 9, 12, 14, 15, 16, 17, 18, 19
<223> OTHER INFORMATION: /mod_base = "2'-hydroxy
corresponding nucleoside" <400> SEQUENCE: 369 aucgccgcgu
cgcagaagat t 21 <210> SEQ ID NO 370 <211> LENGTH: 21
<212> TYPE: DNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: sense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1, 2, 3, 5, 6, 7, 9, 10, 11,
14, 17, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-O-methyl corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 4, 8, 12, 13, 15, 16 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 370 gccauuuguu cagugguuct t 21 <210>
SEQ ID NO 371 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 4, 5, 6, 8, 10, 11, 13, 18, 19
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 7, 9, 12, 14, 15, 16, 17 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 371 cgauccauac ugcggaacut t 21 <210>
SEQ ID NO 372 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 4, 5, 6, 7, 8, 10, 11, 12, 15, 16, 18,
19 <223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 9, 13, 14, 17 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 372 ucaccucugc cuaaucauct t 21 <210>
SEQ ID NO 373 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 6, 7, 8, 9, 10, 11, 12, 13, 16, 17, 18,
19 <223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 4, 5, 14, 15 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 373 guggacuucu cucaauuuut t 21 <210>
SEQ ID NO 374 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 4, 5, 7, 8, 10, 12, 13, 14, 15, 16
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 6, 9, 11, 17, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 374 gggucaccau auucuugggt t 21 <210>
SEQ ID NO 375 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 5, 7, 8, 10, 17, 18, 19 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 4, 6, 9, 11, 12, 13, 14, 15, 16 <223>
OTHER INFORMATION: /mod_base = "2'-hydroxy corresponding
nucleoside" <400> SEQUENCE: 375 gccgcgucgc agaagaucut t
21
<210> SEQ ID NO 376 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 5, 6, 8, 9, 11, 13, 14, 16 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 4, 7, 10, 12, 15, 17, 18, 19 <223>
OTHER INFORMATION: /mod_base = "2'-hydroxy corresponding
nucleoside" <400> SEQUENCE: 376 ucaaucgccg cgucgcagat t 21
<210> SEQ ID NO 377 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 5, 7, 9, 10, 11, 13, 16, 18, 19
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 4, 6, 8, 12, 14, 15, 17 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 377 uggauguguc ugcggcguut t 21 <210>
SEQ ID NO 378 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 6, 7, 8, 12, 13, 14, 15, 16
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 5, 9, 10, 11, 17, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 378 uacuguucaa gccuccaagt t 21 <210>
SEQ ID NO 379 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 6, 7, 10, 12, 13, 15, 16, 17, 19
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 5, 8, 9, 11, 14, 18 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 379 guuuacuagu gccauuugut t 21 <210>
SEQ ID NO 380 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 6, 8, 9, 11, 12, 13, 15, 16, 17
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 4, 5, 7, 10, 14, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 380 acuagugcca uuuguucagt t 21 <210>
SEQ ID NO 381 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 4, 6, 7, 9, 16, 17, 18, 19 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 5, 8, 10, 11, 12, 13, 14, 15 <223>
OTHER INFORMATION: /mod_base = "2'-hydroxy corresponding
nucleoside" <400> SEQUENCE: 381 ccgcgucgca gaagaucuct t 21
<210> SEQ ID NO 382 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 6, 8, 9, 12, 14, 15, 16, 17,
18 <223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 7, 10, 11, 13, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 382 uaucuuauca acacuuccgt t 21 <210>
SEQ ID NO 383 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 9, 10, 11, 13, 16, 17, 18, 19
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 5, 6, 7, 8, 12, 14, 15 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 383 ggccaaaauu cgcaguccct t 21 <210>
SEQ ID NO 384 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 5, 6, 7, 8, 9, 11, 12, 13, 16, 17,
19 <223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 4, 10, 14, 15, 18 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 384 uucaccucug ccuaaucaut t 21 <210>
SEQ ID NO 385 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 6, 7, 8, 10, 11, 14, 16, 17, 19
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 4, 5, 9, 12, 13, 15, 18 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 385 cucaguuuac uagugccaut t 21 <210>
SEQ ID NO 386 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 6, 7, 8, 10, 11, 12, 14, 15, 16,
17, 18, 19 <223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 5, 9, 13 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 386 uguugcccgu uuguccucut t 21 <210> SEQ ID NO 387
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: sense strand
of dsRNA <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1, 2, 4,
6, 7, 9, 10, 11, 13, 14, 15, 18 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
21 <223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 5, 8, 12, 16, 17, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 387 uagugccauu uguucagugt t 21 <210>
SEQ ID NO 388 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 4, 5, 7, 11, 13, 17, 18 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 6, 8, 9, 10, 12, 14, 15, 16, 19
<223> OTHER INFORMATION: /mod_base = "2'-hydroxy
corresponding nucleoside" <400> SEQUENCE: 388 aggcuguagg
cauaaauugt t 21 <210> SEQ ID NO 389 <211> LENGTH: 21
<212> TYPE: DNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: sense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1, 2, 4, 6, 7, 8, 10, 13, 15,
16, 17, 18 <223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 5, 9, 11, 12, 14, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 389 augugucugc ggcguuuuat t 21 <210>
SEQ ID NO 390 <211> LENGTH: 20 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 2, 4, 6,
8, 10, 12, 14, 16, 18 <223> OTHER INFORMATION: /mod_base =
"2'-O-methyl corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1, 3, 5,
7, 9, 11, 13, 15, 17, 19 <223> OTHER INFORMATION: /mod_base =
"2'-deoxy-2'-fluoro corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 20
<223> OTHER INFORMATION: /mod_base = "3'-3'-linked
desoxythymidine" <400> SEQUENCE: 390 augugucugc ggcguuuuat 20
<210> SEQ ID NO 391 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 7, 8, 9, 10, 12, 13, 14, 15,
16, 18 <223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 6, 11, 17, 19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 391 acuucgcuuc accucugcat t 21 <210> SEQ ID NO 392
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: sense strand
of dsRNA <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1, 2, 3,
5, 7, 9, 10, 11, 12, 14, 15, 16, 17, 19 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 4, 6, 8, 13, 18
<223> OTHER INFORMATION: /mod_base = "2'-hydroxy
corresponding nucleoside" <400> SEQUENCE: 392 cgugugcacu
ucgcuucact t 21 <210> SEQ ID NO 393 <211> LENGTH: 21
<212> TYPE: DNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: sense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1, 2, 5, 9, 10, 11, 12, 13, 14,
15, 16, 19 <223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 4, 6, 7, 8, 17, 18 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 393 gugguggacu ucucucaaut t 21 <210>
SEQ ID NO 394 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 5, 6, 7, 9, 12, 14, 15, 16, 17, 19
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 4, 8, 10, 11, 13, 18 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 394 ugugucugcg gcguuuuaut t 21 <210>
SEQ ID NO 395 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 5, 7, 9, 10, 12, 13, 14, 16, 17, 18
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 4, 6, 8, 11, 15, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 395 aagguauguu gcccguuugt t 21 <210>
SEQ ID NO 396 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 5, 8, 9, 12, 13, 14, 15 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 4, 6, 7, 10, 11, 16, 17, 18, 19
<223> OTHER INFORMATION: /mod_base = "2'-hydroxy
corresponding nucleoside" <400> SEQUENCE: 396 ucaacgaccg
accuugaggt t 21 <210> SEQ ID NO 397 <211> LENGTH: 21
<212> TYPE: DNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: sense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base
<222> LOCATION: 1, 2, 3, 11, 12, 13, 14, 15, 19 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 4, 5, 6, 7, 8, 9, 10, 16, 17, 18 <223>
OTHER INFORMATION: /mod_base = "2'-hydroxy corresponding
nucleoside" <400> SEQUENCE: 397 cauaagagga cucuuggact t 21
<210> SEQ ID NO 398 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 6, 9, 10, 13, 14, 15, 16 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 4, 5, 7, 8, 11, 12, 17, 18, 19 <223>
OTHER INFORMATION: /mod_base = "2'-hydroxy corresponding
nucleoside" <400> SEQUENCE: 398 gucaacgacc gaccuugagt t 21
<210> SEQ ID NO 399 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 4, 5, 6, 7, 8, 14 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 3, 9, 10, 11, 12, 13,
15, 16, 17, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 399
auauucuugg gaacaagagt t 21 <210> SEQ ID NO 400 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1, 2, 3,
4, 5, 7, 9, 10, 12, 16 <223> OTHER INFORMATION: /mod_base =
"2'-O-methyl corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 6, 8, 11, 13, 14, 15, 17, 18, 19 <223>
OTHER INFORMATION: /mod_base = "2'-hydroxy corresponding
nucleoside" <400> SEQUENCE: 400 ugcucguguu acaggcgggt t 21
<210> SEQ ID NO 401 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 4, 5, 7, 8, 10, 12, 13, 15 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 6, 9, 11, 14, 16, 17, 18, 19 <223>
OTHER INFORMATION: /mod_base = "2'-hydroxy corresponding
nucleoside" <400> SEQUENCE: 401 caaucgccgc gucgcagaat t 21
<210> SEQ ID NO 402 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 5, 6, 7, 11, 12, 13, 14, 15, 19
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 4, 8, 9, 10, 16, 17, 18 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 402 acuguucaag ccuccaagct t 21 <210>
SEQ ID NO 403 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 6, 8, 9, 11, 18, 19 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 5, 7, 10, 12, 13, 14, 15, 16, 17 <223>
OTHER INFORMATION: /mod_base = "2'-hydroxy corresponding
nucleoside" <400> SEQUENCE: 403 cgccgcgucg cagaagauct t 21
<210> SEQ ID NO 404 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 7, 8, 9, 12, 15, 16, 17, 19
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 6, 10, 11, 13, 14, 18 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 404 cauuuguuca gugguucgut t 21 <210>
SEQ ID NO 405 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 8, 9, 10, 11, 13, 17 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 5, 6, 7, 12, 14, 15, 16, 18, 19 <223>
OTHER INFORMATION: /mod_base = "2'-hydroxy corresponding
nucleoside" <400> SEQUENCE: 405 cgcugaaucc cgcggacgat t 21
<210> SEQ ID NO 406 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 5, 6, 8, 9, 11, 13, 14, 15, 16, 17
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 4, 7, 10, 12, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 406 ugggucacca uauucuuggt t 21 <210>
SEQ ID NO 407 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 6, 8, 9, 12, 13, 14, 16, 18,
19 <223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 7, 10, 11, 15, 17 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 407 uccucugccg auccauacut t 21 <210>
SEQ ID NO 408 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 4, 5, 8, 11, 12, 15, 16, 17, 18
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 6, 7, 9, 10, 13, 14, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 408 augucaacga ccgaccuugt t 21 <210>
SEQ ID NO 409 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 7, 8, 9, 12, 13, 15, 16, 17,
18 <223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 6, 10, 11, 14, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 409 ccucugccua aucaucucat t 21 <210>
SEQ ID NO 410 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 5, 7, 9, 11, 12, 13, 14, 16, 17, 18,
19 <223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 4, 6, 8, 10, 15 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 410 accgugugca cuucgcuuct t 21 <210>
SEQ ID NO 411 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 7, 8, 9, 11, 13, 14, 16
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 5, 6, 10, 12, 15, 17, 18, 19 <223>
OTHER INFORMATION: /mod_base = "2'-hydroxy corresponding
nucleoside" <400> SEQUENCE: 411 ugccgaucca uacugcggat t 21
<210> SEQ ID NO 412 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 6, 7, 8, 12, 13, 14, 16, 19 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 4, 5, 9, 10, 11, 15, 17, 18 <223>
OTHER INFORMATION: /mod_base = "2'-hydroxy corresponding
nucleoside" <400> SEQUENCE: 412 cagagucuag acucguggut t 21
<210> SEQ ID NO 413 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 4, 5, 6, 10, 11, 12, 13, 14, 18, 19
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 7, 8, 9, 15, 16, 17 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 413 cuguucaagc cuccaagcut t 21 <210>
SEQ ID NO 414 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 6, 7, 9, 13, 15, 19 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 3, 4, 5, 8, 10, 11,
12, 14, 16, 17, 18 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 414
ggaggcugua ggcauaaaut t 21 <210> SEQ ID NO 415 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: sense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1, 2, 7,
8, 10, 14, 16 <223> OTHER INFORMATION: /mod_base =
"2'-O-methyl corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 4, 5, 6, 9, 11, 12, 13, 15, 17, 18, 19
<223> OTHER INFORMATION: /mod_base = "2'-hydroxy
corresponding nucleoside" <400> SEQUENCE: 415 aggaggcugu
aggcauaaat t 21 <210> SEQ ID NO 416 <211> LENGTH: 21
<212> TYPE: DNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: sense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1, 2, 3, 7, 8, 9, 10, 11, 12,
13, 14, 17, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-O-methyl corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 4, 5, 6, 15, 16 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 416 gguggacuuc ucucaauuut t 21 <210>
SEQ ID NO 417 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 5, 6, 7, 8, 9, 10, 11, 13, 14, 15, 16,
17, 19 <223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 4, 12, 18 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 417 gcaacuuuuu caccucugct t 21 <210> SEQ ID NO 418
<211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: sense strand
of dsRNA <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 2, 4, 6,
8, 10, 12, 14, 16, 18 <223> OTHER INFORMATION: /mod_base =
"2'-O-methyl corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1, 3, 5,
7, 9, 11, 13, 15, 17, 19 <223> OTHER INFORMATION: /mod_base =
"2'-deoxy-2'-fluoro corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 20
<223> OTHER INFORMATION: /mod_base = "3'-3'-linked
desoxythymidine" <400> SEQUENCE: 418 cugcucgugu uacaggcgat
20
<210> SEQ ID NO 419 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 5, 7, 8, 10, 11, 12, 14, 15, 16, 19
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 4, 6, 9, 13, 17, 18 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 419 cuagugccau uuguucagut t 21 <210>
SEQ ID NO 420 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 4, 5, 8, 9, 10, 12, 14, 15, 17
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 6, 7, 11, 13, 16, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 420 cugccgaucc auacugcggt t 21 <210>
SEQ ID NO 421 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 4, 6, 8, 9, 10, 11, 13, 14, 15, 16, 18,
19 <223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 5, 7, 12, 17 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 421 gugugcacuu cgcuucacct t 21 <210>
SEQ ID NO 422 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 6, 8, 9, 11, 15, 19 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 5, 7, 10, 12, 13, 14, 16, 17, 18 <223>
OTHER INFORMATION: /mod_base = "2'-hydroxy corresponding
nucleoside" <400> SEQUENCE: 422 gcucguguua caggcgggct t 21
<210> SEQ ID NO 423 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 5, 6, 7, 8, 10, 11, 14, 16, 17, 18,
19 <223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 4, 9, 12, 13, 15 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 423 ccuaucuuau caacacuuct t 21 <210>
SEQ ID NO 424 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 7, 8, 10, 11, 13, 15, 16, 18
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 5, 6, 9, 12, 14, 17, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 424 ucucaaucgc cgcgucgcat t 21 <210>
SEQ ID NO 425 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 6, 7, 8, 10, 12, 13, 14, 15, 16,
17, 18 <223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 5, 9, 11, 19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 425 gcccgucugu gccuucucat t 21 <210> SEQ ID NO 426
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: sense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1, 2, 4, 5, 6, 7, 9, 10, 13,
15, 16, 17, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-O-methyl corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 8, 11, 12, 14 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 426 cuaucuuauc aacacuucct t 21 <210>
SEQ ID NO 427 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 4, 5, 7, 8, 9, 11, 12, 13, 15, 16, 17,
18, 19 <223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 6, 10, 14 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 427 auguugcccg uuuguccuct t 21 <210> SEQ ID NO 428
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: sense strand
of dsRNA <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1, 2, 4,
6, 7, 9, 10, 11, 13, 14, 15, 17, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 3, 5, 8, 12, 16
<223> OTHER INFORMATION: /mod_base = "2'-hydroxy
corresponding nucleoside" <400> SEQUENCE: 428 guauguugcc
cguuugucct t 21 <210> SEQ ID NO 429 <211> LENGTH: 21
<212> TYPE: DNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: sense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1, 2, 3, 4, 6, 7, 8, 9, 11, 12,
13, 14, 15, 17, 19 <223> OTHER INFORMATION: /mod_base =
"2'-O-methyl corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 5, 10, 16, 18 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 429 cuucgcuuca ccucugcact t 21 <210> SEQ ID NO 430
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: sense strand
of dsRNA <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1, 2, 3,
5, 7, 8, 9, 10, 12, 13, 14, 15, 17, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 4, 6, 11, 16
<223> OTHER INFORMATION: /mod_base = "2'-hydroxy
corresponding nucleoside" <400> SEQUENCE: 430 ugugcacuuc
gcuucaccut t 21 <210> SEQ ID NO 431 <211> LENGTH: 21
<212> TYPE: DNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: sense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1, 2, 3, 8, 9, 10, 12, 15, 16,
17, 18 <223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 4, 5, 6, 7, 11, 13, 14, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 431 gccaaaauuc gcagucccgt t 21 <210>
SEQ ID NO 432 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 5, 6, 7, 9, 11, 12, 14, 18
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 4, 8, 10, 13, 15, 16, 17, 19 <223>
OTHER INFORMATION: /mod_base = "2'-hydroxy corresponding
nucleoside" <400> SEQUENCE: 432 ccugcucgug uuacaggcgt t 21
<210> SEQ ID NO 433 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1, 2, 6,
8, 12, 13, 14, 16, 18, 19 <223> OTHER INFORMATION: /mod_base
= "2'-O-methyl corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 4, 5, 7, 9, 10, 11, 15, 17 <223>
OTHER INFORMATION: /mod_base = "2'-hydroxy corresponding
nucleoside" <400> SEQUENCE: 433 uggagugugg auucgcacut t 21
<210> SEQ ID NO 434 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 6, 7, 10, 11, 12, 13, 18 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 4, 5, 8, 9, 14, 15, 16, 17, 19 <223>
OTHER INFORMATION: /mod_base = "2'-hydroxy corresponding
nucleoside" <400> SEQUENCE: 434 aacgaccgac cuugaggcat t 21
<210> SEQ ID NO 435 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 7, 8, 9, 13, 14, 15, 17 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 4, 5, 6, 10, 11, 12, 16, 18, 19
<223> OTHER INFORMATION: /mod_base = "2'-hydroxy
corresponding nucleoside" <400> SEQUENCE: 435 acagagucua
gacucguggt t 21 <210> SEQ ID NO 436 <211> LENGTH: 21
<212> TYPE: DNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: sense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1, 2, 3, 4, 6, 7, 9, 11, 12, 14
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 5, 8, 10, 13, 15, 16, 17, 18, 19 <223>
OTHER INFORMATION: /mod_base = "2'-hydroxy corresponding
nucleoside" <400> SEQUENCE: 436 aaucgccgcg ucgcagaagt t 21
<210> SEQ ID NO 437 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 5, 7, 8, 10, 11, 12, 14, 15, 16, 18,
19 <223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 4, 6, 9, 13, 17 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 437 gguauguugc ccguuuguct t 21 <210>
SEQ ID NO 438 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 6, 7, 8, 10, 12, 13, 15 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 4, 5, 9, 11, 14, 16, 17, 18, 19 <223>
OTHER INFORMATION: /mod_base = "2'-hydroxy corresponding
nucleoside" <400> SEQUENCE: 438 gccgauccau acugcggaat t 21
<210> SEQ ID NO 439 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 7, 8, 9, 10, 12, 13, 16, 18,
19 <223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 6, 11, 14, 15, 17 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 439 gcccuaucuu aucaacacut t 21 <210>
SEQ ID NO 440 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 7, 8, 11, 13, 14, 16, 17, 18
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 6, 9, 10, 12, 15, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 440 aguuuacuag ugccauuugt t 21 <210>
SEQ ID NO 441 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 7, 10, 11, 14, 15, 16, 17
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 5, 6, 8, 9, 12, 13, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 441 ugucaacgac cgaccuugat t 21 <210>
SEQ ID NO 442 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 6, 7, 8, 9, 12, 13, 14, 15,
16, 17 <223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 10, 11, 18, 19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 442 acuucucuca auuuucuagt t 21 <210> SEQ ID NO 443
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: sense strand
of dsRNA <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1, 2, 4,
9, 11, 12, 13, 14, 15, 16, 18, 19 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
21 <223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 5, 6, 7, 8, 10, 17 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 443 gcgcgggacg uccuuuguct t 21 <210>
SEQ ID NO 444 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 7, 8, 9, 11, 14, 18, 19 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 4, 5, 6, 10, 12, 13, 15, 16, 17 <223>
OTHER INFORMATION: /mod_base = "2'-hydroxy corresponding
nucleoside" <400> SEQUENCE: 444 ucuagacucg ugguggacut t 21
<210> SEQ ID NO 445 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 7, 9, 10, 12, 17, 18, 19
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 6, 8, 11, 13, 14, 15, 16 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 445 gauccauacu gcggaacuct t 21 <210>
SEQ ID NO 446 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 6, 7, 10, 11, 12, 14, 16, 17, 19
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 5, 8, 9, 13, 15, 18 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 446 cucugccgau ccauacugct t 21 <210>
SEQ ID NO 447 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 5, 6, 9, 10, 11, 13, 15, 16, 18
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 4, 7, 8, 12, 14, 17, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 447 ucugccgauc cauacugcgt t 21 <210>
SEQ ID NO 448 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 7, 8, 11, 12, 13, 15, 17, 18
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 6, 9, 10, 14, 16, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 448 ccucugccga uccauacugt t 21 <210>
SEQ ID NO 449 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 4, 5, 6, 7, 8, 9, 10, 11, 12, 14, 16,
19 <223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 13, 15, 17, 18 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 449 gcaccucucu uuacgcggut t 21 <210>
SEQ ID NO 450 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 6, 7, 8, 9, 10, 11, 12, 14, 15, 16, 17,
19 <223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 4, 5, 13, 18 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 450 aagaacuccc ucgccucgct t 21 <210>
SEQ ID NO 451 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 4, 5, 6, 7, 8, 9, 10, 12, 13, 14, 15,
17 <223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 11, 16, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 451 gaacucccuc gccucgcagt t 21 <210>
SEQ ID NO 452 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 6, 9, 10, 11, 12, 13, 14, 19
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 7, 8, 15, 16, 17, 18 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 452 ucucucaauu uucuagggct t 21 <210>
SEQ ID NO 453 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 4, 6, 8, 9, 10, 11, 12, 13, 14, 15, 16,
18 <223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 5, 7, 17, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 453 gggcgcaccu cucuuuacgt t 21 <210>
SEQ ID NO 454 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 5, 6, 7, 9, 11, 12, 14, 19 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 4, 8, 10, 13, 15, 16, 17, 18 <223>
OTHER INFORMATION: /mod_base = "2'-hydroxy corresponding
nucleoside" <400> SEQUENCE: 454 ccgauccaua cugcggaact t 21
<210> SEQ ID NO 455 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 6, 7, 8, 9, 11, 12, 13, 14, 16
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 10, 15, 17, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 455 aacucccucg ccucgcagat t 21 <210>
SEQ ID NO 456 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 6, 7, 9, 10, 13, 14, 15, 17,
19 <223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 8, 11, 12, 16, 18 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 456 cuccucugcc gauccauact t 21 <210>
SEQ ID NO 457 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 5, 7, 11, 12, 13, 15, 17, 18, 19
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 4, 6, 8, 9, 10, 14, 16 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 457 ggagugugga uucgcacuct t 21 <210>
SEQ ID NO 458 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 5, 7, 9, 10, 11, 12, 13, 14, 15, 16,
17, 19 <223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 4, 6, 8, 18 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 458 cgggcgcacc ucucuuuact t 21 <210> SEQ ID NO 459
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: sense strand
of dsRNA <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1, 2, 3,
4, 5, 8, 9, 11, 12, 14, 16, 17, 19 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
21 <223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 6, 7, 10, 13, 15, 18 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 459 gucucaaucg ccgcgucgct t 21 <210>
SEQ ID NO 460 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 6, 8, 9, 11, 16, 17, 18, 19
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 5, 7, 10, 12, 13, 14, 15 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 460 auccauacug cggaacucct t 21 <210>
SEQ ID NO 461 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 5, 6, 7, 8, 9, 10, 11, 12, 13, 15,
17 <223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 4, 14, 16, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 461 cgcaccucuc uuuacgcggt t 21
<210> SEQ ID NO 462 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 4, 7, 8, 11, 12, 13, 14, 19 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 5, 6, 9, 10, 15, 16, 17, 18 <223>
OTHER INFORMATION: /mod_base = "2'-hydroxy corresponding
nucleoside" <400> SEQUENCE: 462 caacgaccga ccuugaggct t 21
<210> SEQ ID NO 463 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 4, 6, 7, 9, 14, 15, 16, 17, 18
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 5, 8, 10, 11, 12, 13, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 463 ccauacugcg gaacuccuat t 21 <210>
SEQ ID NO 464 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 5, 6, 7, 8, 10, 14, 17, 18, 19
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 4, 9, 11, 12, 13, 15, 16 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 464 ugaaucccgc ggacgaccct t 21 <210>
SEQ ID NO 465 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 5, 6, 7, 8, 9, 10, 11, 13, 14, 15, 16,
18 <223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 4, 12, 17, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 465 agaacucccu cgccucgcat t 21 <210>
SEQ ID NO 466 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 5, 7, 8, 9, 10, 11, 12, 13, 14, 15,
17, 19 <223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 4, 6, 16, 18 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 466 ggcgcaccuc ucuuuacgct t 21 <210> SEQ ID NO 467
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: sense strand
of dsRNA <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1, 2, 4,
6, 7, 8, 9, 10, 11, 12, 13, 14, 16, 18 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 3, 5, 15, 17, 19
<223> OTHER INFORMATION: /mod_base = "2'-hydroxy
corresponding nucleoside" <400> SEQUENCE: 467 gcgcaccucu
cuuuacgcgt t 21 <210> SEQ ID NO 468 <211> LENGTH: 21
<212> TYPE: DNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: sense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1, 2, 3, 7, 8, 9, 10, 12, 16,
19 <223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 4, 5, 6, 11, 13, 14, 15, 17, 18 <223>
OTHER INFORMATION: /mod_base = "2'-hydroxy corresponding
nucleoside" <400> SEQUENCE: 468 gcugaauccc gcggacgact t 21
<210> SEQ ID NO 469 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220>
FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 6, 8, 9, 10, 11, 13, 14, 15,
16, 17, 19 <223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 7, 12, 18 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 469 cacuucgcuu caccucugct t 21 <210> SEQ ID NO 470
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: sense strand
of dsRNA <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1, 2, 3,
6, 7, 9, 10, 12, 14, 15, 17 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
21 <223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 4, 5, 8, 11, 13, 16, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 470 cucaaucgcc gcgucgcagt t 21 <210>
SEQ ID NO 471 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 6, 7, 10, 12, 13, 17, 18, 19
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 5, 8, 9, 11, 14, 15, 16 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 471 ucccgucggc gcugaaucct t 21 <210>
SEQ ID NO 472 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 6, 7, 8, 9, 11, 15, 18, 19 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 4, 5, 10, 12, 13, 14, 16, 17 <223>
OTHER INFORMATION: /mod_base = "2'-hydroxy corresponding
nucleoside" <400> SEQUENCE: 472 cugaaucccg cggacgacct t 21
<210> SEQ ID NO 473 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 5, 6, 7, 11, 12, 13, 15, 18 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 4, 8, 9, 10, 14, 16, 17, 19 <223>
OTHER INFORMATION: /mod_base = "2'-hydroxy corresponding
nucleoside" <400> SEQUENCE: 473 agagucuaga cucguggugt t 21
<210> SEQ ID NO 474 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 5, 7, 8, 10, 15, 16, 17, 18, 19
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 4, 6, 9, 11, 12, 13, 14 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 474 uccauacugc ggaacuccut t 21 <210>
SEQ ID NO 475 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 4, 5, 9, 10, 11, 12, 14, 18 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 6, 7, 8, 13, 15, 16, 17, 19 <223>
OTHER INFORMATION: /mod_base = "2'-hydroxy corresponding
nucleoside" <400> SEQUENCE: 475 gcgcugaauc ccgcggacgt t 21
<210> SEQ ID NO 476 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1, 2, 3,
5, 9, 10, 11, 13, 15, 16, 17, 18, 19 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
21 <223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 4, 6, 7, 8, 12, 14 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 476 aguguggauu cgcacuccut t 21 <210>
SEQ ID NO 477 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 6, 7, 8, 10, 12, 13, 15, 19
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 5, 9, 11, 14, 16, 17, 18 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 477 cccugcucgu guuacaggct t 21 <210>
SEQ ID NO 478 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 4, 5, 6, 7, 9, 13, 16, 17, 18
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 8, 10, 11, 12, 14, 15, 19 <223>
OTHER INFORMATION: /mod_base = "2'-hydroxy corresponding
nucleoside" <400> SEQUENCE: 478 gaaucccgcg gacgacccgt t 21
<210> SEQ ID NO 479 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 4, 5, 7, 9, 10, 11, 12, 16, 19
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 6, 8, 13, 14, 15, 17, 18 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 479 aagcugugcc uuggguggct t 21 <210>
SEQ ID NO 480 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 7, 8, 9, 11, 13, 14, 16
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 6, 10, 12, 15, 17, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 480 gcccugcucg uguuacaggt t 21 <210>
SEQ ID NO 481 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 7, 8, 11, 13, 14, 18, 19
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 6, 9, 10, 12, 15, 16, 17 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 481 gucccgucgg cgcugaauct t 21 <210>
SEQ ID NO 482 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 7, 8, 11, 13, 14, 15, 16, 17
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 6, 9, 10, 12, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 482 aucuuaucaa cacuuccggt t 21 <210>
SEQ ID NO 483 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 5, 6, 9, 11, 12, 13, 14, 15
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 4, 7, 8, 10, 16, 17, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 483 cuuaucaaca cuuccggaat t 21 <210>
SEQ ID NO 484 <211> LENGTH: 20 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2, 4, 6, 8, 10, 12, 14, 16, 18 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1, 3, 5, 7, 9, 11, 13, 15, 17,
19 <223> OTHER INFORMATION: /mod_base = "2'-deoxy-2'-fluoro
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 20 <223> OTHER
INFORMATION: /mod_base = "3'-3'-linked desoxythymidine" <400>
SEQUENCE: 484 cuuaucaaca cuuccggaat 20 <210> SEQ ID NO 485
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 8, 11, 13 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
21 <223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 6, 7, 9, 10, 12, 14, 15, 16,
17, 18, 19 <223> OTHER INFORMATION: /mod_base = "2'-hydroxy
corresponding nucleoside" <400> SEQUENCE: 485 aaacgggcaa
cauaccuugt t 21 <210> SEQ ID NO 486 <211> LENGTH: 21
<212> TYPE: DNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: antisense strand of dsRNA <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
3, 5, 7, 9, 11, 13, 15, 17, 19 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
2, 4, 6, 8, 10, 12, 14, 16, 18 <223> OTHER INFORMATION:
/mod_base = "2'-deoxy-2'-fluoro corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <400> SEQUENCE: 486
taccaauuua ugccuacagt t 21 <210> SEQ ID NO 487 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1, 6, 16
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2, 3, 4, 5, 7, 8, 9, 10, 11, 12, 13, 14, 15,
17, 18, 19 <223> OTHER INFORMATION: /mod_base = "2'-hydroxy
corresponding nucleoside" <400> SEQUENCE: 487 uaugauaaaa
cgccgcagat t 21 <210> SEQ ID NO 488 <211> LENGTH: 21
<212> TYPE: DNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: antisense strand of dsRNA <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
3, 5, 7, 9, 11, 13, 15, 17, 19 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
2, 4, 6, 8, 10, 12, 14, 16, 18 <223> OTHER INFORMATION:
/mod_base = "2'-deoxy-2'-fluoro corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <400> SEQUENCE: 488
taugauaaaa cgccgcagat t 21 <210> SEQ ID NO 489 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 9, 13
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 6, 7, 8, 10, 11, 12, 14, 15,
16, 17, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 489
gagaugauua ggcagaggut t 21 <210> SEQ ID NO 490 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 5, 7, 9, 11, 13, 15, 17, 19 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 2, 4, 6, 8, 10, 12, 14, 16, 18
<223> OTHER INFORMATION: /mod_base = "2'-deoxy-2'-fluoro
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<400> SEQUENCE: 490 tacaaauggc acuaguaaat t 21 <210>
SEQ ID NO 491 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: antisense strand of dsRNA <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
3, 5, 7, 9, 11, 13, 15, 17, 19 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
2, 4, 6, 8, 10, 12, 14, 16, 18 <223> OTHER INFORMATION:
/mod_base = "2'-deoxy-2'-fluoro corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <400> SEQUENCE: 491
tagaugauua ggcagaggut t 21 <210> SEQ ID NO 492 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 4, 9, 15,
17 <223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 5, 6, 7, 8, 10, 11, 12, 13, 14, 16,
18, 19 <223> OTHER INFORMATION: /mod_base = "2'-hydroxy
corresponding nucleoside" <400> SEQUENCE: 492 gaccaauuua
ugccuacagt t 21 <210> SEQ ID NO 493 <211> LENGTH: 21
<212> TYPE: DNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: antisense strand of dsRNA <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
1 <223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 4, 14, 18 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 5, 6, 7, 8,
9, 10, 11, 12, 13, 15, 16, 17, 19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 493 ugauaaaacg ccgcagacat t 21 <210> SEQ ID NO 494
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 3, 5, 7, 9, 11, 13, 15, 17, 19
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 2, 4, 6, 8, 10, 12,
14, 16, 18 <223> OTHER INFORMATION: /mod_base =
"2'-deoxy-2'-fluoro corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <400> SEQUENCE: 494 tgauaaaacg ccgcagacat t 21
<210> SEQ ID NO 495 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 5, 12, 15, 18 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 4, 6, 7, 8,
9, 10, 11, 13, 14, 16, 17, 19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 495 ugaacaaaug gcacuaguat t 21 <210> SEQ ID NO 496
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 3, 5, 7, 9, 11, 13, 15, 17, 19
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 2, 4, 6, 8, 10, 12,
14, 16, 18 <223> OTHER INFORMATION: /mod_base =
"2'-deoxy-2'-fluoro corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <400> SEQUENCE: 496 tgaacaaaug gcacuaguat t 21
<210> SEQ ID NO 497 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 3, 5, 7,
9, 11, 13, 15, 17, 19 <223> OTHER INFORMATION: /mod_base =
"2'-O-methyl corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 2, 4, 6,
8, 10, 12, 14, 16, 18 <223> OTHER INFORMATION: /mod_base =
"2'-deoxy-2'-fluoro corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <400> SEQUENCE: 497 tgcagaggug aaaaaguugt t 21
<210> SEQ ID NO 498 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 6, 13 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 4, 5, 7, 8,
9, 10, 11, 12, 14, 15, 16, 17, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 498 cgaaccacug aacaaauggt t 21
<210> SEQ ID NO 499 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 6, 9, 13 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 4, 5, 7, 8,
10, 11, 12, 14, 15, 16, 17, 18, 19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 499 ugcgucagca aacacuuggt t 21 <210> SEQ ID NO 500
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 3, 5, 7, 9, 11, 13, 15, 17, 19
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 2, 4, 6, 8, 10, 12,
14, 16, 18 <223> OTHER INFORMATION: /mod_base =
"2'-deoxy-2'-fluoro corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <400> SEQUENCE: 500 tgcgucagca aacacuuggt t 21
<210> SEQ ID NO 501 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 3, 5, 7,
9, 11, 13, 15, 17, 19 <223> OTHER INFORMATION: /mod_base =
"2'-O-methyl corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 2, 4, 6,
8, 10, 12, 14, 16, 18 <223> OTHER INFORMATION: /mod_base =
"2'-deoxy-2'-fluoro corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <400> SEQUENCE: 501 tgaaccacug aacaaauggt t 21
<210> SEQ ID NO 502 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 3, 10, 13, 16 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 4, 5, 6, 7, 8,
9, 11, 12, 14, 15, 17, 18, 19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 502 aacaaauggc acuaguaaat t 21 <210> SEQ ID NO 503
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 3, 5, 7, 9, 11, 13, 15, 17, 19
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 2, 4, 6, 8, 10, 12,
14, 16, 18 <223> OTHER INFORMATION: /mod_base =
"2'-deoxy-2'-fluoro corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <400> SEQUENCE: 503 tgaugauuag gcagaggugt t 21
<210> SEQ ID NO 504 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1, 4, 7, 17 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 2, 3, 5, 6, 8, 9, 10,
11, 12, 13, 14, 15, 16, 18, 19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 504 cacuaguaaa cugagccagt t 21 <210> SEQ ID NO 505
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 3, 5, 7, 9, 11, 13, 15, 17, 19
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 2, 4, 6, 8, 10, 12,
14, 16, 18 <223> OTHER INFORMATION: /mod_base =
"2'-deoxy-2'-fluoro corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <400> SEQUENCE: 505 taacgggcaa cauaccuugt t 21
<210> SEQ ID NO 506 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 3, 5, 7,
9, 11, 13, 15, 17, 19 <223> OTHER INFORMATION: /mod_base =
"2'-O-methyl corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 2, 4, 6,
8, 10, 12, 14, 16, 18 <223> OTHER INFORMATION: /mod_base =
"2'-deoxy-2'-fluoro corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <400> SEQUENCE: 506 tacuaguaaa cugagccagt t 21
<210> SEQ ID NO 507 <211> LENGTH: 21
<212> TYPE: DNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: antisense strand of dsRNA <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
1 <223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 5, 11, 13 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 4, 6, 7, 8,
9, 10, 12, 14, 15, 16, 17, 18, 19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 507 aauuuaugcc uacagccuct t 21 <210> SEQ ID NO 508
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 7, 10, 13 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
21 <223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 6, 8, 9, 11, 12, 14, 15, 16,
17, 18, 19 <223> OTHER INFORMATION: /mod_base = "2'-hydroxy
corresponding nucleoside" <400> SEQUENCE: 508 aaauggcacu
aguaaacugt t 21 <210> SEQ ID NO 509 <211> LENGTH: 21
<212> TYPE: DNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: antisense strand of dsRNA <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
1 <223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 2, 10, 13, 15 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 3, 4, 5, 6, 7, 8,
9, 11, 12, 14, 16, 17, 18, 19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 509 acaaacgggc aacauaccut t 21 <210> SEQ ID NO 510
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 3, 5, 7, 9, 11, 13, 15, 17, 19
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 2, 4, 6, 8, 10, 12,
14, 16, 18 <223> OTHER INFORMATION: /mod_base =
"2'-deoxy-2'-fluoro corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <400> SEQUENCE: 510 tggacaaacg ggcaacauat t 21
<210> SEQ ID NO 511 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 3, 5, 7,
9, 11, 13, 15, 17, 19 <223> OTHER INFORMATION: /mod_base =
"2'-O-methyl corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 2, 4, 6,
8, 10, 12, 14, 16, 18 <223> OTHER INFORMATION: /mod_base =
"2'-deoxy-2'-fluoro corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <400> SEQUENCE: 511 tauuuaugcc uacagccuct t 21
<210> SEQ ID NO 512 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 5, 15 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 4, 6, 7, 8,
9, 10, 11, 12, 13, 14, 16, 17, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 512 augauaaaac gccgcagact t 21 <210>
SEQ ID NO 513 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 3 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 4, 5, 6, 7, 8,
9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 513 ggcagaggug aaaaaguugt t 21 <210>
SEQ ID NO 514 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 13, 15 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 14,
16, 17, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 514
ugaagcgaag ugcacacggt t 21 <210> SEQ ID NO 515 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 5, 7, 9, 11, 13, 15, 17, 19 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 2, 4, 6, 8, 10, 12, 14, 16, 18
<223> OTHER INFORMATION: /mod_base = "2'-deoxy-2'-fluoro
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<400> SEQUENCE: 515 tgaagcgaag ugcacacggt t 21 <210>
SEQ ID NO 516 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 3, 5, 7,
9, 11, 13, 15, 17, 19 <223> OTHER INFORMATION: /mod_base =
"2'-O-methyl corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 2, 4, 6,
8, 10, 12, 14, 16, 18 <223> OTHER INFORMATION: /mod_base =
"2'-deoxy-2'-fluoro corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <400> SEQUENCE: 516 tacgggcaac auaccuugat t 21
<210> SEQ ID NO 517 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 3, 5, 7,
9, 11, 13, 15, 17, 19 <223> OTHER INFORMATION: /mod_base =
"2'-O-methyl corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 2, 4, 6,
8, 10, 12, 14, 16, 18 <223> OTHER INFORMATION: /mod_base =
"2'-deoxy-2'-fluoro corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <400> SEQUENCE: 517 taauggcacu aguaaacugt t 21
<210> SEQ ID NO 518 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 15, 18 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 4, 5, 6, 7,
8, 9, 10, 11, 12, 13, 14, 16, 17, 19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 518 aauugagaga aguccaccat t 21 <210> SEQ ID NO 519
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 3, 5, 7, 9, 11, 13, 15, 17, 19
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 2, 4, 6, 8, 10, 12,
14, 16, 18 <223> OTHER INFORMATION: /mod_base =
"2'-deoxy-2'-fluoro corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <400> SEQUENCE: 519 tcaaacgggc aacauaccut t 21
<210> SEQ ID NO 520 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 8, 11, 17 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 4, 5, 6, 7,
9, 10, 12, 13, 14, 15, 16, 18, 19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 520 ccgccuguaa cacgagcagt t 21 <210> SEQ ID NO 521
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 5, 13, 16, 18 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
21 <223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 6, 7, 8, 9, 10, 11, 12, 14, 15,
17, 19 <223> OTHER INFORMATION: /mod_base = "2'-hydroxy
corresponding nucleoside" <400> SEQUENCE: 521 aggacaaacg
ggcaacauat t 21 <210> SEQ ID NO 522 <211> LENGTH: 21
<212> TYPE: DNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: antisense strand of dsRNA <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
1 <223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 7, 10, 12 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
21 <223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 6, 8, 9, 11, 13, 14, 15, 16,
17, 18, 19 <223> OTHER INFORMATION: /mod_base = "2'-hydroxy
corresponding nucleoside" <400> SEQUENCE: 522 aacgggcaac
auaccuugat t 21 <210> SEQ ID NO 523 <211> LENGTH: 21
<212> TYPE: DNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: antisense strand of dsRNA <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
1 <223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 15 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 4, 5, 6, 7,
8, 9, 10, 11, 12, 13, 14, 16, 17, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 523 uccggaagug uugauaagat t 21 <210>
SEQ ID NO 524 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 3, 5, 7,
9, 11, 13, 15, 17, 19 <223> OTHER INFORMATION: /mod_base =
"2'-O-methyl corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 2, 4, 6,
8, 10, 12, 14, 16, 18 <223> OTHER INFORMATION: /mod_base =
"2'-deoxy-2'-fluoro corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <400> SEQUENCE: 524 tccggaagug uugauaagat t 21
<210> SEQ ID NO 525 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 8, 12 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 4, 5, 6, 7,
9, 10, 11, 13, 14, 15, 16, 17, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 525 agaugauuag gcagaggugt t 21 <210>
SEQ ID NO 526 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 5, 17 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 4, 6, 7, 8,
9, 10, 11, 12, 13, 14, 15, 16, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 526 aguccaagag uccucuuaut t 21 <210>
SEQ ID NO 527 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 3, 5, 7,
9, 11, 13, 15, 17, 19 <223> OTHER INFORMATION: /mod_base =
"2'-O-methyl corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 2, 4, 6,
8, 10, 12, 14, 16, 18 <223> OTHER INFORMATION: /mod_base =
"2'-deoxy-2'-fluoro corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <400> SEQUENCE: 527 tugauaaaac gccgcagact t 21
<210> SEQ ID NO 528 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 13 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 4, 5, 6, 7,
8, 9, 10, 11, 12, 14, 15, 16, 17, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 528 guccgcggga uucagcgcct t 21 <210>
SEQ ID NO 529 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1..19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 529 ugagaucuuc ugcgacgcgt t 21
<210> SEQ ID NO 530 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 16 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 4, 5, 6, 7,
8, 9, 10, 11, 12, 13, 14, 15, 17, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 530 aaggucgguc guugacauut t 21 <210>
SEQ ID NO 531 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 4, 7, 10 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 5, 6, 8, 9,
11, 12, 13, 14, 15, 16, 17, 18, 19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 531 uggcacuagu aaacugagct t 21 <210> SEQ ID NO 532
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 3, 5, 7, 9, 11, 13, 15, 17, 19
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 2, 4, 6, 8, 10, 12,
14, 16, 18 <223> OTHER INFORMATION: /mod_base =
"2'-deoxy-2'-fluoro corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <400> SEQUENCE: 532 tauugagaga aguccaccat t 21
<210> SEQ ID NO 533 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1..19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 533 ucuucugcga cgcggcgaut t 21 <210> SEQ ID NO 534
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 5, 12 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
21 <223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 6, 7, 8, 9, 10, 11, 13, 14, 15,
16, 17, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 534
gaaccacuga acaaauggct t 21 <210> SEQ ID NO 535 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 8, 11
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 6, 7, 9, 10, 12, 13, 14, 15,
16, 17, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 535
aguuccgcag uauggaucgt t 21 <210> SEQ ID NO 536 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 7, 11
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 6, 8, 9, 10, 12, 13, 14, 15,
16, 17, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 536
gaugauuagg cagaggugat t 21 <210> SEQ ID NO 537 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate
group" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 17 <223> OTHER INFORMATION: /mod_base =
"2'-O-methyl corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13,
14, 15, 16, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 537
aaaauugaga gaaguccact t 21 <210> SEQ ID NO 538 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 3, 9
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 4, 5, 6, 7, 8, 10, 11, 12, 13, 14, 15,
16, 17, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 538
cccaagaaua uggugaccct t 21 <210> SEQ ID NO 539 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1..19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 539 agaucuucug cgacgcggct t 21 <210> SEQ ID NO 540
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1..19 <223>
OTHER INFORMATION: /mod_base = "2'-hydroxy corresponding
nucleoside" <400> SEQUENCE: 540 ucugcgacgc ggcgauugat t 21
<210> SEQ ID NO 541 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 8, 12, 14, 18 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 4, 5, 6, 7,
9, 10, 11, 13, 15, 16, 17, 19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 541 aacgccgcag acacauccat t 21 <210> SEQ ID NO 542
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 15, 18 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
21 <223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13,
14, 16, 17, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 542
cuuggaggcu ugaacaguat t 21 <210> SEQ ID NO 543 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 2, 9, 12,
15 <223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 3, 4, 5, 6, 7, 8, 10, 11, 13, 14, 16, 17,
18, 19 <223> OTHER INFORMATION: /mod_base = "2'-hydroxy
corresponding nucleoside" <400> SEQUENCE: 543 acaaauggca
cuaguaaact t 21 <210> SEQ ID NO 544 <211> LENGTH: 21
<212> TYPE: DNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: antisense strand of dsRNA <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
1 <223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 6, 13, 16 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 4, 5, 7, 8,
9, 10, 11, 12, 14, 15, 17, 18, 19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 544 cugaacaaau ggcacuagut t 21 <210>
SEQ ID NO 545 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1..19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 545 gagaucuucu gcgacgcggt t 21 <210> SEQ ID NO 546
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 13, 18 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
21 <223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 14,
15, 16, 17, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 546
cggaaguguu gauaagauat t 21 <210> SEQ ID NO 547 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1..19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 547 gggacugcga auuuuggcct t 21 <210> SEQ ID NO 548
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 6, 10 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
21 <223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 7, 8, 9, 11, 12, 13, 14, 15,
16, 17, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 548
augauuaggc agaggugaat t 21 <210> SEQ ID NO 549 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 5, 8, 11
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 6, 7, 9, 10, 12, 13, 14, 15, 16,
17, 18, 19 <223> OTHER INFORMATION: /mod_base = "2'-hydroxy
corresponding nucleoside" <400> SEQUENCE: 549 auggcacuag
uaaacugagt t 21 <210> SEQ ID NO 550 <211> LENGTH: 21
<212> TYPE: DNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: antisense strand of dsRNA <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
1 <223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 7, 15, 18 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 4, 5, 6, 8,
9, 10, 11, 12, 13, 14, 16, 17, 19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 550 agaggacaaa cgggcaacat t 21 <210> SEQ ID NO 551
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 8, 15, 18 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
21 <223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2, 3, 4, 5, 6, 7, 9, 10, 11, 12, 13, 14, 16,
17, 19 <223> OTHER INFORMATION: /mod_base = "2'-hydroxy
corresponding nucleoside" <400> SEQUENCE: 551 cacugaacaa
auggcacuat t 21 <210> SEQ ID NO 552 <211> LENGTH: 21
<212> TYPE: DNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: antisense strand of dsRNA <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
1 <223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1, 6, 12, 14 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 2, 3, 4, 5, 7, 8, 9,
10, 11, 13, 15, 16, 17, 18, 19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 552 caauuuaugc cuacagccut t 21 <210> SEQ ID NO 553
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 11, 15, 17 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
21 <223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2, 3, 4, 5, 6, 7, 8, 9, 10, 12, 13, 14, 16,
18, 19 <223> OTHER INFORMATION: /mod_base = "2'-hydroxy
corresponding nucleoside" <400> SEQUENCE: 553 uaaaacgccg
cagacacaut t 21 <210> SEQ ID NO 554 <211> LENGTH: 21
<212> TYPE: DNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: antisense strand of dsRNA <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
3, 5, 7, 9, 11, 13, 15, 17, 19 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
2, 4, 6, 8, 10, 12, 14, 16, 18 <223> OTHER INFORMATION:
/mod_base = "2'-deoxy-2'-fluoro corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <400> SEQUENCE: 554
taaaacgccg cagacacaut t 21 <210> SEQ ID NO 555 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 3
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14,
15, 16, 17, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 555
ugcagaggug aagcgaagut t 21 <210> SEQ ID NO 556 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 14, 16
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13,
15, 17, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 556
gugaagcgaa gugcacacgt t 21 <210> SEQ ID NO 557 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 14, 17
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13,
15, 16, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 557
auugagagaa guccaccact t 21 <210> SEQ ID NO 558 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 2, 12,
16, 18 <223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 3, 4, 5, 6, 7, 8, 9, 10, 11, 13, 14, 15,
17, 19 <223> OTHER INFORMATION: /mod_base = "2'-hydroxy
corresponding nucleoside" <400> SEQUENCE: 558 auaaaacgcc
gcagacacat t 21 <210> SEQ ID NO 559 <211> LENGTH: 21
<212> TYPE: DNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: antisense strand of dsRNA <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
1 <223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1, 9, 12, 14 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2, 3, 4, 5, 6, 7, 8, 10, 11, 13, 15, 16, 17,
18, 19 <223> OTHER INFORMATION: /mod_base = "2'-hydroxy
corresponding nucleoside" <400> SEQUENCE: 559 caaacgggca
acauaccuut t 21 <210> SEQ ID NO 560 <211> LENGTH: 21
<212> TYPE: DNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: antisense strand of dsRNA <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
1 <223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 4 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 5, 6, 7, 8,
9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 560 ccucaagguc ggucguugat t 21 <210>
SEQ ID NO 561 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 4, 16 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 5, 6, 7, 8,
9, 10, 11, 12, 13, 14, 15, 17, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 561 guccaagagu ccucuuaugt t 21 <210>
SEQ ID NO 562 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 3 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 4, 5, 6, 7, 8,
9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 562 cucaaggucg gucguugact t 21 <210>
SEQ ID NO 563 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 11, 17 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 4, 5, 6, 7,
8, 9, 10, 12, 13, 14, 15, 16, 18, 19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 563 cucuuguucc caagaauaut t 21 <210> SEQ ID NO 564
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 9, 12, 18 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
21 <223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 6, 7, 8, 10, 11, 13, 14, 15,
16, 17, 19 <223> OTHER INFORMATION: /mod_base = "2'-hydroxy
corresponding nucleoside" <400> SEQUENCE: 564 cccgccugua
acacgagcat t 21 <210> SEQ ID NO 565 <211> LENGTH: 21
<212> TYPE: DNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: antisense strand of dsRNA <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
1 <223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1..19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 565 uucugcgacg cggcgauugt t 21 <210> SEQ ID NO 566
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 16 <223> OTHER INFORMATION: /mod_base =
"2'-O-methyl corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13,
14, 15, 17, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 566
gcuuggaggc uugaacagut t 21 <210> SEQ ID NO 567 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1..19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 567 gaucuucugc gacgcggcgt t 21 <210> SEQ ID NO 568
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 7, 14 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
21 <223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 6, 8, 9, 10, 11, 12, 13, 15,
16, 17, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 568
acgaaccacu gaacaaaugt t 21 <210> SEQ ID NO 569 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 15
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13,
14, 16, 17, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 569
ucguccgcgg gauucagcgt t 21 <210> SEQ ID NO 570 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 2, 8, 18
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 3, 4, 5, 6, 7, 9, 10, 11, 12, 13, 14, 15,
16, 17, 19 <223> OTHER INFORMATION: /mod_base = "2'-hydroxy
corresponding nucleoside" <400> SEQUENCE: 570 ccaagaauau
ggugacccat t 21 <210> SEQ ID NO 571 <211> LENGTH: 21
<212> TYPE: DNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: antisense strand of dsRNA <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
1 <223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 3, 13 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 4, 5, 6, 7, 8,
9, 10, 11, 12, 14, 15, 16, 17, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 571 aguauggauc ggcagaggat t 21 <210>
SEQ ID NO 572 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1, 17 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 2, 3, 4, 5, 6, 7, 8,
9, 10, 11, 12, 13, 14, 15, 16, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 572 caaggucggu cguugacaut t 21 <210>
SEQ ID NO 573 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 10, 14 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 4, 5, 6, 7,
8, 9, 11, 12, 13, 15, 16, 17, 18, 19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 573 ugagaugauu aggcagaggt t 21 <210> SEQ ID NO 574
<211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 12, 14 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 4, 5, 6, 7,
8, 9, 10, 11, 13, 15, 16, 17, 18, 19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 574 gaagcgaagu gcacacggut t 21 <210> SEQ ID NO 575
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 5, 8, 18 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
21 <223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 6, 7, 9, 10, 11, 12, 13, 14, 15,
16, 17, 19 <223> OTHER INFORMATION: /mod_base = "2'-hydroxy
corresponding nucleoside" <400> SEQUENCE: 575 uccgcaguau
ggaucggcat t 21 <210> SEQ ID NO 576 <211> LENGTH: 21
<212> TYPE: DNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: antisense strand of dsRNA <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
1 <223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 3, 11 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 4, 5, 6, 7, 8,
9, 10, 12, 13, 14, 15, 16, 17, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 576 accacgaguc uagacucugt t 21 <210>
SEQ ID NO 577 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 17 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 4, 5, 6, 7,
8, 9, 10, 11, 12, 13, 14, 15, 16, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 577 agcuuggagg cuugaacagt t 21 <210>
SEQ ID NO 578 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 4, 10, 12 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 5, 6, 7, 8,
9, 11, 13, 14, 15, 16, 17, 18, 19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 578 auuuaugccu acagccucct t 21 <210> SEQ ID NO 579
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 9, 11 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
21 <223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 4, 5, 6, 7, 8, 10, 12, 13, 14, 15, 16,
17, 18, 19 <223> OTHER INFORMATION: /mod_base = "2'-hydroxy
corresponding nucleoside" <400> SEQUENCE: 579 uuuaugccua
cagccuccut t 21 <210> SEQ ID NO 580 <211> LENGTH: 21
<212> TYPE: DNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: antisense strand of dsRNA <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
1 <223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 16 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 4, 5, 6, 7,
8, 9, 10, 11, 12, 13, 14, 15, 17, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 580 aaauugagag aaguccacct t 21 <210>
SEQ ID NO 581 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 2 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 3, 4, 5, 6, 7, 8,
9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 581 gcagagguga aaaaguugct t 21 <210>
SEQ ID NO 582 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 3, 5, 7,
9, 11, 13, 15, 17, 19 <223> OTHER INFORMATION: /mod_base =
"2'-O-methyl corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 2, 4, 6,
8, 10, 12, 14, 16, 18 <223> OTHER INFORMATION: /mod_base =
"2'-deoxy-2'-fluoro corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <400> SEQUENCE: 582 tcgccuguaa cacgagcagt t 21
<210> SEQ ID NO 583 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 7, 14, 17 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 4, 5, 6, 8,
9, 10, 11, 12, 13, 15, 16, 18, 19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 583 acugaacaaa uggcacuagt t 21 <210> SEQ ID NO 584
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 4, 7, 17 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
21 <223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 5, 6, 8, 9, 10, 11, 12, 13, 14, 15,
16, 18, 19 <223> OTHER INFORMATION: /mod_base = "2'-hydroxy
corresponding nucleoside" <400> SEQUENCE: 584 ccgcaguaug
gaucggcagt t 21 <210> SEQ ID NO 585 <211> LENGTH: 21
<212> TYPE: DNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: antisense strand of dsRNA <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
1 <223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 15, 17 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 4, 5, 6, 7,
8, 9, 10, 11, 12, 13, 14, 16, 18, 19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 585 ggugaagcga agugcacact t 21 <210> SEQ ID NO 586
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 10, 13 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
21 <223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 6, 7, 8, 9, 11, 12, 14, 15,
16, 17, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 586
gcccgccugu aacacgagct t 21 <210> SEQ ID NO 587 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 11, 16
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12, 13, 14,
15, 17, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 587
gaaguguuga uaagauaggt t 21 <210> SEQ ID NO 588 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1..19 <223>
OTHER INFORMATION: /mod_base = "2'-hydroxy corresponding
nucleoside" <400> SEQUENCE: 588 ugcgacgcgg cgauugagat t 21
<210> SEQ ID NO 589 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 9, 11 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 4, 5, 6, 7,
8, 10, 12, 13, 14, 15, 16, 17, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 589 ugagaaggca cagacgggct t 21 <210>
SEQ ID NO 590 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 12, 17 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 4, 5, 6, 7,
8, 9, 10, 11, 13, 14, 15, 16, 18, 19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 590 ggaaguguug auaagauagt t 21 <210> SEQ ID NO 591
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 6, 14, 17 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
21 <223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 7, 8, 9, 10, 11, 12, 13, 15,
16, 18, 19 <223> OTHER INFORMATION: /mod_base = "2'-hydroxy
corresponding nucleoside" <400> SEQUENCE: 591 gaggacaaac
gggcaacaut t 21 <210> SEQ ID NO 592 <211> LENGTH: 21
<212> TYPE: DNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: antisense strand of dsRNA <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
1 <223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 4, 12, 15, 17 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 5, 6, 7, 8,
9, 10, 11, 13, 14, 16, 18, 19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 592 ggacaaacgg gcaacauact t 21 <210> SEQ ID NO 593
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 4 <223> OTHER INFORMATION: /mod_base =
"2'-O-methyl corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14,
15, 16, 17, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 593
gugcagaggu gaagcgaagt t 21 <210> SEQ ID NO 594 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 16, 18
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13,
14, 15, 17, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 594
aggugaagcg aagugcacat t 21 <210> SEQ ID NO 595 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1..19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding
nucleoside" <400> SEQUENCE: 595 cgggacugcg aauuuuggct t 21
<210> SEQ ID NO 596 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 7, 10, 16 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 4, 5, 6, 8,
9, 11, 12, 13, 14, 15, 17, 18, 19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 596 cgccuguaac acgagcaggt t 21 <210> SEQ ID NO 597
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 11, 13, 18 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
21 <223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12, 14, 15,
16, 17, 19 <223> OTHER INFORMATION: /mod_base = "2'-hydroxy
corresponding nucleoside" <400> SEQUENCE: 597 agugcgaauc
cacacuccat t 21 <210> SEQ ID NO 598 <211> LENGTH: 21
<212> TYPE: DNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: antisense strand of dsRNA <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
1 <223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 6 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 4, 5, 7, 8,
9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 598 ugccucaagg ucggucguut t 21 <210>
SEQ ID NO 599 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 2, 10 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 3, 4, 5, 6, 7, 8,
9, 11, 12, 13, 14, 15, 16, 17, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 599 ccacgagucu agacucugut t 21 <210>
SEQ ID NO 600 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1..19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 600 cuucugcgac gcggcgauut t 21 <210> SEQ ID NO 601
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 11, 14, 16 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
21 <223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 4, 5, 6, 7, 8, 9, 10, 12, 13, 15, 17,
18, 19 <223> OTHER INFORMATION: /mod_base = "2'-hydroxy
corresponding nucleoside" <400> SEQUENCE: 601 gacaaacggg
caacauacct t 21 <210> SEQ ID NO 602 <211> LENGTH: 21
<212> TYPE: DNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: antisense strand of dsRNA <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
1 <223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 6, 9 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 4, 5, 7, 8,
10, 11, 12, 13, 14, 15, 16, 17, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 602 uuccgcagua uggaucggct t 21 <210>
SEQ ID NO 603 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 9, 14 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 4, 5, 6, 7,
8, 10, 11, 12, 13, 15, 16, 17, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 603 aguguugaua agauagggct t 21 <210>
SEQ ID NO 604 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1, 8, 11, 14 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 2, 3, 4, 5, 6, 7, 9,
10, 12, 13, 15, 16, 17, 18, 19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 604 caaauggcac uaguaaacut t 21 <210> SEQ ID NO 605
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2, 18 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
21 <223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14,
15, 16, 17, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 605
ucaaggucgg ucguugacat t 21 <210> SEQ ID NO 606 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 2
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14,
15, 16, 17, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 606
cuagaaaauu gagagaagut t 21 <210> SEQ ID NO 607 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 3
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14,
15, 16, 17, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 607
gacaaaggac gucccgcgct t 21 <210> SEQ ID NO 608 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 5, 8, 16
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 6, 7, 9, 10, 11, 12, 13, 14, 15,
17, 18, 19 <223> OTHER INFORMATION: /mod_base = "2'-hydroxy
corresponding nucleoside" <400> SEQUENCE: 608 aguccaccac
gagucuagat t 21 <210> SEQ ID NO 609 <211> LENGTH: 21
<212> TYPE: DNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: antisense strand of dsRNA <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
1 <223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 9, 12 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 4, 5, 6, 7,
8, 10, 11, 13, 14, 15, 16, 17, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 609 gaguuccgca guauggauct t 21 <210>
SEQ ID NO 610 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 2, 5, 15 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 3, 4, 6, 7, 8, 9,
10, 11, 12, 13, 14, 16, 17, 18, 19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 610 gcaguaugga ucggcagagt t 21 <210> SEQ ID NO 611
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 6, 16 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
21 <223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 4, 5, 7, 8, 9, 10, 11, 12, 13, 14, 15,
17, 18, 19 <223> OTHER INFORMATION: /mod_base = "2'-hydroxy
corresponding nucleoside" <400> SEQUENCE: 611 cgcaguaugg
aucggcagat t 21 <210> SEQ ID NO 612 <211> LENGTH: 21
<212> TYPE: DNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: antisense strand of dsRNA <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
1 <223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1, 4, 14 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 2, 3, 5, 6, 7, 8, 9,
10, 11, 12, 13, 15, 16, 17, 18, 19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 612 caguauggau cggcagaggt t 21 <210> SEQ ID NO 613
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 7 <223> OTHER INFORMATION: /mod_base =
"2'-O-methyl corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 6, 8, 9, 10, 11, 12, 13, 14,
15, 16, 17, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 613
accgcguaaa gagaggugct t 21 <210> SEQ ID NO 614 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1..19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 614 gcgaggcgag ggaguucuut t 21 <210> SEQ ID NO 615
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1..19 <223>
OTHER INFORMATION: /mod_base = "2'-hydroxy corresponding
nucleoside" <400> SEQUENCE: 615 cugcgaggcg agggaguuct t 21
<210> SEQ ID NO 616 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 5 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 4, 6, 7, 8,
9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 616 gcccuagaaa auugagagat t 21 <210>
SEQ ID NO 617 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 3 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14,
15, 16, 17, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 617
cguaaagaga ggugcgccct t 21 <210> SEQ ID NO 618 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 7, 10
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 6, 8, 9, 11, 12, 13, 14, 15,
16, 17, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 618
guuccgcagu auggaucggt t 21 <210> SEQ ID NO 619 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1..19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 619 ucugcgaggc gagggaguut t 21 <210> SEQ ID NO 620
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2, 12 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
21 <223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 3, 4, 5, 6, 7, 8, 9, 10, 11, 13, 14, 15,
16, 17, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 620
guauggaucg gcagaggagt t 21 <210> SEQ ID NO 621 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 12, 14
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 13, 15,
16, 17, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 621
gagugcgaau ccacacucct t 21 <210> SEQ ID NO 622 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 2
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14,
15, 16, 17, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 622
guaaagagag gugcgcccgt t 21 <210> SEQ ID NO 623 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1..19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 623 gcgacgcggc gauugagact t 21 <210> SEQ ID NO 624
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 10, 13 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
21 <223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 6, 7, 8, 9, 11, 12, 14, 15,
16, 17, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 624
ggaguuccgc aguauggaut t 21
<210> SEQ ID NO 625 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 6 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 4, 5, 7, 8,
9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 625 ccgcguaaag agaggugcgt t 21 <210>
SEQ ID NO 626 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 5 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 4, 6, 7, 8,
9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 626 gccucaaggu cggucguugt t 21 <210>
SEQ ID NO 627 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1, 12, 15 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 2, 3, 4, 5, 6, 7, 8,
9, 10, 11, 13, 14, 16, 17, 18, 19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 627 uaggaguucc gcaguauggt t 21 <210> SEQ ID NO 628
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 18 <223> OTHER INFORMATION: /mod_base =
"2'-O-methyl corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13,
14, 15, 16, 17, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 628
gggucguccg cgggauucat t 21 <210> SEQ ID NO 629 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1..19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 629 ugcgaggcga gggaguucut t 21 <210> SEQ ID NO 630
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 4 <223> OTHER INFORMATION: /mod_base =
"2'-O-methyl corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14,
15, 16, 17, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 630
gcguaaagag aggugcgcct t 21 <210> SEQ ID NO 631 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 5
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 6, 7, 8, 9, 10, 11, 12, 13, 14,
15, 16, 17, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 631
cgcguaaaga gaggugcgct t 21 <210> SEQ ID NO 632 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 16 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 4, 5, 6, 7,
8, 9, 10, 11, 12, 13, 14, 15, 17, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 632 gucguccgcg ggauucagct t 21 <210>
SEQ ID NO 633 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 2 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 3, 4, 5, 6, 7, 8,
9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<400> SEQUENCE: 633 gcagagguga agcgaagugt t 21 <210>
SEQ ID NO 634 <211> LENGTH: 21 <212> TYPE: DNA
<213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1
<223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1..19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 634 cugcgacgcg gcgauugagt t 21 <210> SEQ ID NO 635
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 6 <223> OTHER INFORMATION: /mod_base =
"2'-O-methyl corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 7, 8, 9, 10, 11, 12, 13, 14,
15, 16, 17, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 635
ggauucagcg ccgacgggat t 21 <210> SEQ ID NO 636 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 17
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13,
14, 15, 16, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 636
ggucguccgc gggauucagt t 21 <210> SEQ ID NO 637 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1, 4, 12
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 2, 3, 5, 6, 7, 8, 9, 10, 11, 13, 14, 15, 16,
17, 18, 19 <223> OTHER INFORMATION: /mod_base = "2'-hydroxy
corresponding nucleoside" <400> SEQUENCE: 637 caccacgagu
cuagacucut t 21 <210> SEQ ID NO 638 <211> LENGTH: 21
<212> TYPE: DNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: antisense strand of dsRNA <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
1 <223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 11, 14 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 4, 5, 6, 7,
8, 9, 10, 12, 13, 15, 16, 17, 18, 19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 638 aggaguuccg caguauggat t 21 <210> SEQ ID NO 639
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate
group" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 14 <223> OTHER INFORMATION: /mod_base =
"2'-O-methyl corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13,
15, 16, 17, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 639
cguccgcggg auucagcgct t 21 <210> SEQ ID NO 640 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 14, 16
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13,
15, 17, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 640
aggagugcga auccacacut t 21 <210> SEQ ID NO 641 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 6, 9, 15
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 7, 8, 10, 11, 12, 13, 14, 16,
17, 18, 19 <223> OTHER INFORMATION: /mod_base = "2'-hydroxy
corresponding nucleoside" <400> SEQUENCE: 641 gccuguaaca
cgagcagggt t 21 <210> SEQ ID NO 642 <211> LENGTH: 21
<212> TYPE: DNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: antisense strand of dsRNA <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
1 <223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1..19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 642 cgggucgucc gcgggauuct t 21 <210> SEQ ID NO 643
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 7, 12, 14 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
21 <223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 4, 5, 6, 8, 9, 10, 11, 13, 15, 16, 17,
18, 19 <223> OTHER INFORMATION: /mod_base = "2'-hydroxy
corresponding nucleoside" <400> SEQUENCE: 643 gccacccaag
gcacagcuut t 21 <210> SEQ ID NO 644 <211> LENGTH: 21
<212> TYPE: DNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: antisense strand of dsRNA <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
1 <223> OTHER INFORMATION: /mod_base = "nucleoside: lacks
5'-phosphate group" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 5, 8, 14 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 21 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate thymidine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 1, 2, 3, 4, 6, 7, 9,
10, 11, 12, 13, 15, 16, 17, 18, 19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <400>
SEQUENCE: 644 ccuguaacac gagcagggct t 21 <210> SEQ ID NO 645
<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 1 <223> OTHER
INFORMATION: /mod_base = "nucleoside: lacks 5'-phosphate group"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 5 <223> OTHER INFORMATION: /mod_base =
"2'-O-methyl corresponding nucleoside" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 21
<223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 6, 7, 8, 9, 10, 11, 12, 13, 14,
15, 16, 17, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 645
gauucagcgc cgacgggact t 21 <210> SEQ ID NO 646 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 14
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13,
15, 16, 17, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 646
ccggaagugu ugauaagaut t 21 <210> SEQ ID NO 647 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1 <223> OTHER INFORMATION: /mod_base =
"nucleoside: lacks 5'-phosphate group" <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 16
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13,
14, 15, 17, 18, 19 <223> OTHER INFORMATION: /mod_base =
"2'-hydroxy corresponding nucleoside" <400> SEQUENCE: 647
uuccggaagu guugauaagt t 21 <210> SEQ ID NO 648 <211>
LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial
sequence <220> FEATURE: <223> OTHER INFORMATION:
Description of the artificial sequence: antisense strand of dsRNA
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 3, 5, 7, 9, 11, 13, 15, 17, 19 <223>
OTHER INFORMATION: /mod_base = "2'-O-methyl corresponding
nucleoside" <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 2, 4, 6, 8, 10, 12, 14, 16, 18
<223> OTHER INFORMATION: /mod_base = "2'-deoxy-2'-fluoro
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate thymidine"
<400> SEQUENCE: 648 tuccggaagu guugauaagt t 21 <210>
SEQ ID NO 649 <211> LENGTH: 17 <212> TYPE: RNA
<213> ORGANISM: Hepatitis B virus <400> SEQUENCE: 649
aagguauguu gcccguu 17 <210> SEQ ID NO 650 <211> LENGTH:
17 <212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 650 cugcggcguu uuaucau 17 <210> SEQ ID
NO 651 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 651 ccucugccua
aucaucu 17 <210> SEQ ID NO 652 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 652 uguaggcaua aauuggu 17 <210> SEQ ID
NO 653 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 653 gucugcggcg
uuuuauc 17 <210> SEQ ID NO 654 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 654 acuagugcca uuuguuc 17 <210> SEQ ID
NO 655 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 655 cauuuguuca
gugguuc 17 <210> SEQ ID NO 656 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 656 caaguguuug cugacgc 17 <210> SEQ ID
NO 657 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 657 uuacuagugc
cauuugu 17 <210> SEQ ID NO 658 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 658 uggcucaguu uacuagu 17 <210> SEQ ID
NO 659 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 659 aggcuguagg
cauaaau 17 <210> SEQ ID NO 660 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 660 aguuuacuag ugccauu 17 <210> SEQ ID
NO 661 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 661 gguauguugc
ccguuug 17 <210> SEQ ID NO 662 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 662 ucugcggcgu uuuauca 17 <210> SEQ ID
NO 663 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 663 aacuuuuuca
ccucugc 17 <210> SEQ ID NO 664 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 664 cgugugcacu ucgcuuc 17 <210> SEQ ID
NO 665 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 665 gguggacuuc
ucucaau 17 <210> SEQ ID NO 666 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 666 ugcucguguu acaggcg 17 <210> SEQ ID
NO 667 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 667 auguugcccg
uuugucc 17 <210> SEQ ID NO 668 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 668 caagguaugu ugcccgu 17 <210> SEQ ID
NO 669 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 669 cuuaucaaca
cuuccgg 17 <210> SEQ ID NO 670 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 670 accucugccu aaucauc 17 <210> SEQ ID
NO 671 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 671 uaagaggacu
cuuggac 17 <210> SEQ ID NO 672 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 672 gcgcugaauc ccgcgga 17 <210> SEQ ID
NO 673 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 673 gcgucgcaga
agaucuc 17 <210> SEQ ID NO 674 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 674 augucaacga ccgaccu 17 <210> SEQ ID
NO 675 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 675 cucaguuuac
uagugcc 17 <210> SEQ ID NO 676 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 676 ucgccgcguc gcagaag 17 <210> SEQ ID
NO 677 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 677 ccauuuguuc
agugguu 17 <210> SEQ ID NO 678 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 678 gauccauacu gcggaac 17 <210> SEQ ID
NO 679 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 679 caccucugcc
uaaucau 17 <210> SEQ ID NO 680 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 680 uggacuucuc ucaauuu 17 <210> SEQ ID
NO 681 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 681 ggucaccaua
uucuugg 17 <210> SEQ ID NO 682 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 682 ccgcgucgca gaagauc 17 <210> SEQ ID
NO 683 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 683 caaucgccgc
gucgcag 17 <210> SEQ ID NO 684 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 684 ggaugugucu gcggcgu 17 <210> SEQ ID
NO 685 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 685 acuguucaag
ccuccaa 17 <210> SEQ ID NO 686 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 686 uuuacuagug ccauuug 17 <210> SEQ ID
NO 687 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 687 cuagugccau
uuguuca 17 <210> SEQ ID NO 688 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 688 cgcgucgcag aagaucu 17 <210> SEQ ID
NO 689 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 689 aucuuaucaa
cacuucc 17 <210> SEQ ID NO 690 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 690 gccaaaauuc gcagucc 17 <210> SEQ ID
NO 691 <211> LENGTH: 17 <212> TYPE: RNA
<213> ORGANISM: Hepatitis B virus <400> SEQUENCE: 691
ucaccucugc cuaauca 17 <210> SEQ ID NO 692 <211> LENGTH:
17 <212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 692 ucaguuuacu agugcca 17 <210> SEQ ID
NO 693 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 693 guugcccguu
uguccuc 17 <210> SEQ ID NO 694 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 694 agugccauuu guucagu 17 <210> SEQ ID
NO 695 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 695 ggcuguaggc
auaaauu 17 <210> SEQ ID NO 696 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 696 ugugucugcg gcguuuu 17 <210> SEQ ID
NO 697 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 697 cuucgcuuca
ccucugc 17 <210> SEQ ID NO 698 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 698 gugugcacuu cgcuuca 17 <210> SEQ ID
NO 699 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 699 ugguggacuu
cucucaa 17 <210> SEQ ID NO 700 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 700 gugucugcgg cguuuua 17 <210> SEQ ID
NO 701 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 701 agguauguug
cccguuu 17 <210> SEQ ID NO 702 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 702 caacgaccga ccuugag 17 <210> SEQ ID
NO 703 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 703 auaagaggac
ucuugga 17 <210> SEQ ID NO 704 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 704 ucaacgaccg accuuga 17 <210> SEQ ID
NO 705 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 705 uauucuuggg
aacaaga 17 <210> SEQ ID NO 706 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 706 gcucguguua caggcgg 17 <210> SEQ ID
NO 707 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 707 aaucgccgcg
ucgcaga 17 <210> SEQ ID NO 708 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 708 cuguucaagc cuccaag 17 <210> SEQ ID
NO 709 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 709 gccgcgucgc
agaagau 17 <210> SEQ ID NO 710 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 710 auuuguucag ugguucg 17 <210> SEQ ID
NO 711 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 711 gcugaauccc
gcggacg 17 <210> SEQ ID NO 712 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 712 gggucaccau auucuug 17 <210> SEQ ID
NO 713 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 713 ccucugccga
uccauac 17 <210> SEQ ID NO 714 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 714 ugucaacgac cgaccuu 17 <210> SEQ ID
NO 715 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 715 cucugccuaa
ucaucuc 17 <210> SEQ ID NO 716 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 716 ccgugugcac uucgcuu 17 <210> SEQ ID
NO 717 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 717 gccgauccau
acugcgg 17 <210> SEQ ID NO 718 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 718 agagucuaga cucgugg 17 <210> SEQ ID
NO 719 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 719 uguucaagcc
uccaagc 17 <210> SEQ ID NO 720 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 720 gaggcuguag gcauaaa 17 <210> SEQ ID
NO 721 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 721 ggaggcugua
ggcauaa 17 <210> SEQ ID NO 722 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 722 guggacuucu cucaauu 17 <210> SEQ ID
NO 723 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 723 caacuuuuuc
accucug 17 <210> SEQ ID NO 724 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 724 uagugccauu uguucag 17 <210> SEQ ID
NO 725 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 725 ugccgaucca
uacugcg 17 <210> SEQ ID NO 726 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 726 ugugcacuuc gcuucac 17 <210> SEQ ID
NO 727 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 727 cucguguuac
aggcggg 17 <210> SEQ ID NO 728 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 728 cuaucuuauc aacacuu 17 <210> SEQ ID
NO 729 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 729 cucaaucgcc
gcgucgc 17 <210> SEQ ID NO 730 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 730 cccgucugug ccuucuc 17 <210> SEQ ID
NO 731 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 731 uaucuuauca
acacuuc 17 <210> SEQ ID NO 732 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 732 uguugcccgu uuguccu 17 <210> SEQ ID
NO 733 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 733 uauguugccc
guuuguc 17 <210> SEQ ID NO 734 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 734 uucgcuucac cucugca 17 <210> SEQ ID
NO 735 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 735 gugcacuucg
cuucacc 17 <210> SEQ ID NO 736 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 736 ccaaaauucg caguccc 17 <210> SEQ ID
NO 737 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 737 cugcucgugu
uacaggc 17 <210> SEQ ID NO 738 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 738 ggagugugga uucgcac 17 <210> SEQ ID
NO 739 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 739 acgaccgacc
uugaggc 17 <210> SEQ ID NO 740 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 740 cagagucuag acucgug 17 <210> SEQ ID
NO 741 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus
<400> SEQUENCE: 741 aucgccgcgu cgcagaa 17 <210> SEQ ID
NO 742 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 742 guauguugcc
cguuugu 17 <210> SEQ ID NO 743 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 743 ccgauccaua cugcgga 17 <210> SEQ ID
NO 744 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 744
cccuaucuuaucaacac 17 <210> SEQ ID NO 745 <211> LENGTH:
17 <212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 745 guuuacuagu gccauuu 17 <210> SEQ ID
NO 746 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 746 gucaacgacc
gaccuug 17 <210> SEQ ID NO 747 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 747 cuucucucaa uuuucua 17 <210> SEQ ID
NO 748 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 748 cgcgggacgu
ccuuugu 17 <210> SEQ ID NO 749 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 749 cuagacucgu gguggac 17 <210> SEQ ID
NO 750 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 750
auccauacugcggaacu 17 <210> SEQ ID NO 751 <211> LENGTH:
17 <212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 751 ucugccgauc cauacug 17 <210> SEQ ID
NO 752 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 752
cugccgauccauacugc 17 <210> SEQ ID NO 753 <211> LENGTH:
17 <212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 753 cucugccgau ccauacu 17 <210> SEQ ID
NO 754 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 754 caccucucuu
uacgcgg 17 <210> SEQ ID NO 755 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 755 agaacucccu cgccucg 17 <210> SEQ ID
NO 756 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 756 aacucccucg
ccucgca 17 <210> SEQ ID NO 757 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 757 cucucaauuu ucuaggg 17 <210> SEQ ID
NO 758 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 758 ggcgcaccuc
ucuuuac 17 <210> SEQ ID NO 759 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 759 cgauccauac ugcggaa 17 <210> SEQ ID
NO 760 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 760 acucccucgc
cucgcag 17 <210> SEQ ID NO 761 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 761 uccucugccg auccaua 17 <210> SEQ ID
NO 762 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 762 gaguguggau
ucgcacu 17 <210> SEQ ID NO 763 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 763 gggcgcaccu cucuuua 17 <210> SEQ ID
NO 764 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 764 ucucaaucgc
cgcgucg 17 <210> SEQ ID NO 765 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 765 uccauacugc ggaacuc 17 <210> SEQ ID
NO 766 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 766
gcaccucucu uuacgcg 17 <210> SEQ ID NO 767 <211> LENGTH:
17 <212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 767 aacgaccgac cuugagg 17 <210> SEQ ID
NO 768 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 768 cauacugcgg
aacuccu 17 <210> SEQ ID NO 769 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 769 gaaucccgcg gacgacc 17 <210> SEQ ID
NO 770 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 770 gaacucccuc
gccucgc 17 <210> SEQ ID NO 771 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 771 gcgcaccucu cuuuacg 17 <210> SEQ ID
NO 772 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 772 cgcaccucuc
uuuacgc 17 <210> SEQ ID NO 773 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 773 cugaaucccg cggacga 17 <210> SEQ ID
NO 774 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 774 acuucgcuuc
accucug 17 <210> SEQ ID NO 775 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 775 ucaaucgccg cgucgca 17 <210> SEQ ID
NO 776 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 776 cccgucggcg
cugaauc 17 <210> SEQ ID NO 777 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 777 ugaaucccgc ggacgac 17 <210> SEQ ID
NO 778 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 778 gagucuagac
ucguggu 17 <210> SEQ ID NO 779 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 779 ccauacugcg gaacucc 17 <210> SEQ ID
NO 780 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 780 cgcugaaucc
cgcggac 17 <210> SEQ ID NO 781 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 781 guguggauuc gcacucc 17 <210> SEQ ID
NO 782 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 782 ccugcucgug
uuacagg 17 <210> SEQ ID NO 783 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 783 aaucccgcgg acgaccc 17 <210> SEQ ID
NO 784 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 784 agcugugccu
ugggugg 17 <210> SEQ ID NO 785 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 785 cccugcucgu guuacag 17 <210> SEQ ID
NO 786 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 786 ucccgucggc
gcugaau 17 <210> SEQ ID NO 787 <211> LENGTH: 17
<212> TYPE: RNA <213> ORGANISM: Hepatitis B virus
<400> SEQUENCE: 787 ucuuaucaac acuuccg 17 <210> SEQ ID
NO 788 <211> LENGTH: 17 <212> TYPE: RNA <213>
ORGANISM: Hepatitis B virus <400> SEQUENCE: 788 uuaucaacac
uuccgga 17 <210> SEQ ID NO 789 <211> LENGTH: 21
<212> TYPE: DNA <213> ORGANISM: Artificial sequence
<220> FEATURE: <223> OTHER INFORMATION: Description of
the artificial sequence: sense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1, 2, 3,
5, 7, 8, 12, 14, 15, 16, 17 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
4, 5, 9, 10, 11, 13, 18, 19 <223> OTHER INFORMATION:
/mod_base = "2'-hydroxy corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
21 <223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <400> SEQUENCE: 789 cuuacgcuga guacuucgat t 21
<210> SEQ ID NO 790 <211> LENGTH: 21 <212> TYPE:
DNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: antisense strand of dsRNA <220> FEATURE:
<221> NAME/KEY: modified_base <222> LOCATION: 1, 2, 3,
4, 5, 6, 8, 9, 10, 12, 13, 14, 15, 17, 18, 19 <223> OTHER
INFORMATION: /mod_base = "2'-hydroxy corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 7, 11, 16 <223> OTHER INFORMATION:
/mod_base = "2'-O-methyl corresponding nucleoside" <220>
FEATURE: <221> NAME/KEY: modified_base <222> LOCATION:
21 <223> OTHER INFORMATION: /mod_base = "5'-phosphorothioate
thymidine" <400> SEQUENCE: 790 ucgaaguacu cagcguaagt t 21
<210> SEQ ID NO 791 <211> LENGTH: 21 <212> TYPE:
RNA <213> ORGANISM: Artificial sequence <220> FEATURE:
<223> OTHER INFORMATION: Description of the artificial
sequence: sense strand of dsRNA <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 2, 4, 6, 11, 14, 20
<223> OTHER INFORMATION: /mod_base = "2'-O-methyl
corresponding nucleoside" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 21 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate uridine" <400>
SEQUENCE: 791 ccacaugaag cagcacgacu u 21 <210> SEQ ID NO 792
<211> LENGTH: 23 <212> TYPE: RNA <213> ORGANISM:
Artificial sequence <220> FEATURE: <223> OTHER
INFORMATION: Description of the artificial sequence: antisense
strand of dsRNA <220> FEATURE: <221> NAME/KEY:
modified_base <222> LOCATION: 21, 22 <223> OTHER
INFORMATION: /mod_base = "2'-O-methyl corresponding nucleoside"
<220> FEATURE: <221> NAME/KEY: modified_base
<222> LOCATION: 22 <223> OTHER INFORMATION: /mod_base =
"5'-phosphorothioate uridine" <220> FEATURE: <221>
NAME/KEY: modified_base <222> LOCATION: 23 <223> OTHER
INFORMATION: /mod_base = "5'-phosphorothioate cytidine" <400>
SEQUENCE: 792 aagucgugcu gcuucaugug guc 23
* * * * *
References